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Abstract
Despite a few exceptional examples, our understanding of neural circuit
computation remains limited. A full understanding of a given computa-
tional circuit requires knowledge of the function of the individual compo-
nents and a wiring diagram. The brain is composed of extremely complex
cellular networks, consisting of numerous cell-types - some of which likely
remain unknown - connected by orders of magnitude more synapses. Our
understanding is largely shrouded by our lack of tools for probing neuronal
circuits with high-throughput. Therefore, we have developed methods of
encoding information about neuronal circuits into DNA, a biologically rel-
evant high-density storage medium. Advances in high-throughput DNA
sequencing may enable the dissection of neural circuits with unprecedented
depth.
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1Introduction
Heterogeneity is a defining feature of biological systems – from populations of bacterial
cells to complex tissues such as the brain. A complete understanding of complex biolog-
ical systems will require simultaneous high-throughput measurements across multiple
scales. For example, the brain is composed of several dozen cell types connected by or-
ders of magnitude more synapses. Deconstruction of a neural circuit, therefore, would
minimally require measurements of connectivity between all of the cells in the circuit as
well as their individual transcription profiles. The advent of high-throughput sequenc-
ing has provided researchers with access to data streams of unprecedented scale. By
re-encoding information about individual cells and their interactions within a network
into deoxyribonucleic acids (DNA), high-throughput sequencing can be harnessed to
probe the dynamics of complex biological networks.
A surprising amount of evidence exists to suggest that individual cells, even when
derived from apparently homogenous sources, exhibit a wide range of characteristics.
This heterogeneity amongst cells has a profound implication on the overall function of
the system. For example, bacterial populations exploit pre-established heterogeneity to
survive during periods of atypical stress due to the presence of antibiotics and/or lack of
available nutrients [Ryall et al. 2012]. Cells which make up tissues of higher organisms,
despite their concordant function, have also been shown to consist of a heterogenous
population of cells. This is perhaps most striking in the brain, where several dozen cell
types interact to endow an animal with abstract functions such as perception, thought,
and behavior. Neuroscientists seek cellular and circuit explanations of these complex
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traits. For example, what are the roles of individual cell-types, and their pattern of
connectivity, in computing the confidence of a decision?
Circuit level explanations of computation and behavior represent the gold standard.
However, the circuit architectures that underlie these complex computations are mostly
unknown. This is largely because of a lack of high-throughput methods for mapping
neural connectivity at single neuron resolution. We have established a method and a
suite of molecular components for achieving this goal that relies on DNA Barcoding
of Individual Neuronal Connections (BOINC), which can subsequently be read out by
standard high-throughput sequencing techniques [Zador et al. 2012].
1.1 The importance of single-neuron connectivity
Connectivity can be studied at different spatial scales. Conventional neuroanatomical
methods probe the connectivity between brain regions. Such analysis reveals, for exam-
ple, that the retina is connected to the visual thalamus, which in turn is connected to
the visual cortex. The importance of mesoscopic connectivity in the mammalian brain
is uncontroversial – different brain areas represent different kinds of information and
have clearly distinct functions, so it is easy to see how knowing the connections among
areas at the mesoscopic level will be useful. There are currently several major efforts to
describe systematically the mesoscopic-scale connectivity of the mouse, macaque, and
human brain [Bohland et al. 2009, Oh et al. 2014].
Mesoscopic connectivity represents the natural anatomical complement to conven-
tional physiological approaches, such as extracellular recording, for studying how pop-
ulations of neurons encode information and control behavior. However, such physio-
logical approaches tend to obscure the identity and heterogeneity of the neurons under
study. From the point of view of conventional extracellular recording, neurons within
a brain area (e.g., visual area MT) differ only by their responses to sensory inputs and
other external variables. Indeed, in physiological studies neurons are often referred
to as interchangeable units; differences among nearby neurons are often attributed to
random variation. Such assumptions are often incorporated into theoretical models,
in which it is often assumed that cortical wiring is random, and therefore, only the
statistical properties of neural connections, such as the average number of inputs per
2
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neuron, need be specified [Hill et al. 2012, Koulakov et al. 2009, Shadlen and Newsome
1998].
In the absence of data about the relationship between the function of a neuron, its
cell type, and its position within the local circuit, a description of connectivity at the
mesoscopic level may seem sufficient. However, the circuits in Figure 1.1 illustrate how
connectivity beyond the mesoscopic – at the level of synaptic contacts between pairs of
individual neurons – can also be useful. In the motion detection circuit in Figure 1.1A,
sequential activation of input neurons from left to right (1, 4, 7, 10) will generate less
activity in the output neuron (0) than activation from right to left (10, 7, 4, 1). The
lateral inhibition circuit in Figure 1.1B is wired similarly, but the addition of a few
extra inhibitory connections renders it insensitive to directional motion.
Figure 1.1: The wiring of neural circuits is highly structured - Two similar circuits
in which the computation is readily deduced from the wiring. Circuit (a) is directionally
selective, whereas (b) performs a center-surround computation. Red cells are inhibitory
and blue cells are excitatory.
These simple examples reveal how detailed information about cell-types and connec-
tivity can provide immediate insight into the computations a circuit performs and can
generate hypotheses that can be tested physiologically. In practice, most computations
are not understood at this level of precision. In part the reason is simply that de-
tailed circuit information is largely unavailable. Indeed, the complete wiring diagram,
or “connectome”, is known for only a single nervous system, that of the tiny worm C.
elegans, with 302 neurons connected by about 7,000 synapses [Varshney et al. 2011,
White et al. 1986]. Interestingly, the utility of the connectome in C. elegans is some-
what limited because function is highly multiplexed, with different neurons performing
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different roles depending on the state of neuromodulation [Bargmann 2012], possibly as
a mechanism for compensating for the small number of neurons. Mammalian circuits
contain orders of magnitude more neurons than C. elegans. Although neuromodulation
is important in mammalian circuits – and should be measured in addition to wiring
(see chapter 4), the need to multiplex function may not be as severe as in C. elegans,
which may render the relationship between circuitry and function more transparent.
In mammals there is ample evidence that the connectivity of a neuron correlates
with its function. For example, whether a neuron in primary visual cortex is simple or
complex is correlated with cell layer; cell layer is in turn a surrogate for connectivity.
Even more striking is the finding that neurons in primary visual cortex that project
to the motion-sensitive area MT represent a homogenous population whose motion
sensitivity is more similar to that of neurons in MT than to other V1 neurons [Movshon
and Newsome 1996]. Observations such as these reinforce the notion that connectivity
predicts function.
1.2 Current approaches to the connectome
There are currently two main approaches to determining single cell connectivity. The
first is based on physiology. This approach can be quite powerful and has yielded tan-
talizing evidence of the precise nature of the connectivity of cortical circuits. In one
series of experiments, Callaway and colleagues used laser scanning photostimulation to
probe connectivity in visual cortex [Yoshimura and Callaway 2005]. They found that
if two nearby neurons in layer 2/3 are connected, then they share input from single
neurons in layer 4, but if they are not connected they do not share input. Thus, the
input from layer 4 to layer 2/3 appears to consist of at least two independent subnet-
works, which happen to overlap in space. In a different set of experiments, Chklovskii
and colleagues [Song et al. 2005] used whole cell methods to assess connectivity among
triplets of neurons. By enumerating all 16 possible ways that three neurons can be
connected, they discovered that several connectivity motifs were overrepresented above
the chance levels predicted by the pairwise connection probabilities. Thus connectivity
among triplets of cortical neurons deviates markedly from the null hypothesis of ran-
dom connectivity. Unfortunately, physiological approaches do not readily scale up to
an entire brain. Nevertheless, findings such as these hint at the rich structure yet to
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be uncovered in cortical circuits and motivate the development of higher throughput
technologies.
The second approach is based on electron microscopy (EM). EM is required because
light microscopy (LM) does not have sufficient resolution to establish whether two
nearby neuronal processes are merely close or whether they have actually formed a
synapse. Reconstruction of serial electron micrographs has yielded what to date is the
only complete connectome, that of C. elegans [Varshney et al. 2011, White et al. 1986].
However, even for this simple nervous system, the reconstruction required a heroic effort
– over 50 person-years of labor to collect and analyze the images. The difficulty of EM-
based reconstruction arises from the fact that stacks of many individual images need
to be aligned to track each axonal or dendritic process back to the soma; misalignment
of even a single pair of images can result in an error in the wiring diagram, rendering
the reconstruction of long-range connections particularly challenging. It is a testament
to the importance of the connectivity problem that several research groups have made
remarkable progress in automated EM reconstruction [Bock et al. 2011, Chklovskii et al.
2010, Lichtman and Denk 2011].
Several recent technical advances raise the possibility that a third class of ap-
proaches, based on light microscopy, may succeed in mapping circuit connectivity.
GRASP (GFP Reconstitution Across Synaptic Partners) [Feinberg et al. 2008, Kim
et al. 2012, Yamagata and Sanes 2012] and ID-PRIME [Liu et al. 2013] allow synaptic
contacts to be resolved at the level of light microscopy. Brainbow [Livet et al. 2007]
can be used to trace axons and dendrites over considerable distance. Spatial resolu-
tion, difficulties in tracing from cell body to synapse, and the limited color depth of
fluorophores limit these approaches in practice to sparse connectivity mapping.
1.3 Sequencing the Connectome
Here we propose to exploit high-throughput DNA sequencing to probe the connectivity
of neural circuits at single-neuron resolution. Sequencing technology has not previously
been applied in the context of neural connectivity, but the sequencing approach has
tremendous potential. The advantage of sequencing is that it is already fast – sequenc-
ing billions of nucleotides per day is now routine – and, like microprocessor technology,
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getting faster exponentially. Moreover, the cost of sequencing is plummeting. It cur-
rently costs less than $5,000 to sequence an entire human genome, and the race is on
to reach the $1,000 genome. Thus, by converting brain connectivity from a problem of
microscopy to a problem of sequencing, it becomes tractable using current technology.
BOINC, the method we propose for converting connectivity into a sequencing prob-
lem, can be broken down conceptually into three components (Figure 1.2). First, each
neuron must be labeled with a unique sequence of nucleotides – a DNA barcode (Fig-
ure 1.2A). The requisite barcoding is conceptually similar – though different in detail
– to the generation of antibody diversity by B cells in the immune system through
somatic recombination. The idea of barcoding individual neurons (see chapter 2 for
details) is inspired by Brainbow, except that here DNA sequences substitute for flu-
orophores (XFPs). The advantage of using sequences is diversity: whereas Brainbow
allows for at most hundreds of color combinations, a barcode consisting of even 20
random nucleotides can uniquely label 420 = 1012 neurons, far more than the number
of neurons (108) in a mouse brain.
Second, barcodes from synaptically connected neurons must be associated and am-
plified (Figure 1.2B). We set out to create such a system with several design criteria:
(1) scalable to a full brain, (2) easily ported to a variety of organisms (without ma-
jor re-design), (3) minimally toxic to the host organism, and (4) unperturbed synapse
formation and maintenance. One potential way to associate a pre- and postsynaptic
barcode is by means of a transsynaptic virus such as rabies virus (RV) [Wickersham
et al. 2007] or pseudo-rabies virus (PRV) [Ekstrand et al. 2008]. These viruses have
evolved exquisite mechanisms for moving genetic material across synapses and have
been used extensively for tracing neural circuits in rodents. However, scaling viral
transsynaptic spread to a full brain would require complex engineering in order to
achieve exclusively monosynaptic spread from every neuron. Moreover, transsyanptic
viruses such as RV and PRV are highly toxic and exhibit limited host range. Therefore,
we instead decided to associate barcodes by way of a highly engineered synapse-specific
protein-protein interaction (for details see chapter 3). Once associated, barcode pairs
are joined and amplified.
Finally, barcodes pairs are sequenced and the data is processed. If upon sequencing
we observe pre-synaptic barcode 2 with post-synaptic barcodes 21 and 24, we can infer
that neuron 2 is connected to neurons 21 and 24. Since most neurons are only sparsely
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Figure 1.2: Barcoding of Individual Neuronal Connections - There are many
possible implementations for each step of BOINC. (a) First, each neuron must be labeled
with a unique sequence of nucleotides – a DNA barcode. For simplicity, here we consider
a unidirectional connection between two populations of neurons, pre (1-8) and post (21-
28). (b) Second, barcodes from synaptically connected neurons must be associated, joined,
and amplified. (C) Finally, barcode pairs are subjected to high-throughput sequencing to
reconstruct a connectivity matrix.
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connected to other neurons in the brain – for example, in the mouse cortex a typical
neuron is connected with perhaps 103 of its 108 potential partners – only a small subset
of the potential pre-post barcode pairs will actually be observed. Thus upon high-
throughput sequencing, we can fill in the non-zero elements of the sparse connectivity
matrix (Figure 1.2C).
In its simplest form the sequencing approach yields only a connectivity matrix.
Missing from this matrix are at least two kinds of useful information typically obtained
with conventional methods based on microscopy: information about the brain region
(e.g., primary auditory cortex, striatum, etc.) from which each barcode originates,
and information about the cell type (e.g., dopaminergic, fast-spiking GABAergic, etc.)
of each barcoded neuron. However, several strategies can be used to augment the
connectivity matrix with both kinds of information (see subsection 1.3.3 and chapter 4).
Thus, as sequencing-based connectivity analysis matures, it may generate a view of
connectivity similar to that provided by traditional methods.
1.3.1 Costs
In the 3.5 years between the introduction of next generation DNA sequencing tech-
nologies in January 2008 to the most recent data in July 2011, the cost of sequencing
fell by a factor of 1,000 [Wetterstrand 2013]. This 15-fold yearly rate of improvement
far exceeds even Moores law, according to which computer costs drop 2-fold every 2
years. Just as Moore’s law drove and was driven by the computer revolution, so the
drop in sequencing costs is driven by the prospect of a genomics revolution in medicine.
Although such a precipitous rate of improvement of sequencing cannot be sustained in-
definitely, it would not be surprising if commercial pressures were to drive costs down
by another factor of 100 or more over the next few years.
How much would it cost to sequence the cortex of a mouse? We can put a lower
bound on the current sequencing cost as follows. The mouse cortex consists of about
4.6∗106 neurons [Roth and Dicke 2005]. Suppose that each cortical neuron connects to
about 103 other cortical neurons, so that there are 4.6∗106∗103 = 4.6∗109 connections.
If we assume that each barcode is 20 nucleotides, then we have 4.6 ∗ 109 connections ∗
20 nucleotides/barcode ∗ 2 barcodes/connection = 1.66 ∗ 1011 nucleotides. Assuming
that the fraction of unsampled connections is exp
2k
N , where k is the number of reads
and N is the number of barcodes, then with 3-fold oversampling (4.6∗1011 nucleotides)
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we would expect to sample 95% of connections. At $0.1/106 nucleotides (July 2013,
for up to date information see: sequencing cost per megabase), this would cost $48,000
and could easily drop several orders of magnitude in a few years. A similar calculation
for Drosophila melanogaster, with 105 neurons and 107 connections, yields $1/brain;
and for C. elegans, with 302 neurons and 7,000 connections, sequencing costs would
be essentially negligible. Although these are best case estimates and do not include
costs other than sequencing, the possibility of a $1 Drosophila connectome, or a $1,000
mouse cortical connectome, emphasizes the promise of recasting neural connectivity
as a sequencing problem. For an in-depth review of the costs of current and future
connectomics methods see: [Marblestone et al. 2013].
1.3.2 Advantages and limitations of the sequencing approach
Like any method, the sequencing approach is subject to false positives (i.e., inferred
connections that do not exist) and false negatives (actual connections that are missed).
Although the prevalence of each type of error will depend on the details of the im-
plementation, with the sequencing approach most errors will likely be false negatives.
Possible sources of false negatives include failure of barcode association and undersam-
pling of the amplified barcode pairs. Most sequencing errors will also result in false
negatives, but these can be minimized by judicious design of the barcodes. Possible
sources of false positives include loss of synapse specificity in the association of bar-
codes and insufficient diversity in the pool of possible barcodes. False positives are
likely to be an important source of error in microscopy-based approaches in which in-
accurate tracing of a neuronal process across tissue sections can lead to misattribution
of a synaptic connection to the wrong parent.
The sequencing approach provides different information from conventional microscopy-
based approaches. Electron microscopy provides a wealth of data not available in the
sequencing approach, including information about neuronal morphology, as well as
about the subcellular placement, number, and size of synapses. It is possible that some
of this information could be preserved with extensions to the sequencing approach (see
subsection 1.3.3), but in the first implementations this information will be missing.
On the other hand, the sequencing approach has the potential to provide direct access
to the molecular expression profile of individual neurons – whether it is dopaminergic
or expresses a marker, such as parvalbumin, that tags the neuron as belonging to a
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particular subtype of interneuron. Moreover, with the sequencing approach, local and
long-range connections are equally accessible; by contrast, with microscopy the proba-
bility of inaccurately tracing a synaptic connection increases with distance, rendering
the reconstruction of inter-areal connections a particular challenge.
1.3.3 Extensions of the method
In theory any cellular information that can be encoded into DNA can be incorporated
into the sequencing approach. By tagging DNA-encoded information with the same
cellular barcodes used for connectivity mapping, our approach can be extended to
include a rich array of information. Information that is endogenously encoded in DNA,
such as the epigenetic state of the cell or the cellular transcriptome profile, can very
easily be encoded by joining the barcode with the nucleic acid information. Indeed,
the structure of the connectivity matrix may largely depend upon information such as
cell-type, as shown in Figure 1.3 [Pfeffer et al. 2013]. One implementation of this idea
is discussed in Appendix E.
A new method, which relies on fluorescence in situ sequencing (FISSEQ) [Lee et al.
2014], has the promise of combining both the advantages of sequencing and imaging
for circuit mapping. The technique was originally conceived for the high throughput
sequencing of mRNA transcripts in situ, but can be repurposed for the sequencing of
cellular barcodes. In theory, this technique could allow for the combination of functional
imaging of cells during behavior (via 2-photon microscopy), mapping of neural circuit
connectivity (via FISSEQ of cellular barcodes), and identification of individual cell
types (via mRNA FISSEQ) in a single specimen [Marblestone et al. 2013; 2014].
Recently it has been proposed that other signals, such as the activity of a neuron,
could be encoded in DNA [Alivisatos et al. 2012, Kording 2011]. There are countless
other examples of additional information of interest including: the spatial coordinates
of a cell within the brain, whether the synapse has been recently potentiated, the
presence of neuromodulators, etc. that can theoretically be encoded into DNA. Because
of its high information storage capacity, DNA is an attractive medium for encoding of
different signals. Thus, the DNA-based connectome may one day serve as a foundation
upon which additional layers of complex information about neural circuits can be added
to uncover the fundamentals of neural circuit computation.
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Figure 1.3: Cell-type reveals additional structure in the connectivity matrix -
(a) Without knowledge of cell-type, a simple connectivity matrix can be reconstructed. (b)
Knowledge of cell-type reveals additional high-order structure in the connectivity matrix
(i.e. red cells receive input only from other red cells, whereas blue cells receive input from
both red and blue cells.)
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1.3.4 Conclusions and perspectives
The appeal of the sequencing approach rests in its promise of high throughput, as de-
fined by cost and mapping time. Low-cost sequencing of brain circuits could be used
as a screening test to generate hypotheses about how circuits change with develop-
ment, learning, genetic manipulations, or any other experimental factor. For example,
autism has been hypothesized to arise from genetic lesions that disrupt local and long-
range connectivity, but different autism candidate genes may disrupt circuits differently
[Geschwind and Levitt 2007]. High-throughput circuit screening would enable a sys-
tematic comparison of the similarities and differences among brain circuits in animal
models of autism. A high-throughput circuit screen has the potential to transform how
experiments are designed.
What will we learn from sequencing the connectome? Perhaps it is instructive to
turn to the lessons learned from sequencing the human genome. Knowledge of the
complete genome provides the starting point for much of modern biological research,
transforming how research is conducted in the post-genomic era. A cheap and rapid
method for deciphering the wiring diagram of an entire brain may have a comparably
profound impact on neuroscience research.
1.4 Acknowledgements
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2In vivo generation of DNA
sequence diversity for cellular
barcoding
2.1 Abstract
We have developed a novel method of uniquely tagging individual cells in
vivo with a genetic “barcode” that can be recovered by DNA sequencing.
Our method is a two-component system comprised of a genetic barcode
cassette whose fragments are shuﬄed by Rci (recombinase for clustered in-
version), a site-specific DNA invertase. The system is highly scalable, with
the potential to generate theoretical diversities in the billions. We demon-
strate the feasibility of this technique in Escherichia coli. Currently, this
method could be employed to track the dynamics of populations of microbes
through various bottlenecks. Advances of this method should prove useful in
tracking interactions of cells within a network, and/or heterogeneity within
complex biological samples.
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2.2 Introduction
Reverse engineering any complex system requires the simultaneous monitoring of indi-
vidual components. Recent advances in high-throughput DNA sequencing have given
biologists unprecedented access to massively parallel data streams. Genetic barcoding
– the labeling of individual cells with a unique DNA sequence – when combined with
these technologies, will enable monitoring of millions or billions of cells within complex
populations. This approach has proved useful in tagging neurons [Golden et al. 1995]
and hematopoietic stem cells [Gerlach et al. 2013, Lu et al. 2011, Naik et al. 2013]
for lineage analysis and could be applied to the normal and/or abnormal development
of other cell populations or tissues, including tumours. Indeed, in vivo barcoding of
individual neurons is the requisite first step towards converting neuronal connectivity
into a form readable by high-throughput DNA sequencing [Zador et al. 2012].
Most current approaches for tagging individual cells with a genetic barcode rely
on the creation of diverse libraries in vitro and subsequent delivery of genetic material
into a host cell at low-copy number. Such in vitro approaches are limited by cloning
bottlenecks that cause reduced library diversities and sequence biases, by incomplete
labeling of all cells within a population, by the possibility of introducing multiple
barcodes per cell, and by the challenges of working across organisms (e.g. retroviral
barcoding cannot be applied in some organisms like Caenorhabditis elegans).
In vivo barcoding has the potential to overcome all of these limitations. Mecha-
nisms for generating diversity in vivo exist, endogenously, in many organisms – most
notably the mammalian immune system. However, efforts to repurpose the immune sys-
tem’s V(D)J recombination for in vivo cellular barcoding [Gerlach et al. 2013] yielded
limited barcode diversity – on the order of a dozen unique sequences – in cells other
than lymphocytes [Schumacher 2014]. Exogenous recombinases have been successfully
applied to generate diverse combinations of colors for cellular tagging purposes. This
technique, better known as Brainbow [Livet et al. 2007], relies on Cre recombinase to
rearrange a cassette resulting in the stochastic expression of a subset of different col-
ored fluorescent proteins (XFPs) in neurons. The theoretical diversity of Brainbow is
in the hundreds, but cannot be easily assayed with DNA sequencing because it relies
heavily on gene copy number variation as well as recombination. We reasoned that by
replacing XFPs with unique sequences, we could design a barcoding system with the
14
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potential to achieve diversities that matched the scale of high-throughput sequencing
technologies.
We have developed a novel method of generating sequence diversity in vivo for the
purpose of cellular barcoding. Our method, which relies on a DNA invertase – Rci,
recombinase for clustered inversion [Kubo et al. 1988] – to shuﬄe fragments of DNA,
has the potential to easily achieve diversities over 109 unique sequences. Here, we show
that this method can be applied for the in vivo generation of diversity in E. coli.
2.3 Materials & Methods
2.3.1 In silico simulations
We performed in silico simulations to determine the behavior of different cassette archi-
tectures. For Cre-based cassettes, ncell cassettes (ncell = 10000) of nfrag fragments
(nfrag = 100) were operated on independently. Each fragment was flanked on its 5’
end with a loxP site in sense orientation (5’-GCATACAT-3’) and on its 3’ end with a
loxP site in the antisense orientation. Concatenation of fragments resulted in cassettes
in which adjacent fragments (excluding ends) were separated by two loxP sites in op-
posing orientation. We defined Cre recombination as two independent binding events
to loxP sites. Binding of Cre to a pair of loxP sites always resulted in recombination,
where the result (inversion or excision) was defined by the relative orientation of the
sites defined in a look up table (updated after each event). Completion was defined
to be the point at which Cre can no longer mediate an excision event. The number of
recombination events required to reach completion was tracked for each cassette. For
Rci-based cassettes, ncell cassettes (ncell = 10000) of nfrag fragments (nfrag = 10)
were operated on independently. Here, we considered two architectures. For the first
architecture, each fragment of the cassette was flanked on its 5’ end with an sfx site
in sense orientation and on its 3’ end with an sfx site in the antisense orientation.
Concatenation of fragments resulted in cassettes in which adjacent fragments (exclud-
ing ends) were separated by two sfx sites in opposing orientation. For the purpose of
simulations, we consider each pair of sfx sites between fragments to be equivalent to a
single bidirectional sfx site. We defined Rci recombination as two independent binding
events to sfx sites. In this case, binding of Rci to a pair of sfx sites always resulted in
recombination (inversion). Simulations were allowed to proceed for m recombination
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events per cassette. For the second Rci architecture, the 5’ end of the cassette begins
with a single sfx site in sense orientation, followed by a single sequence fragment. The
cassette is extended by addition of an sfx site and a sequence fragment, with the ori-
entation of sfx sites alternating throughout the cassette. The cassette is terminated
at its 3’ end by an sfx site in antisense orientation. We defined Rci recombination as
two independent binding events to sfx sites. Binding of Rci to a pair of sfx sites only
resulted in recombination if the sfx sites were in opposite orientations (inversion only).
Simulations were allowed to proceed for m recombination events per cassette. The code
for running all simulations is provided in supplementary materials (section 2.6).
2.3.2 Synthesis of barcode cassettes
A 5-fragment barcode cassette was synthesized as a minigene by IDT and inserted
into a standard plasmid (IDP190). Several different sfx sites were used to avoid per-
fect inverted repeats to simplify DNA synthesis. The cassette was constructed as
ANCHOR105-sfx101R-BC1-sfx102L-BC2-sfx106R-BC3-sfx112L-BC4-sfx109R-BC5-sfx101L-
ANCHOR56 where R indicates the sfx sequence in 5’-3’ orientation and L indicates
the reverse orientation (where orientation is determined by the core sequence: 5’-
GTGCCAA-3’). The barcode cassette was synthesized with flanking sequences for
use in PCR amplification and sequencing (#3:ANCHOR105 and #4:ANCHOR56). In
addition, the cassette was flanked by restriction sites (PciI) and flanking primer se-
quences (#1:BC F and #2:BC R) for subsequent polymerase chain reaction (PCR)
and cloning.
2.3.3 Plasmid construction
The 5-fragment barcode cassette (from plasmid #IDP190) was amplified using primers
#1:BC F and #2:BC R, digested with PciI, and cloned into pet22b. A strain of E.
coli harbouring the pEK204 plasmid, which encodes Rci recombinase (NCBI Refer-
ence Sequence: NC 013120.1), was ordered from NCTC (NCTC 13452: J53-derived E.
coli. GenBank accession number EU935740). The open reading frame of Rci was ob-
tained by PCR of the pEK204 plasmid with primers #7:NdeI-Rci F and #8:NotI-Rci R,
which add restriction sites NdeI and NotI, respectively. Rci was cloned into plasmid
pet22b using restriction sites NdeI and NotI (thus removing the periplasmic localiza-
tion signal of pet22b) to create Plasmid #IDP205:(T7→Rci; 5BC). The constitutively
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active promoter, pKat (Registry of Standard Biological Parts: BBa I14034, http://
parts.igem.org/Part:BBa_I14034), and a ribosomal binding site (RBS): AGGAGG,
flanked by restriction sites BglII and NdeI were synthesized as complementary oligos
#9:s-pKat promoter and #10:as-pKat promoter, annealed, digested, and subsequently
cloned into #IDP205 to make plasmid #DIG35:(pKat→Rci, 5BC). To extend the bar-
code cassette we amplified #IDP205 using primers #11:BamHI-BC5 F and #12: NheI-
BC5 R, and cut with BamHI and NheI. The insert, BC6-BC11, was digested from
BCextension (synthesized by GeneWiz) with BamHI and NheI. The backbone and in-
sert were ligated to make plasmid #DIG70:(T7→Rci, 5BC). The constitutively active
promoter, pKat, and a ribosomal binding site (RBS) flanked by restriction sites BglII
and NdeI were synthesized as complementary oligos #9:s-pKat promoter and #10:as-
pKat promoter, annealed, digested, and subsequently cloned into #DIG70 to make
plasmid #DIG71:(pKat→Rci, 11BC). All cloning was performed using Top10 chemi-
cally competent cells (Invitrogen) with growth at 37◦C.
2.3.4 Bacterial culture & shuﬄing
For initial tests with T7 induced expression of Rci, plasmids IDP205 or DIG35 were
transformed into E. coli strain BL21(DE3) (NEB) and grown in 5ml of normal or
OvernightExpress (Millipore) supplemented media overnight. Plasmid DNA was iso-
lated and the Rci coding sequence was removed (to prevent further shuﬄing) by double
digestion (NdeI-NotI), blunting (Mung Bean), and re-ligation (Roche Rapid Ligation
kit). The transformed ligation was plated for clonal analysis. Clonal analysis involved
the selection of single colonies, growth in LB for 16 hours, plasmid isolation, and Sanger
sequencing with ANCHOR105 used as a primer. For tests of the pKat driven expression,
plasmids IDP205 or DIG35 were transformed into E. coli strain Top10 cells (Invitro-
gen) and grown in 5ml of LB overnight. Plasmid DNA was isolated and the Rci coding
sequence was removed (to prevent further shuﬄing) by double digestion (NdeI-NotI),
blunting (Mung Bean), and re-ligation (Roche Rapid Ligation kit). The transformed
ligation was plated for clonal analysis. Clonal analysis involved the selection of single
colonies, growth in LB for 16 hours, plasmid isolation, and Sanger sequencing with
ANCHOR105 used as a primer. For high-throughput sequencing by PacBio, plasmids
IDP205, DIG35, and DIG71 were transformed into Top10 cells (Invitrogen) and grown
overnight in 50mL of LB. Plasmid DNA was isolated and digested with PciI to release
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the barcode cassette. The barcode cassette was prepared for PacBio sequencing using
the PacBio SMRTbell Template Prep Kit according to the manufacturers instructions
and cassettes from each original plasmid were sequenced on a single SMRT cell. PacBio
sequences were collapsed into circular consensus reads using the PacBio command line
tools.
2.3.5 Barcode reconstruction
Our sequence alignment algorithm is written in Matlab and uses the Matlab Bioinfor-
matics Toolbox. Sequencing reads are processed independently. Each known barcode
fragment is aligned to the sequence read (in both orientations) with a thresholded
Smith-Waterman alignment [Smith and Waterman 1981] and the position of the seg-
ment along the read is stored. The threshold is set by a bootstrap method. Briefly, one
hundred randomly generated 100-mers are aligned to all of the sequence traces and a
score is associated with each alignment. The mean score plus two standard deviations
is considered the threshold for all subsequent alignments. The complete barcode can
be reconstructed based on the positions of each segment. Because the algorithm relies
only on local alignment, this method is extremely robust to sequencing errors.
2.3.6 Sequences
Table 2.1: Primers used in the Rci study
1 BC F (5BC) gctttacctcgcactgcccagagtg
2 BC R (5BC) agactcatgcatcgtgccactgtgttcg
3 ANCHOR56 ttgcgaacctcatcactcgttgc
4 ANCHOR105 tgaggcaaggaagatgctgtcc
7 NdeI-Rci F tctacatatgccgtctccacgcatccgt
8 NotI-Rci R actggcggccgcttacagcggtgtgctgc
9 s-pKat promoter acctagatctcattattgcaattaataaacaactaacggacaattctacctaacaaggaggtaccatatgacct
10 as-pKat promoter aggtcatatggtacctccttgttaggtagaattgtccgttagttgtttattaattgcaataatgagatctaggt
11 BamHI-BC5 F tctaggatccggcaatactttcgtgccaatccgg
12 NheI-BC5 R actggctagcgcaacgagtgatgaggttcgcaa
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Table 2.2: sfx sites used in Rci study
sfx101 ggcaatactttcgtgccaatccggtacgtgg
sfx102 ctgctggcctacgtgccaatccggtacgtgg
sfx106 gcacgtaggccagtgccaatccggtacctgg
sfx109 ttctctgcaagcgtgccaatccggtacgtgg
sfx112 gccaagcttgttgtgccaatccggtacgtgg
Table 2.3: Barcode sequences used in the Rci study
BC1 ccaattggtagtttgtccagaactcagattttaacagcagaggacgcatgctctaccttcatgatccactgacgtccctgaggctgcaatacatgcaacg
BC2 aggcagtctccgcggtaagtcctagtgcaatggcgcttttttaccctcgtcctcgagaagaggggacgccagtgcagatatctttaatgtggtaattggg
BC3 aggactcttggccctccgcccttaggcagtgcatactcttccataaacgggctgttagttatggcgtccgaggattcaaaaaggtgagcgaactcggccg
BC4 atccggagagacgggcttcaaagctgcctgacgacggttgcgcgtccgtatcaaaatcctcctaataagcccccgtcactgttggttgaagagcccagga
BC5 cgggttggccagatgtgcgattatatcgcttaatggctcttgggccgcggtgcgttaccttgcaggaattgaggccgtccgttaatttcccttgcataca
BC6 ggatccgtcaaatgtgattgatgccctcgatccccgtggagatgagatgcctggctggtcggggtgcaaaccgatcaataacaatcgtcactttcgaggt
BC7 ccccgcactgatgcctaaacctcgcaggtctttaggatattgacgcttgacgatgtcccacgattaaaccggtgtgcaaccttggatgctgattaatcgc
BC8 gcgagatgaatggacgggtctggttcgaacgatgtattaattgatgcaggagccccgcacacctaaatatcgatccgggtatgtttaatggtgcgatggc
BC9 ggctgccctctcctacttacgggtatcggctcccagccccacgtcgcgctctgttctcaaccaactaggatctgatgcacgagattaacgttgacgttgt
BC10 tacaccggcccgagcgtcgtcctttctatagatggcttccagcgactcaccaggagtgttctggttgggaactacttcgaacgctatgagccttccctat
BC11 tgctgaaacagttaatactgggacttattcttgggactgatagggttatgacgcttcttatgttctccggcgtacagtgaagaaaaatcaatcctatatc
Table 2.4: Plasmids used in the Rci study
IDP190 5BC Cassette
IDP205 T7→Rci; 5BC Cassette
DIG35 pKAT→Rci; 5BC Cassette
BCext BC6-BC11 extension
DIG70 T7→Rci; 11BC Cassette
DIG71 T7→Rci; 11BC Cassette
All other relevant sequences and plasmid maps are provided in Supplementary Ma-
terials (section 2.6).
2.4 Results
2.4.1 Design of Cre-based barcoding
Our design goals were to create a modular genetically encoded barcode system that
is easily scalable, cross-platform (applicable across model organisms), compatible with
high-throughput sequencing technologies, and robust to sequencing errors. Our ulti-
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mate goal is to generate unique barcodes to label all of the cells of the mouse cortex
– approximately 1x107 neurons [Roth and Dicke 2005]. In general, if the repertoire of
possible barcodes is substantially greater than the number of cells in the population of
interest, then even randomly generated barcodes will label most cells uniquely. Specif-
ically, if n is the number of cells and k is the number of possible barcodes, then under
simple assumptions the fraction of uniquely labeled cells will be e−n/k. Thus assuming
one barcode per cell, a barcode repertoire exceeding the number of cells by a factor of
100 will yield 99% uniquely labeled cells. Therefore, we sought a barcode system with
the potential to scale to at least 100x107 = 109 unique barcodes. Our initial design
relied on Cre recombinase to shuﬄe and pare down a cassette of n barcode fragments
(each fragment flanked by lox sites in alternating orientation) by stochastic inversion
and excision events to leave a single fragment (Figure 2.1A).
Cre acts by binding to and mediating recombination between two of its cognate
DNA sequences, called lox sites. Cre-mediated recombination between any two com-
patible lox sites in the same orientation causes the excision of the intervening sequence
elements. In contrast, recombination between lox sites in opposing orientation causes
the inversion of any intervening sequence elements.
This architecture (shown in Figure 2.1A) has a theoretical diversity of 2n after
completion, since any fragment, j, of the n fragments can end in either the forward or
inverted orientation (Figure 2.1A). Several variant lox sites have been discovered with
a wide variety of characteristics [Lee and Saito 1998, Missirlis et al. 2006, Siegel et al.
2001]. The Brainbow [Livet et al. 2007] system, for example, employed three lox sites
that were shown to be mutually incompatible including loxP (the wild-type lox site),
loxN [Livet et al. 2007], and lox2272 [Lee and Saito 1998] (Figure 2.1B). We reasoned
that a Cre-based barcoding approach could be extended to achieve higher diversities by
concatenating k cassettes of n fragments, where each cassette employs one of a subset
of incompatible lox sites (Figure 2.1C). Here, the theoretical diversity is (2n)k because
each cassette operates independently. Thus with n = 100, k = 4, theoretical diversities
reach our goal of 109 unique sequences.
Unfortunately, many of the reported lox variants have not been validated for com-
plete incompatibility or pairwise efficiency. Moreover, because of the repetitive nature
of lox sites it would be difficult to synthesize cassettes with the hundreds of fragments
required to achieve our target diversity. For example, an architecture with n = 100,
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Figure 2.1: Design of Cre barcode cassettes - (a) n sequence fragments, each flanked
by loxP sites (black triangles) in opposing orientations are concatenated to form a cassette.
Upon Cre recombination, the cassette is shuﬄed and pared down until a single fragment,
j, remains in either orientation. (b) Several variant mutually incompatible lox sites have
been described, each of which has a pair of mutations in the spacer sequence. (c) The
diversity attainable by Cre recombination can be increased by concatenating k cassettes,
where each cassette utilizes an incompatible lox site. Cre recombination results in the
independent shuﬄing of each of the k cassettes. (d) The diversity as a function of length
for cassettes containing n = 100 fragments (100bp each) concatenated together. Lengths
> 60kb are needed to reach the requisite diversity of 109. (e) The distribution of the
number of recombination events needed for each cassette to reach completion.
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k = 4, where each fragment is above the minimum length (∼100bp) for efficient recom-
bination [Hoess et al. 1985], requires a large genomic insertion with a length greater
than 60kb (Figure 2.1D). Finally, simulations suggested that Cre-based architectures
are subject to considerable biases that limit the diversities that can be achieved in
practice (subsubsection 2.6.1.1, Figure 2.7).
2.4.2 Employing DNA invertases for cassette shuﬄing
The key limitation of Cre-based designs is that Cre mediates both inversion and exci-
sion/insertion. Because insertion is a bimolecular reaction whereas excision is a uni-
molecular reaction, in general equilibrium will favour excision over insertion. Thus the
equilibrium diversity of a Cre-based cassette scales linearly with the number of frag-
ments n. In simulations (see subsection 2.3.1), 10 to 40 recombination events were
performed on each cassette before reaching completion (Figure 2.1E). The diversity
of the Cre-based cassettes could, in principle, be increased by preventing the reaction
from proceeding to completion. In the limit, if only inversions were permitted, then the
fragments of the cassette would be shuﬄed rather than pared down. Intuitively, the
advantage of eliminating excision events can be understood by analogy to a deck of n
playing cards, in which each card can occur in either orientation (face up or face down).
If excisions dominate, then the diversity is given by eliminating all but one card. If
inversions dominate, then the diversity is given by all the possible sequences of n shuf-
fled cards (n!) multiplied by all of the possible orientations (2n). Thus eliminating
excisions allows the diversity (given by Equation 2.1) to increase supra-exponentially,
rather than linearly, with the number of elements n.
D(n) = 2nn! (2.1)
With only 10 fragments, the diversity reaches > 3x109 unique sequences. Impor-
tantly, the equilibrium state of this architecture, as the number of recombination events
m approaches infinity, is an equal distribution of all potential unique sequences [Wei
and Koulakov 2012]. In practice, m will reach some finite number that may result
in cassette biases. However, simply extending the cassette by one fragment can com-
pensate for any modest biases of this architecture. Moreover, because the barcodes
are made of a small number of known sequence fragments, reconstruction of barcode
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sequences even from highly error prone sources becomes possible. The order and ori-
entation of each fragment within the cassette after recombination can be determined
simply by performing 2n pairwise alignments (each fragment in both orientations is
aligned to the recovered sequence). This results in barcodes that are robust to many
classes of sequencing errors.
We thus adopted a strategy based on DNA invertases - recombinases that can me-
diate only inversions [Johnson 2002]. Rci (recombinase for clustered inversion) is a
site-specific recombinase (SSR) of the integrase (Int) family, of which Cre is also a
member [Kubo et al. 1988]. Rci recognizes 31bp sfx sites and mediates recombination
events only between sites in inverted orientation (inversions) – it cannot mediate exci-
sion events between sites in the same orientation. Unlike other inversion systems, such
as Hin and Gin [Johnson et al. 1988], Rci does not appear to require any co-factors or
enhancer sequences [Gyohda and Komano 2000]. Because of this, we selected Rci as
our recombinase and designed a new barcode cassette in which segments of DNA are
shuﬄed by inversion-only recombination events (Figure 2.2A).
2.4.3 Design and synthesis of a 5BC cassette
Initially, we planned to synthesize DNA in which n = 5 fragments, each flanked by
sfx sites in opposite orientation, were concatenated to form a barcode cassette. After
concatenation, each fragment is separated from its immediate neighbor by two sfx sites
in opposite orientation (similar to the architecture proposed for Cre in Figure 2.1A).
However, DNA synthesis constraints and plasmid stability forced us to redesign the
cassette to minimize the effects of repetitive elements (the sfx sites). Ultimately, we
employed an architecture in which individual fragments are separated by a single sfx site
the orientation of which alternates between successive fragments (Figure 2.2A), relying
on several compatible sfx site variants to further reduce complexity [Gyohda et al.
2002] (Figure 2.2B). This architecture achieves a somewhat lower diversity. Fragments
originating in odd positions within the cassette (i.e. position 1, 3, 5, etc.) can only
occupy odd positions after recombination. Likewise, fragments originating in even
positions can only occupy even positions after recombination. This leads to a reduced
diversity, given by Equation 2.2.
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Figure 2.2: Design of Rci barcode cassettes - (a) The Rci cassette is formed by
concatenation of n sequence fragments, in which individual fragments are separated by a
single sfx site the orientation of which alternates between successive fragments. Upon Rci
recombination, the cassette is shuﬄed. Because Rci cannot mediate excision events, the
cassette remains the same length, but the relative position of each fragment within the
cassette can change. (b) sfx sites share a central spacer sequence and right arm sequence,
but have little sequence conservation in the left arm. 5 different sfx sequences were used in
this study. (c) The diversity of the Rci cassette as a function of the number of fragments, n.
Cassettes with > 20 fragments can generate sufficient diversity to label all cells in complex
organs/organisms. (d) The diversity as a function of length for Rci cassettes (assuming
100bp fragments). Lengths ∼1-2kb are needed to reach the requisite diversity of 109.
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D(n) = 2n(
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!)2; n is odd (2.2b)
where D is the total diversity and n is the number of fragments in the cassette. De-
spite the reduction of diversity due to the modified architecture, only 12 fragments are
required (n = 12) to achieve our target diversity of > 109. Additional segments greatly
increase the diversity making this a scalable approach (Figure 2.2C). Moreover, un-
like the Cre-based architecture, the Rci-based cassettes reach our requisite diversity at
reasonable cassette lengths of ∼1-2kb (Figure 2.2D). Ultimately, a 5-fragment (100bp
fragments) barcode cassette was synthesized utilizing 5 different sfx site sequences to
decrease the repetitive nature of the cassette to aid in synthesis and replication. In ad-
dition, known anchor sequences (ANCHOR105 and ANCHOR56) positioned at either
end of the cassette, were added outside of the recombination region to aid in sequence
reconstruction. The final 5-fragment cassette, 5BC (Figure 2.3A), was cloned into a
low-copy plasmid containing the Rci gene (resulting in plasmid IDP205). This ensures
that all barcode cassettes that are transformed into bacterial cells will be exposed to
the Rci coding sequence. Plasmid IDP205 (T7→Rci; 5BC) contains the Rci gene driven
by the inducible T7 promoter. This plasmid is remarkably stable, showing no signs of
recombination in the absence of induction across many generations (Figure 2.8).
2.4.4 Testing of the 5BC cassette in vivo
We transformed two populations of E. Coli BL21-DE3 (NEB) cells with plasmid IDP205
(T7→Rci; 5BC) and grew 10mL cultures overnight. One culture was grown under con-
ditions that induce the expression of Rci from the T7 promoter (see methods). After
growth, cells were plated for clonal analysis on plates that did not support Rci ex-
pression. Twenty colonies were chosen for each condition (+ and − Rci induction)
and analyzed by Sanger sequencing. Without induction of Rci expression, no recom-
bination was observed (0 of 20 colonies sequenced, data not shown). Moreover, the
induction of Rci led only to modest recombination – shuﬄing the cassette in 8 of the 20
reconstructed barcode sequences (Figure 2.3B). Interestingly, each of the final products
could be explained by a single recombination event (Figure 2.9).
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Figure 2.3: In vivo testing of Rci recombination on barcode cassettes - (a) A
barcode cassette containing 5 fragments, which were separated by various sfx sites in al-
ternating orientations, was synthesized. Anchor sequences flanked the cassette for use in
PCR and sequence reconstruction. (b) Induction of Rci expression from the T7 inducible
promoter results in shuﬄing in some, but not all cassettes. (c) Induction of Rci expression
from the T7 inducible promoter results in Rci protein that is largely insoluble. (d) Expres-
sion of Rci from a medium-strength, constitutively active promoter results in expression of
soluble Rci protein and (e) robust shuﬄing of the cassette.
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We reasoned that the inefficient shuﬄing might be due to protein aggregation and
insolubility due to high overexpression, as is often the case with T7 overexpression
[Moore et al. 1993]. To test this we fused an HA-tag at the N-terminus of Rci and tested
the expression level and solubility via western blot. Indeed, we found that HA-Rci was
found only in the insoluble fraction (Figure 2.3C), perhaps explaining the inefficient
shuﬄing observed. Thus, we tested expression of HA-Rci from a different promoter, a
medium strength constitutively active promoter, pKat (Registry of Standard Biological
Parts: BBa I14034), and found that the protein was soluble when expressed from this
promoter (Figure 2.3D). Therefore, we cloned the pKat promoter in place of T7 to
make plasmid DIG35 (pKat→Rci; 5BC) and tested for shuﬄing efficiency. Briefly, we
transformed DIG35 (pKat→Rci; 5BC) into Top10 competent cells and grew cultures
overnight. To stop shuﬄing, plasmid DNA was isolated and the sequence for the Rci
gene was removed via restriction enzyme digestion. Plasmids were re-transformed and
colonies were selected for Sanger sequencing. DNA was isolated from each colony and
subjected to Sanger sequencing. Sequence reads were analyzed with our alignment algo-
rithm in order to reconstruct full barcodes. Reads that could not be fully reconstructed
from sequencing data were discarded from further analysis.
Expression of Rci from this promoter, pKat, resulted in robust shuﬄing (Fig-
ure 2.3E). Of the 22 reconstructed (3 sequences failed reconstruction) cassette se-
quences, each had undergone shuﬄing to yield 19 unique barcode sequences. Moreover,
all of the final barcode sequences could only be explained by multiple (>1) recombi-
nation events. Based on these positive preliminary results, we next subjected the 5BC
cassette to high-throughput DNA sequencing.
2.4.5 High-throughput sequencing of shuﬄed 5BC
Advances in high-throughput sequencing have allowed for unprecedented access to mas-
sive quantities of DNA sequence data. We took advantage of high-throughput sequenc-
ing to sequence the shuﬄed 5BC cassettes at depths that allowed for a more thorough
analysis of the actual in vivo behavior of barcode generation by Rci. Because of the
length of our potential cassettes (∼1-2kb to reach diversities of 109), we chose the
PacBio sequencing platform.
Briefly, we transformed E. coli Top10 (Invitrogen) cells with either plasmid IDP205
(T7→Rci; 5BC – negative control) or DIG35 (pKat→Rci; 5BC) and allowed cultures
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to grow overnight. DNA was isolated and digested to release the barcode cassette. The
barcode cassettes were then prepared for high-throughput sequencing on the PacBio
RS II and sequenced.
Using our algorithm, we reconstructed 5887 barcodes from 7203 circular consensus
reads (see subsection 2.3.5) obtained from cells in which Rci was not expressed (plasmid
IDP205; T7→Rci, 5BC). Of the reconstructed barcodes, 5886/5887 gave the original
sequence (Figure 2.4A).
These data indicated that the PacBio sequencing platform could handle the highly
repetitive nature of the barcode cassettes and would allow for high-throughput sequenc-
ing of cassettes without the introduction of recombination during sequencing from tem-
plate switching or other sources. When Rci was expressed off of the pKat promoter
(DIG35) the cassette was shuﬄed robustly (Figure 2.4B). Here, we reconstructed 5243
barcodes from 6105 circular consensus reads, of which there were 203 unique sequences.
After shuﬄing, each position along the cassette is populated with a relatively even dis-
tribution of all of the possible fragments, with only slight biases at the ends of the
cassette (Figure 2.4B). In other words, the occupancy at each position of the cassette,
while still preferential for the original fragment sequence, approaches randomness (Fig-
ure 2.4C). This important observation indicates that there are no biological constraints
on our design that prohibit the full exploration of the barcode space. Simulations of
shuﬄing of a 5BC cassette under simple assumptions (see section 2.3 for details) show
that the occupancy at any given position reaches equilibrium after ∼6 or more recom-
bination events per cassette (Figure 2.4D). Comparison of the simulated data and the
data collected from in vivo shuﬄing suggests that our cassettes likely experienced 2-3
recombination events on average in vivo (Figure 2.4D).
Even this limited amount of recombination resulted in an observed 203 unique
sequences (out of a theoretical 384; n = 5, diversity = 25x3x(2!)2). Intuitively, after
a small number of recombination events, the cassette remains biased at each position
to its initial state (Figure 2.4D). As the number of recombination events increases,
however, the cassette goes to equilibrium, and there is a nearly uniform distribution of
each fragment at each position in the cassette (Figure 2.4D). In the limit, the cassette
will reach an equilibrium state in which every possible barcode is equally probable (16).
This proof of principle experiment shows that in vivo recombination by Rci on a
cassette is efficient at shuﬄing the original sequence into a unique barcode. However,
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Figure 2.4: High-throughput sequencing of 5BC Rci cassette after in vivo shuf-
fling - (a) Cassettes are stable in the absence of Rci expression and can be reconstructed
from PacBio sequencing data. (b) Expression of Rci from the constitutively active pKat
promoter results in robust shuﬄing of the 5BC cassette. The colormaps show the distri-
bution of fragment occupancy at each position in the cassette. Colors are scaled from 0 to
25% for visualization. (c) The bias at each position was calculated as the number of times
the original fragment appeared in its original position divided by the number of cassettes.
The dotted black line indicates the expected occupancy of the original fragment at each
position in a cassette with completely random occupancy. (d) The bias at each position
within a cassette subjected to m = 2, 4, 6, 8, or 10 recombination events was simulated.
The dotted black line indicates the expected occupancy of the original fragment at each
position in a cassette with completely random occupancy. The solid black line indicates
the data observed in vivo.
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the theoretical diversities of the 5BC cassette are well below our initial goals. Therefore,
we sought to expand the cassette to achieve higher diversities.
2.4.6 High-throughput sequencing of shuﬄed 11BC
To explore the feasibility of achieving diversities that are capable of labeling large popu-
lations of cells, we expanded the cassette to 11 fragments. We synthesized a 6-fragment
extension to our original cassette and concatenated this with our original 5BC cassette
to create an 11BC cassette (Figure 2.5A). Importantly, plasmids harbouring this cas-
sette were stable across many generations and showed no evidence of recombination in
the absence of Rci expression (Figure 2.10).
The theoretical diversity of this cassette is 211x6x(5!)2 = 176, 947, 200. Unfortu-
nately, there is currently no sequencing technology that has both the requisite depth
and read-length to appropriately cover the potential diversity of the 11BC cassette.
Nevertheless, we used high-throughput sequencing on the PacBio platform to sample
the barcodes produced by the recombination of the 11BC cassette. Briefly, we trans-
formed Top10 bacterial cells with plasmid DIG71 (pKat→Rci; 11BC cassette) and
cultured the cells overnight. The barcode cassette was released by restriction digestion
and subjected to high-throughput sequencing on the PacBio RS II.
Shuﬄing of the 11BC cassette in vivo was efficient (Figure 2.5B). We reconstructed
1786 barcodes, of which 1723 were unique. Again we observe that, after shuﬄing in
vivo, each position along the cassette is populated with a relatively even distribution of
all of the possible fragments (Figure 2.5B), approaching a completely random cassette
(Figure 2.5C). Based on simulations, we estimate that the 11BC cassettes have expe-
rienced more than 5 recombination events on average (Figure 2.5D). As suggested by
simulations, further shuﬄing will lead to an increasingly random cassette (Figure 2.11).
2.5 Discussion
To our knowledge, this is the first example of an in vivo barcoding scheme with the
potential to scale to uniquely label all of the individual cells of an entire tissue or organ-
ism. The system, which takes advantage of a recombinase to shuﬄe fragments within
a cassette has several advantageous characteristics. Recombinases similar to Rci (i.e.
Cre, FLP, PhiC31) have been successfully employed across a wide variety of organisms,
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Figure 2.5: High-throughput sequencing of 11BC Rci cassette after in vivo
shuﬄing - (a) A 6-fragment extension was concatenated with the 5BC cassette to yield
the 11BC cassette. (b) Expression of Rci from the constitutively active pKat promoter
results in robust shuﬄing of a high-diversity 11BC cassette. The colormaps show the
distribution of fragment occupancy at each position in the cassette. Colors are scaled from
0 to 25%. (c) The bias at each position was calculated as the number of times the original
fragment appeared in its original position divided by the number of cassettes. The dotted
black line indicates the expected occupancy of the original fragment at each position in a
cassette with completely random occupancy. (d) The bias at each position within a cassette
subjected to m = 5, 10, or 15 recombination events was simulated. The dotted black line
indicates the expected occupancy of the original fragment at each position in a cassette
with completely random occupancy. The solid black line indicates the data observed in
vivo.
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suggesting that our barcoding system could be easily ported to organisms beyond E.
coli, either by expressing Rci or alternatively, by employing designs that take advantage
of asymmetric mutant recombination sites [Colloms et al. 2014] of other recombinases.
In addition, the system is highly scalable – addition of a single fragment to a cassette
results in an exponential gain in diversity. Moreover, because the input space is small
(only a handful of unique segments), each segment can be designed to be maximally or-
thogonal, thus rendering barcode readout highly robust to DNA sequencing errors. We
took advantage of this fact in designing our barcode reconstruction algorithm, which
relies on local alignment between the known input fragments and the final imperfect
sequence recovered from high-throughput sequencing.
In its current form, however, this paradigm has at least several shortcomings that
will need to be addressed before the system can be used at a larger scale. First,
the expression of the Rci protein must be controlled in order to induce shuﬄing at
a specific time point and then stopped to prevent further recombination events. In
theory this can be accomplished through the use of an inducible promoter (i.e. T7 pro-
moter, Tetracycline-responsive promoter, etc.). In practice, the expression level and
recombination efficiency will need to be monitored at different levels of induction to
permit solubility, genomic stability, and optimal recombination kinetics. Second, the
cassettes, despite their design, were still subject to various poorly understood biases.
Further work will be needed on Rci (and other recombinases) to determine the pair-
wise efficiencies between different recombination sites, the efficiency of recombination
as a function of length between recombination sites, and to increase the recombination
kinetics to achieve the maximal number of recombination events per unit time. As we
saw in our simulations, a higher number of recombination events leads to far greater
diversity and less bias. The biases that we detected, particularly in the case of the
5BC cassette, were likely exacerbated by the fact that we introduced a homogeneous
barcode into exponentially dividing cells, where the kinetics of cell division likely out-
pace that of recombination (at least initially). In terminally differentiated cells, such
as neurons, this is less of an issue as the expression of the recombinase can be sustained
for long periods of times (i.e. weeks or months). However, in the case of dividing cells,
recombinase expression must be pulsed for short durations to allow shuﬄing and then
abruptly stopped to permit lineage tracing. An additional limitation of our design is
that the barcodes are carried on extrachromosomal plasmids and thus cannot be used
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for lineage tracing in organisms that do not allow for plasmid replication and inheri-
tance. Introduction of the cassette into the genome of E. coli can be accomplished by
homologous recombination and should be straightforward. Genetic engineering tools
such as ZFNs, TALENS, or CRISPR will allow introduction of barcode cassettes in
other organisms.
There are two factors that need to be considered in terms of the compatibility of
our technique with current DNA sequencing technology. The first is read depth, or the
number of amplicons that can be read in a single DNA sequencing run. The second
is the read length, or the number of bases that can be obtained for a given amplicon
which is currently the main limitation that constrains the application of our barcoding
system. Over the last several years, both read depth and read length have increased
steadily. It is likely that this trend will continue and that sequencing technology will
soon be able to economically meet the needs of our barcoding system. Furthermore,
additional research on Rci could allow for the optimization of barcode fragment lengths
to permit recombination with shorter fragments – thereby decreasing the length of the
cassette to be within reach of current next-gen sequencing platforms. Nevertheless, it
is useful here to review the current high-throughput sequencing technologies and the
compatibility with the barcoding approach outlined here.
Current Illumina technology produces ∼8 billion reads per flow cell, which is enough
to measure millions of barcoded cells at sufficient depth (assuming a uniform 100 reads
per barcode). The read-depth of high-throughput sequencing is thus well matched to
our current system. The other factor that must be considered is the available read
length of current high-throughput sequencing technology. The longest read lengths
currently offered by Illumina are for the MiSeq platform, which currently offers 2x300
= 600bp reads. This limitation severely constrains the scale of our approach. With
600bp reads we can sample barcode cassettes of length <600bp. With our current
design of 100bp fragments separated by 31bp sfx sites, we can read cassettes with
only n = 4 barcode fragments (∼550bp). This limits the achievable diversity to <100
unique barcodes. “Hacking” techniques are available that can push the read length of
the Illumina technology to longer read lengths; 2x500 has recently been demonstrated
[Birol et al. 2013]. Alternatively, stripping a primer after a certain number of reads
and rehybridizing with a new primer would allow for multiple subreads from the same
amplicon – thus allowing probing of the sequence at various sites for reconstruction of
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the full barcode [Illumina 2014, Mellor and Roth 2014]. Moreover, it is likely that this
technology will continue its steady rollout of improvements to both read-depth and
read-length that will allow for a well-matched economical technology for sequencing
barcodes generated by our method.
Alternative sequencing platforms, including Roche 454 or Pacific Biosciences (used
here), offer different specifications that may be more applicable currently. The PacBio
platform allows ∼100k reads of >1kb, and the newest Roche sequencing platform, the
GS FLX Titanium XL+, offers read lengths of up to 1000bp for ∼700,000 reads. This
would allow monitoring of at least 7000 unique sequences. At 1000bp our cassette
design can reach n = 7 barcode fragments for a total diversity of ∼18,000 barcodes. At
this read length and depth, our barcoding technology is well matched and would allow
tracking of ∼7000 barcodes.
Within these constraints, our technology could be applied immediately to a dissec-
tion of dynamics of a microbial population during various stressors including antimicro-
bials, limited resources, or niche competition. Specifically, our technology is uniquely
positioned to probe serial population bottlenecks, which remain poorly understood
[Elena and Lenski 2003]. A population of cells carrying the barcode cassette can be ex-
posed to transient barcode shuﬄing (Figure 2.6A, B, C). The pool can then be probed
by DNA sequencing to test the original distribution of barcodes (Figure 2.6D). At this
point, the population can be exposed to various stressors resulting in a population bot-
tleneck that selects <1000 barcoded cells (Figure 2.6E). After recovery (Figure 2.6F),
the population can be probed again to measure the resulting distribution of barcodes
(Figure 2.6G). The effect of serial bottlenecks can be measured by additional rounds
of transient shuﬄing and exposure to stressors. Other barcoding techniques, such as
shotgun cloning, would not allow for the serial tracking of population dynamics be-
cause new barcodes would need to be introduced at each stage. Our technique will
be advantageous in any situation in which genetic diversity must be introduced at a
specific point in time (i.e. lineage tracing), or in cells in which the introduction of
genetic material is challenging and/or inefficient.
We have shown that in vivo shuﬄing of a cassette of DNA fragments by a re-
combinase – Rci – can generate significant diversities for cellular barcoding purposes.
Barcoding of individual cells within bacterial or yeast populations should prove to be
a useful tool for population geneticists and evolutionary biologists and will allow for a
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Figure 2.6: Overview of an example in vivo barcoding experiment - (a) A barcode
cassette is integrated into a progenitor cell. (b) The progenitor cell gives rise to a large
population of cells, each harbouring the barcode cassette. (c) Barcodes are generated via
transient activity of the recombinase to yield uniquely labelled cells. (d) The barcode pool
is then probed by DNA sequencing to test the original distribution of barcodes. (e) The
population can be exposed to various stressors resulting in a population bottleneck. (f)
This results in a final pool of barcoded cells. (g) The barcode pool is then be assayed again
by DNA sequencing to test the final distribution of barcodes.
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detailed analysis of population genetics and growth dynamics under various conditions.
The system has few moving parts (all that is needed is Rci and a barcode cassette)
and is likely to work across a variety of higher organisms with optimization. This
system, applied in other organisms could pave the way to the dissection of complex
developmental programs, study of heterogeneity within tissues, and/or probing of in-
teractions between cells in a population (i.e. B- and T-cells, neurons, tumours, etc.).
In vivo barcoding will also pave the way to new explorations in systems biology, from
high-throughput monitoring of non-cell-autonomous spread of genetic material to the
variability of single-cell transcription profiles. In combination with other molecular
tools, in vivo barcoding has the potential to provide biologists with unprecedented
knowledge of the complex orchestration of single cells within populations.
2.6 Supplementary Material
2.6.1 Supplementary Notes
2.6.1.1 Supplementary Note 1
Simulations (see section 2.3 for details) suggested that the Cre cassettes are subject
to considerable biases. Specifically, the ends of barcode fragments are favored for
retention (Figure 2.7A). This is explained by the simple observation that there are
more combinations of lox sites that, when acted on by Cre, will result in the excision
of middle fragments (Figure 2.7B). These inherent biases severely limit the practical
diversities that can be generated with Cre-based cassettes.
2.6.1.2 Supplementary Note 2
For details on initial experiments employing Rci in mammalian cells, see Appendix A.
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2.6.2 Supplementary Figures
Figure 2.7: Biases of the Cre barcode architecture - (a) Simulated Cre recom-
bination on 10,000 cassettes of length n = 100 reveals extreme biases for retaining end
fragments. (b) There are many more pairs of lox sites that can lead to the excision of more
central fragments.
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Figure 2.8: 5BC cassette stability during growth - Sanger sequencing of the 5BC
cassette after several generations of growth in bacterial cells shows no recombination of the
cassette.
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Figure 2.9: T7 induced Rci expression - All of the reconstructed sequences resulting
from shuﬄing by induced expression of Rci from the T7 promoter can be explained by a
single recombination event.
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Figure 2.10: 11BC cassette stability during growth - Sanger sequencing of the 11BC
cassette after several generations of growth in bacterial cells shows no recombination of the
cassette.
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Figure 2.11: Cassettes approach complete randomness as the number of re-
combination events increase - (a) Simulated cassettes subjected to 5, 10, or 15 random
recombination events. The colormaps show the distribution of fragment occupancy at each
position in the cassette. Colors are scaled from 0 to 25%. (b) The bias at each position
was calculated as the number of times the original fragment appeared in its original po-
sition divided by the number of cassettes. The dotted black line indicates the expected
occupancy of the original fragment at each position in a cassette with completely random
occupancy.
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2.6.3 Sequences of relevant genetic elements
2.6.3.1 5BC Cassette (synthesized by IDT)
GCTTTACCTCGCACTGCCCAGAGTGACATGTTTGCGAACCTCATCACTCG
TTGCGGCAATACTTTCGTGCCAATCCGGTACGTGGTGTATGCAAGGGAAA
TTAACGGACGGCCTCAATTCCTGCAAGGTAACGCACCGCGGCCCAAGAGC
CATTAAGCGATATAATCGCACATCTGGCCAACCCGCCACGTACCGGATTG
GCACGCTTGCAGAGAATCCTGGGCTCTTCAACCAACAGTGACGGGGGCTT
ATTAGGAGGATTTTGATACGGACGCGCAACCGTCGTCAGGCAGCTTTGAA
GCCCGTCTCTCCGGATGCCAAGCTTGTTGTGCCAATCCGGTACGTGGCGG
CCGAGTTCGCTCACCTTTTTGAATCCTCGGACGCCATAACTAACAGCCCG
TTTATGGAAGAGTATGCACTGCCTAAGGGCGGAGGGCCAAGAGTCCTCCA
GGTACCGGATTGGCACTGGCCTACGTGCCCCAATTACCACATTAAAGATA
TCTGCACTGGCGTCCCCTCTTCTCGAGGACGAGGGTAAAAAAGCGCCATT
GCACTAGGACTTACCGCGGAGACTGCCTCTGCTGGCCTACGTGCCAATCC
GGTACGTGGCGTTGCATGTATTGCAGCCTCAGGGACGTCAGTGGATCATG
AAGGTAGAGCATGCGTCCTCTGCTGTTAAAATCTGAGTTCTGGACAAACT
ACCAATTGGCCACGTACCGGATTGGCACGAAAGTATTGCCGGACAGCATC
TTCCTTGCCTCAACATGTCGAACACAGTGGCACGATGCATGAGTCT
2.6.3.2 BCextension (synthesized by GeneWiz)
CGCGCTAGCGGCAATACTTTCGTGCCAATCCGGTACGTGGGATATAGGAT
TGATTTTTCTTCACTGTACGCCGGAGAACATAAGAAGCGTCATAACCCTA
TCAGTCCCAAGAATAAGTCCCAGTATTAACTGTTTCAGCACCACGTACCG
GATTGGCACGCTTGCAGAGAAATAGGGAAGGCTCATAGCGTTCGAAGTAG
TTCCCAACCAGAACACTCCTGGTGAGTCGCTGGAAGCCATCTATAGAAAG
GACGACGCTCGGGCCGGTGTAGCCAAGCTTGTTGTGCCAATCCGGTACGT
GGACAACGTCAACGTTAATCTCGTGCATCAGATCCTAGTTGGTTGAGAAC
AGAGCGCGACGTGGGGCTGGGAGCCGATACCCGTAAGTAGGAGAGGGCA
GCCCCAGGTACCGGATTGGCACTGGCCTACGTGCGCCATCGCACCATTAA
ACATACCCGGATCGATATTTAGGTGTGCGGGGCTCCTGCATCAATTAATA
CATCGTTCGAACCAGACCCGTCCATTCATCTCGCCTGCTGGCCTACGTGC
CAATCCGGTACGTGGGCGATTAATCAGCATCCAAGGTTGCACACCGGTTT
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AATCGTGGGACATCGTCAAGCGTCAATATCCTAAAGACCTGCGAGGTTTA
GGCATCAGTGCGGGGCCACGTACCGGATTGGCACGAAAGTATTGCCACCT
CGAAAGTGACGATTGTTATTGATCGGTTTGCACCCCGACCAGCCAGGCAT
CTCATCTCCACGGGGATCGAGGGCATCAATCACATTTGACGGATCCGCG
2.6.3.3 Rci sequence (from NCBI Reference Sequence: NC 013120.1 RE-
GION: complement 7291274066)
ATGCCGTCTCCACGCATCCGTAAAATGTCCCTGTCACGCGCACTGGATAA
GTACCTGAAAACAGTTTCTGTTCACAAGAAAGGGCATCAACAGGAGTTTT
ACCGGAGCAATGTTATCAAGCGATATCCCATTGCTCTTCGGAATATGGAC
GAAATAACAACCGTTGATATTGCTACATACAGAGACGTTCGTTTAGCAGA
AATAAACCCCCGAACGGGTAAAGCCATTACAGGTAATACTGTACGTCTTG
AACTCGCCCTTCTGTCATCTCTGTTCAATATTGCTCGTGTTGAATGGGGA
ACCTGTCGTACTAACCCGGTTGAACTGGTTCGCAAGCCGAAAGTATCCTC
CGGACGAGATCGCCGGCTAACGTCTTCAGAAGAACGTCGCCTTTCTCGCT
ATTTCCGCGAAAAAAATCTGATGTTGTATGTCATTTTCCATCTTGCCCTTG
AAACAGCCATGCGGCAGGGCGAAATACTGGCCTTACGTTGGGAGCACATT
GATTTGCGCCACGGTGTGGCTCATTTACCTGAAACCAAAAACGGTCACTC
ACGGGATGTTCCTCTGTCCAGACGTGCCCGTAACTTTCTTCAAATGATGC
CCGTTAATCTCCACGGCAATGTTTTTGATTACACCGCATCCGGCTTTAAA
AATGCCTGGAGAATAGCCACACAACGACTTCGCATCGAGGACCTGCATTT
TCACGATCTACGGCATGAAGCAATAAGCCGCTTCTTCGAACTGGGTAGCC
TGAATGTAATGGAGATTGCTGCAATATCAGGACATCGTTCCATGAATATG
CTGAAACGGTATACTCATCTTCGTGCATGGCAACTGGTCAGTAAGCTTGA
TGCCCGCCGGCGGCAGACACAAAAAGTGGCAGCATGGTTTGTGCCGTATC
CTGCCCATATCACGACTATCGATGAAGAAAATGGGCAGAAAGCGCATCGT
ATTGAGATCGGTGATTTTGATAACCTTCACGTCACTGCCACAACAAAAGA
GGAAGCAGTTCACCGCGCCAGTGAGGTTTTGTTGCGTACACTGGCCATTG
CAGCACAGAAAGGCGAACGTGTCCCATCTCCCGGAGCGTTACCTGTTAAC
GACCCTGACTACATTATGATTTGCCCTCTGAACCCGGGCAGCACACCGCT
GTAA
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2.6.4 Plasmid maps
All plasmids and associated maps are included online at http://nar.oxfordjournals.
org/content/early/2014/07/09/nar.gku604.abstract, and on Benchling.com: https:
//benchling.com/ipeikon/ipeikon_published/
• IDP190: 5BC Cassette
• IDP205: T7→Rci; 5BC Cassette
• DIG35: pKat→Rci; 5BC Cassette
• BCextension: 6 fragment barcode extension
• DIG70: T7→Rci; 11BC Cassette
• DIG71: pKat→Rci; 11BC Cassette
2.6.5 Description of Supplementary Files
All files are included online at http://nar.oxfordjournals.org/content/early/
2014/07/09/nar.gku604.abstract.
• crecode.m : Simulates Cre recombination on a cassette where fragments are sep-
arated by two lox sites in opposing orientation
• rcicode.m : Simulates Rci recombination on a cassette where fragments are sep-
arated by one sfx site in alternating orientation
• rcicode2.m : Simulates Rci recombination on a cassette where fragments are
separated by two sfx sites in opposing orientation
• randDNA.m : Generates random DNA sequences for bootstrapping SW align-
ment thresholds
• procRCI.m : Processes data from Sanger sequencing to reconstruct barcodes
• procRCI PB.m : Processes data from PacBio sequencing to reconstruct barcodes
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2.6.6 Sequencing data files
All files are included online at http://nar.oxfordjournals.org/content/early/
2014/07/09/nar.gku604.abstract.
• 5BC CCS IDP205.fastq : No Rci expression (T7→Rci; 5BC Cassette)
• 5BC CCS DIG35.fastq : Rci expression (pKat→Rci; 5BC Cassette)
• 11BC CCS DIG71.fastq : Rci expression (pKat→Rci; 11BC Cassette)
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3Encoding neural connectivity
into DNA
3.1 Abstract
Neural circuit mapping is generally viewed as a problem of microscopy. No
current method can achieve high-throughput mapping of circuits with single
neuron precision. Here we describe NO-C, a novel approach that transforms
connectivity into a form that can be read out by high-throughput sequencing
via the tethering of RNA barcodes in synaptic complexes. Improvements
of this technique will allow tracing of larger, more complex circuits, or even
full brains. A high-throughput method for tracing complete, or even partial,
connectivity maps of neural circuits at single neuron resolution could serve
as a foundation for neuroscience research.
3.2 Introduction
Neural networks are incredibly sophisticated computational circuits. However, circuit
architectures remain largely unknown. Low throughput methods of probing connec-
tivity including electrophysiology have provided strong evidence for structural deter-
minants of neural circuit function [Song et al. 2005]. These efforts have uncovered
elements of high-order structure within neural circuits as well as spatially intertwined
but non-interconnected networks [Jiang et al. 2013, Yoshimura and Callaway 2005].
While physiological methods have been successful at highlighting circuit connectivity
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phenomena, they cannot be easily scaled for the analysis of larger neural circuits or a
full nervous system.
High-throughput neural connectivity mapping has traditionally been viewed as a
problem of microscopy – electron microscopy (EM) remains the only technique for the
direct imaging of synapses. Tracing of processes through EM stacks remains challenging
and labor-intensive, but several major efforts are underway to increase the through-
put and autonomy of EM [Briggman and Denk 2006, Chklovskii et al. 2010, Kaynig
et al. 2013, Kleinfeld et al. 2011]. Complementary methods based on molecular tools
aim to make neural circuit tracing amenable to light-microscopy techniques [Feinberg
et al. 2008, Kim et al. 2012, Liu et al. 2013, Livet et al. 2007], but these methods
are currently limited to sparse connectivity mapping. No current method can achieve
high-throughput mapping of the wiring diagram of a neural circuit at single-neuron
resolution.
We recently proposed BOINC, a scheme for harnessing the advances of high-throughput
sequencing to map neural connectivity [Zador et al. 2012]. Here, we establish one such
method and a suite of molecular components for achieving this goal. This method,
which we call NO-C – taking specific inspiration from chromosome conformation cap-
ture (3C) techniques [Dekker et al. 2002, Kalhor et al. 2012] – relies on the associa-
tion of cellular RNA barcodes across synaptic partners via tethering of RNA barcodes
to complementary pre- and post-synaptic transmembrane proteins (Figure 3.1A). The
proteins, in turn, are specifically cross-linked to form a covalent complex that can be im-
munoprecipitated (Figure 3.1B). The RNA barcode pairs are fused and converted into
a single nucleic acid string (Figure 3.1C) and subjected to standard high-throughput
sequencing to determine a connectivity matrix (Figure 3.1D).
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Figure 3.1: Overview of NO-C - (a) A population of pre-synaptic neurons and a popula-
tion of post-synaptic neurons are separately endowed with an RNA barcode and a modified
synaptic protein. The modified synaptic proteins bind the RNA barcodes, thereby tether-
ing barcodes to the pre- or post-synaptic membrane, respectively. The proteins meet at the
synapse. (b) The synaptic complex is cross-linked and purified via immunoprecipitation.
Each complex contains a pre-synaptic and post-synaptic protein bound to a pre-synaptic
and post-synaptic barcode. (c) Barcode pairs representing pairs of connected neurons
are joined, amplified, and sequenced. (d) Sequencing data allows the reconstruction of a
connectivity matrix.
48
3.3 Results
3.3 Results
We employed the synaptic proteins Neurexin1B (Nrx1B) and Neuroligin1AB (Nlg1AB),
which were modified to bind RNA barcodes for tethering at the pre- or post-synapse,
respectively. This was accomplished via the fusion of the 22 amino acid RNA binding
protein, λN, to the cytoplasmic domain of Nrx1B and Nlg1AB, and the engineering
of RNA barcodes to contain four repeats of the cognate RNA binding motify, the 15
nucleotide boxB hairpin.
To permit tight linking of the barcodes across synapses, we fused CLIP and SNAP
to Nrx1B and Nlg1AB, respectively. These self-labeling peptides allow for the specific
cross-linking of the two proteins upon addition of a bifunctional (containing reactive
moieties for both CLIP and SNAP) small molecule in trans [Gautier et al. 2009]. The
small molecule contains domains that allow efficient immunoprecipitation (IP) via bi-
otin, and elution, via a cleavable disulfide bridge (Figure 3.2). To aid in biochemistry
and/or visualization, we fused the protein tag Myc to Nrx1B, and HA to Nlg1AB, and
introduced coding sequences for GFP and mCherry into the pre-synaptic and post-
synaptic barcode transcripts, respectively.
Figure 3.2: BG-PEG-(S-S)-Biotin-PEG-BC cross-linker - This cross-linker is
equipped with functional groups BG and BC, which mediate the covalent tagging of SNAP
or CLIP respectively. In addition, the molecule contains a biotin moiety for immunopre-
cipitation, and a cleavable disulfide bridge for non-denaturing elution.
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Obtaining proteins that successfully met all of our criteria – bind RNA barcodes
specifically and efficiently, traffic to and interact at synapses, and permit specific and
efficient covalent cross-linking – required several iterations. For rapid turnaround, the
majority of initial debugging was done in human embryonic kidney (HEK) cells. Fusion
of CLIP or SNAP alone (to Nrx1B and Nlg1AB, respectively) permitted membrane
trafficking and SNAP/CLIP tagging at the cell membrane (Figure 3.3A) and efficient
cross-linking and immunoprecipitation (Figure 3.3B). Unfortunately, the addition of
λN to the extreme C-terminus of either protein (λN(c)) prevented proper membrane
trafficking. Changing the position of the λN domain to well-tolerated positions within
the C-terminal tails of each protein (λN(i), see subsubsection 3.6.3.4) [Dresbach et al.
2004, Fairless et al. 2008, Sara et al. 2005, Slavoff et al. 2011] ameliorated the trafficking
issues (Figure 3.3C), but RNA barcode binding (1xBoxB) was poor (Figure 3.3D). The
addition of long linkers and four repeats of the λN [Daigle and Ellenberg 2007] at
the same position, permitted proper membrane trafficking (Figure 3.3E) in HEK cells,
but expression of these proteins in neurons resulted in poor trafficking (Figure 3.4)
and little to no transneuronal interaction as measured by the proximity ligation assay
(Figure 3.5, Figure 3.6). We therefore tested a variety of RNA binding domains at
different positions in the C-terminal tail until we found a pair of proteins capable of
transneuronal interaction Figure 3.7, Table 3.1, Table 3.2). Ultimately, a single λN
domain, embedded within the C-terminal tail of Nrx1B or Nlg1AB, and separated by
long linkers on either side, allowed proper trafficking and interaction in neurons. These
proteins failed to strongly bind the RNA barcode with 1xBoxB but did bind the RNA
barcode with 4xBoxB with high efficiency and specificity, with little to no background
(Figure 3.8).
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Figure 3.3: Protein design and testing in HEK cells - (a) Fusion of MYC-
CLIP to Neurexin or HA-SNAP to Neuroligin permits proper membrane trafficking and
CLIP/SNAP tagging in HEK cells. (b) Protein tagging and immunoprecipitation from
transiently transfected HEK cells using the cross-linker BG-PEG-Biotin-PEG-BC. (c) Cell-
surface tagging of proteins with a single internal λN domain. (d) RNA-IP from transiently
transfected HEK cells using the cross-linker BG-PEG-Biotin-PEG-BC. PRE=MYC-Clip-
Nrx1B-λN(i). POST=HA-SNAP-Nlg1AB-λN(i). The λN domains were fused directly to
the protein without linker sequences. (e) Cell-surface tagging of proteins with and internal
4xλN domain. GREEN=CLIP-488, RED=SNAP-488.
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Figure 3.4: Membrane protein tagging in neurons - The addition of CLIP/SNAP
domain or the 4xλN domain alone permits trafficking throughout the cell. Simultaneous
fusion of both domains prohibits proper trafficking.
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Figure 3.5: Proximity ligation assay for detecting transneuronal interactions -
(a) Proteins are probed via a primary antibody and a secondary antibody that is covalently
linked to an oligonucleotide. If the proteins are in close proximity, the oligonucletoides
bridge two additional ”test” oligos to form a circle. (b) Ligase seals the nicks in the circle.
(c) Rolling circle amplification creates many copies of the DNA. (d) The resulting ”rolony”
is probed by a fluorescent oligonucleotide with complementarity. (e) This method can be
used to probe interactions across neurons, for example detecting the interaction of the
synaptic proteins MYC-Nrx1B and HA-Nlg1AB.
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Figure 3.6: Employing PLA to find interacting protein pairs - (a) Pre-synaptic
fusion proteins based on MYC-Nrx1B were tested for interaction with the protein HA-
Nlg1AB in Xona microfluidic chambers. (b) Post-synaptic proteins based on HA-Nlg1AB
were tested for interaction with the protein MYC-Nrx1B in Xona microfluidic chambers.
Red=mCherry, White=PLA signal.
54
3.3 Results
Figure 3.7: Employing PLA to test for compatible RNA binding domains - (a)
Various RNA binding domains fused to Myc-CLIP-Nrx1B were tested for their ability to
interact with HA-Nlg1AB using PLA. (b) Various RNA binding domains fused to HA-
SNAP-Nlg1AB were tested for their ability to interact with Myc-Nrx1B using PLA. (c)
Proteins containing a single repeat of the λN domain were tested for interaction with each
other. Red=mcherry, Blue=Dapi, White=PLA signal.
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Table 3.1: Summary of presynaptic proteins tested by PLA
Presynaptic Protein Postsynaptic Protein PLA Signal?
Myc-Neurexin HA-Neuroligin YES
Myc-CLIP-Neurexin HA-Neuroligin YES
Myc-CLIP-Neurexin-4xλN(i) HA-Neuroligin NO
Myc-CLIP-Neurexin-tdMS2(i) HA-Neuroligin NO
Myc-CLIP-Neurexin-4xλN(c) HA-Neuroligin NO
Myc-CLIP-Neurexin-GFP(c)-4xλN(c) HA-Neuroligin NO
Myc-CLIP-Neurexin-1xλN(i) HA-Neuroligin YES
Table 3.2: Summary of postsynaptic proteins tested by PLA
Presynaptic Protein Postsynaptic Protein PLA Signal?
Myc-Neurexin HA-Neuroligin YES
Myc-Neurexin HA-SNAP-Neuroligin YES
Myc-Neurexin HA-SNAP-Neuroligin-4xλN(i) NO
Myc-Neurexin HA-SNAP-Neuroligin-tdMS2(i) YES
Myc-Neurexin HA-SNAP-Neuroligin-1xλN(i) YES
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Figure 3.8: RNA-IP with 1xλN fusion proteins - PRE: Myc-CLIP-Nrx1B-λN(i)
and POST: HA-SNAP-Nlg1AB-λN proteins were transfected into HEK cells with an RNA
barcode containing either 0xBoxB, 1xBoxB, or 4xBoxB. Immunoprecipitation following
cell-surface biotin tagging allowed purification of protein-RNA complexes.
57
3.3 Results
The final proteins, Myc-CLIP-Nrx1B-1xλN(i) (PRE) and HA-SNAP-Nlg1AB-1xλN(i)
(POST), traffic to the HEK cell membrane (Figure 3.9B), can be joined covalently
by addition of the cross-linker before cell-lysis (Figure 3.9C), bind strongly to RNA
barcodes with the 4xBoxB motif (Figure 3.9D), and are efficiently eluted under mild
reducing conditions (Figure 3.9E).
Figure 3.9: Optimization of biochemistry in HEK cells - (a) The pre- and post-
synaptic components of the No-C system. (b) Membrane tagging of fusion proteins.
Green=CLIP-488, RED=SNAP-488. (c) Immunoprecipitations of proteins from tran-
siently transfected cells, after membrane tagging with BG-PEG-Biotin-PEG-BC. (d) RNA-
IP from transiently transfected cells, after membrane tagging with BG-PEG-Biotin-PEG-
BC. (e) Cleavage of immunoprecipitated complexes via application of DTT.
After optimizing the biochemistry in HEK cells, we moved to test the system in
neurons. First, we confirmed that our protein modifications still permitted proper
trafficking of each protein to the cell membrane in neurons (Figure 3.10A,B). To test
for the interaction of the proteins between neurons, we grew cultured primary neu-
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rons in a dual-chamber microfluidic device [Taylor et al. 2005]. This device allows for
the co-culturing of two fluidically isolated populations of cells that are connected via
microfluidic grooves that permit only the growth of axons between chambers. We in-
fected one population of cells with barcoded Sindbis virus [Gerlach et al. 2013, Golden
et al. 1995, Lu et al. 2011] expressing the pre-synaptic components (Sindbis-PRE) and
the other population of cells with barcoded Sindbis virus expressing the post-synaptic
components (Sindbis-POST) (Figure 3.10C). Interactions between the two proteins
were detected preferentially within the post-synaptic chamber by the proximity liga-
tion assay (PLA, see: Figure 3.10C, Figure 3.5), suggesting preferential trafficking of
the proteins to the pre- and post-synaptic compartments, respectively. Using electron
microscopy, we confirmed that the PLA signals often occur at synapses (Figure 3.10D).
With these functional properties confirmed, we set out to develop a method for
joining RNA barcodes specifically and efficiently. A variety of methods were tested
(see Appendix C for details) before settling on emulsion overlap reverse trancription
PCR. Briefly, application of the cross-linker forms covalent complexes of the pre- and
post-protein, which are in turn tightly bound to barcode RNA. Purified complexes are
released from beads, diluted, and emulsified for overlap PCR fusion [DeKosky et al.
2013] (Figure 3.11) using a microfluidic droplet system (Figure 3.12A) such that each
droplet contains on average < 1 complex (Figure 3.12B, Figure 3.13).
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Figure 3.10: Characterization of system components in neurons - (a) Mem-
brane tagging of neurons infected with Sindbis virus expressing Myc-CLIP-Neurexin1B-
λN(i). GREEN=CLIP-488, Red=mCherry. (b) Membrane tagging of neurons infected
with Sindbis virus expressing HA-SNAP-Neuroligin1AB-λN(i). GREEN=SNAP-488,
Red=mCherry. (c) Cells grown in a microfluidic chamber system allow the separate infec-
tion of two interacting populations of cells. PLA can be used in this system to detect the
transneuronal interaction of the pre-synaptic and post-synaptic proteins. GREEN=GFP,
RED=mCherry. White=PLA. (d) Transmission electron microscopy of PLA rolonies with
incorporated iodo-UTP.
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Figure 3.11: Schematic of overlap RT-PCR - (a) Pre-RNA and Post-RNA molecules
containing the barcode sequences, as well as Solexa I and Solexa II sequences for high-
throughput sequencing. (b) The RNA molecules are reverse transcribed to cDNA. (c)
cDNA is subjected to second strand synthesis using a primer that adds a region of ho-
mology between the preRNA and postRNA. (d) Barcodes are amplified individually via
an external primer and a limiting concentration of internal primers. (e) Internal primers
become limiting and the preRNA and postRNA amplicons perform overlapping PCR. (f)
The fused barcode pairs are further amplified using the external primers, before being
subjected to (g) nested PCR amplification using the sequencing primers.
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Figure 3.12: Emulsion PCR for barcode joining - (a) Uniform emulsion droplets
are formed in a microfluidic device at the interface between the aqueous stream containing
PCR mix and the surfactant stream. The emulsion is collected on the microfluidic device
before transferring to a PCR tube. (b) Two separate barcode pairs (A-A and B-B) are
subjected to uniform emulsions simultaneously to probe the concentrations at which overlap
PCR becomes promiscuous. Fraction=.5 is equivalent to an aqueous (non-emulsified) PCR
reaction. Here RNA molecules containing both an pre- and post- segment were employed.
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Figure 3.13: Probing emulsion occupancy via qPCR - (a) DNA molecules containing
a pre- and post- segment were employed for emulsion PCR. Two separate barcode pairs (A-
A and B-B) were emulsified simultaneously and cross-over rates (A-B B-A) were measured
via qPCR. (b) RNA was input to the emulsion. (c) Immunoprecipitated complexes from
two separate immunoprecipitaitons (A-A and B-B) were emulsified. Here the emulsions
were created using a bench-top vortex and are non-uniform in size.
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Sequencing of barcode pairs from complexes formed at the HEK cell membrane gave
results which matched the real-time PCR-based quantification. We obtained ∼100 pre-
synaptic barcodes and ∼100 post-synaptic barcodes, resulting in ∼1000 barcode pairs.
By performing two “zip-coded” experiments in parallel (barcodes are tagged with an
additional sequence, a “zip-code” corresponding to the experiment) and mixing the
complexes at lysis, we find that there is a low, but significant false-positive rate of
∼15% (barcodes from one experiment joined to barcodes of another experiment). This
false-positive rate, importantly, only measures false-positives arising from biochemical
procedures post-lysis (i.e. protein-RNA dissociation, insufficient dilution for emulsions,
etc.). It cannot quantify the false-positive barcode pairs that result from aberrant
localization of the proteins or any other in vivo effects. The false-positive rate appears
to be dominated by the emulsion input concentration (Figure 3.12B, Figure 3.13), and
therefore this can be limited by further dilution of the complexes before emulsification.
Although each of the required biochemical components (barcoding, protein-joining,
RNA barcode joining) has been established, further work will be needed for tracing a
neuronal circuit. First, RNA immunoprecipitations (RNA-IPs) and protein-crosslinking
must be validated in neuronal cells. While the HEK cell results show that RNA-IPs
are efficient and specific with these proteins, the effect of a different cellular context
in neurons must be examined. In addition, the cross-linker (4A long), is significantly
shorter than the lower limit of PLA. It remains possible that the cross-linker will need to
be extended in order to enable efficient cross-linking in neurons. Cleavage of Neurexin
and Neuroligin has been observed in vivo [Peixoto et al. 2012, Saura et al. 2011, Suzuki
et al. 2012] and this cleavage could be significant if it separates the RNA binding
domain from the extracellular CLIP/SNAP domains. Indeed, we have observed that
our proteins, when expressed in neurons, are significantly lower in molecular weight than
when expressed in other cell types. This correlates with decreased enrichment of the
barcode transcripts during RNA-IPs from neurons. Currently, we are testing various
methods to limit cleavage of the proteins after in situ tagging with the cross-linker.
Finally, the expression levels of the proteins from Sindbis must be considered. Over-
expression of certain proteins can cause aberrant localization which will result in either
false-negative barcode pairs, or worse, false-positives arising from nearby processes of
non-synaptic partner cells that express the two-components required for cross-linking.
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Further characterization of the proteins and their localization (and importantly their
interaction zone) is underway using electron microscopy.
This method should serve as a platform for future development towards encoding
neural connectivity, and/or other biological variables – including cellular activity and/or
identity – into a form that can be read by high-throughput sequencing, a technology
which already operates at the scale of the complexity of neural circuits. Improvements
to this method that allow for the co-expression of all of the components within the same
cells – for example, by employing two separate RNA binding domains (Figure 3.7B, Ta-
ble 3.1, Table 3.2) – will allow for bi-directional and local-circuit mapping. Transgenic
techniques, combined with an in vivo barcoding scheme [Peikon et al. 2014] will allow
for scaling this technology to mapping full brains. Spatial positioning of barcoded cells,
while lost in the simplest incarnation, can be recovered by a variety of methods [Zador
et al. 2012], most notably by performing fluorescence in situ sequencing (FISSEQ, see
Appendix F) [Lee et al. 2014].
High-throughput methods for mapping neuronal circuits will have a profound im-
pact on neuroscience research. Circuits can be mapped at different developmental
time-points, across animals with different genetic abnormalities, after discrete behav-
ioral experiences, and/or after exposure to various pharmacological compounds. By
employing DNA sequencing, the field of connectomics may enter an era of “big data”
currently being experienced by other fields of biology, which were the first to harness
DNA sequencing for deciphering genomes and transcriptomes.
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3.4 Materials and Methods
3.4.1 HEK293 cultures
HEK293 cells were grown under standard conditions at 37◦C with 5% CO2 in DMEM
supplemented with 10% FBS and 5% Pen-Strep. Cells are cultured in tissue culture
plates coated with poly-L-lysine to aid adherence to the plate.
3.4.2 Neuronal cultures
Primary cultures of dissociated mouse hippocampal neurons were prepared from E18
mice. Briefly, brains are isolated and placed into cold HBSS. Hippocampi are isolated
and washed 2X with HBSS before being subjected to incubation in HBSS + trypsin
+ DNAse for 15min at 37deg with gentle periodic agitation. Cells are dissociated by
pipetting up and down with a pipette and then a fire polished Pasteur pipette. Cells
are spun at 1000g for 10min at 4◦C, resuspended, counted, and plated at a density
of 200,000 cells per well of a 12-well plate. Neurons are cultured in Neurobasal (Life
Technologies) + 2% B27 (Life Technologies) + 1% Pen-Strep + 0.5mM L-glutamine.
For the first 4 days after dissociation, glutamate is added to the solution at a final
concentration of 125µM. The cells are incubated at 37◦C with 5% CO2.
3.4.2.1 Xona microfluidic cultures
Microfludic chambers (Xona Microfluidics, LLC) are bonded to clean, sterile, and
coated (0.5mg/mL poly-D-lysine) by lightly pressing the microfluidic device on the
glass. 100,000 dissociated hippocampal neurons are plated on each side of the microflu-
idic device. Cells are grown under conditions as described above.
3.4.3 Plasmid construction
All plasmids were constructed with Gibson Assembly and the sequences of all final
plasmids used in this study are available upon request. Briefly, we performed scarless
assembly of up to 6 fragments simultaneously using Gibson assembly. Plasmid back-
bones containing the EF1a promoter and an SV40 polyA tail were amplified by PCR
using primers with complementarity to the inserts. Inserts were prepared by PCR using
primers with complementary to the adjacent fragment (either the vector backbone of
an additional insert).
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3.4.4 Sindbis Production
Sindbis vectors were engineered as aforementioned, using Gibson assembly. Our Sindbis
vectors contain either one or two subgenomic promoters, allowing the production of two
functional transcripts/proteins in infected cells. To produce virus, ∼10µg of vector is
linearized using the PacI site after the subgenomic expression cassette. The linearized
plasmid is purified with a phenol:chloroform extraction, followed by a chloroform extrac-
tion, followed by an ethanol precipitation overnight at -80◦C. The DNA is resuspended
to 500ng/µL and 1µg is used for in vitro transcription from the SP6 promoter using the
mMEssage mMachine SP6 in vitro transcription kit (Life Technologies). The in vitro
transcribed RNA is directly transfected into BHK cells via lipofection, using Lipofec-
tamine 2000 (Life Technologies) according to the manufacturer’s instructions. 24 hours
after transfection, the supernatant is isolated and subjected to ultracentrifugation at
30,000rpm for 2hr in an SW50 rotor. The supernatant is removed and the viral pellet
is resuspended in < 200µL of the remaining cell culture media.
3.4.4.1 Sindbis titering
All viruses are titered via qPCR. Briefly, a standard was prepared by estimating the
number of copies of a Sindbis plasmid from the concentration measured by a spectropho-
tometer (NanoDrop). After isolation of virus by ultracentrifugation, a 1µL aliquot is
mixed with RNAse1 (Epicenter) according to the manufacturer’s instructions (30min
at 37◦C). The RNAse digestion is terminated by the addition of 1mL of Trizol (Life
Technologies), and RNA extraction is performed according to the manufacturer’s in-
structions. RNA is precipitated by adding 1µL of glycoblue (Life Technologies) and
centrifugation for 30min at maximum speed at 4◦C. RNA is resuspended in 6µL of
H2O, and 2µLof RNA are reverse transcribed with a gene-specific primer (j032: 5’-
GGGTCGCCTTGCTTGAAGTG-3’) that primes in the nonstructural protein using
SuperScriptIII (Life Technologies) according to the manufacturer’s instructions. Se-
rial dilutions of the cDNA (1:10 and 1:100) are prepared and 1µL of each is used as
the input to a qPCR using primers (j033: 5’-TATCCGCAGTGCGGTTCCAT-3’ and
j034: 5’-TGTCGCTGAGTCCAGTGTTGG-3’) that bind to the non-structural pro-
teins. The CT values are converted to genome copies by comparing to the standard,
also subjected to the qPCR procedure.
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3.4.5 Barcode Library Production
20ug of plasmid DNA is digested for 2hrs at 37◦C with two restriction enzymes that
were engineered within the RNA coding sequence (NotI-MluI, New England Biolabs).
10-20U of each restriction enzyme is used per µg of DNA. The distance between the
restriction sites is engineered to be ¿10 but ¡30 nt to obviate the need for gel extraction.
Following digestion, the reaction is heat inactivated at 65 or 80◦C for 20min (dependent
on the restriction enzymes used). The reaction is allowed to cool to room temperature
and then 1U/µg of Alkaline Phosphatase is added and incubated for 1hr at 37◦C. The
digested DNA is purified via a purification column (Promega Wizard SV PCR Cleanup)
according to the manufacturer’s instructions.
To prepare the insert, oligonucleotides with a random barcode sequence, flanked by
restriction sites are synthesized and PAGE purified. The oligonucleotides are double
stranded using a reverse primer and Accuprime Pfx (Invitrogen: Accuprime Pfx Super-
mix) under the following thermocycling protocol: 95◦C for 5min followed by 15 cycles
of 95◦C for 15sec, 55◦C for 30sec, and 68◦C for 20sec, followed by a final extension at
68◦C for 5min.
After double stranding, the insert is purified via a purification column (Promega
Wizard SV PCR Cleanup) according to the manufacturer’s instructions. The DNA is
then digested at 37◦C for 2hrs, and purified again via column.
Ligation is performed at a molar ratio of 1:6 (vector to insert) overnight at 4◦C
using T4 DNA ligase (New England Biolabs). We typically ligate approximately 1µg
of DNA to achieve a diversity of 1M barcodes. For different diversities, the ligation
reaction can be scaled up or down. The next day, the ligation product is purified with
AmpureXP DNA beads (Agencourt, Beckman Coulter) according to the manufacturer’s
instructions. The DNA is eluted in 40µL of H2O and electroporated into competent E.
coli (TOP10, Invitrogen), recovered in 50mL SOC for exactly 1hr, and grown overnight
in selective LB at 37◦C. 1/1000 of the recovered cells are plated for estimation of colony
count (i.e. rough estimation of diversity). The next day, DNA is purified via a high-
capacity DNA preparation kit (Qiagen Megaprep).
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3.5 Tagging with BG/BC derivatives
BG- and BC- functionalized derivatives, including the bifunctional cross-linkers were
provided by New England Biolabs (NEB) and used according to the manufacturer’s
instructions. Briefly, a stock of 1mM tag was prepared by diluting 50nmol of the
lyophilized tag in 50µL of anhydrous DMSO. Cells expressing cell-surface CLIP- or
SNAP-fusion proteins were labeled with 5µM tag in DMEM (with 10% FBS). Cells
were incubated with the tag for 30min, washed 3X with DMEM, and prepared for
imaging and/or immunoprecipitation.
3.5.1 Immunoprecipitation
3.5.1.1 Protein immunoprecipitation
After tagging with biotinylated linkers, cells are lysed in ∼1mL of lysis buffer PLB3
per 1M cells. PLB3, a previously described lysis buffer [Bottos et al. 2009] contains
20mM TrisHCl, 150mM NaCl, 4mM KCl, 2.5mM MgCl2, 2.5mM CaCl2, 10% glycerol,
1% CHAPS, 1% TritonX-100, and protease inhibitors (Roche Complete EDTA-free
protease inhibitor). The cells are lysed in the well by pipetting 5-10 times per well
and the lysates are incubated on ice for 30 min, pipetted again, and then spun at top
speed for 30 min at 4◦C to pellet cell debris. A fraction of the lysate is preserved for
total protein analysis via western blot or other means. The remainder of the lysate is
loaded onto 100µL of pre-washed Dynabeads M280 Streptavidin magnetic beads (Life
Technologies) per 1M cells and incubated with gentle rotation overnight at 4◦C. Beads
are washed 6x with PLB3 with ascending salt concentrations (2x with 150mM NaCl,
2x with 300mM NaCl, and 2x with 500mM NaCl).
3.5.1.2 Elution
Protein samples are eluted via addition of 15mM DTT for 1hr at 37◦C (if the cleavable
cross-linker has been used) or via heating to 95◦C in SDS for 5min.
3.5.1.3 Western Blotting
We used antiMYC tag antibody, clone A46 (Millipore) for the detection of the pre-
synaptic proteins and antiHA tag antibody, HA.11 (Covance) for the detection of the
post-synaptic proteins.
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3.5.1.4 RNA immunoprecipitation
RNA-IPs are performed similarly to protein immunoprecipitations (see subsubsec-
tion 3.5.1.1 with slight modifications. For RNA-IP, cells are lysed in PLB3R – PLB3
with the addition of RNAse inhibitors (100U/mL lysis buffer RNAsin, Promega).
For emulsions, the complexes are eluted from beads under non-denaturing condi-
tions (with DTT) and input into emulsions as described (see subsubsection 3.5.3.3).
For qPCR, after the 6X washes, the beads are resuspended in 400µL Proteinase K
buffer (100mM Tris-HCL pH 7.5, 12.5mM EDTA, 150mM Nacl, 1%SDS) with 2µL of
GlycoBlue and 20µL of Proteinase K. The samples are incubated at 65◦C for 1 hour
with gentle shaking (Eppendor mixer). RNA is extracted with acid phenol:chloroform,
then chloroform, and then precipitated overnight in ethanol at -80◦C. RNA is pelleted
via centrifugation, washed once with 70% EtOh, and then resuspended in 10µL of H2O.
The RNA is then subjected to DNAse digestion (RQ1 RNAse-free DNAse, Promega)
according to the manufacturer’s instructions. Finally, the RNA is reverse transcribed
and the cDNA is used as input for qPCR.
Enrichment in qPCR is calculated by first calculating the ∆Ct values for IP-Total
for a housekeeping gene (B-actin) and the barcode containing transcripts – mCherry
or GFP. ∆∆Ct is calculated by BC-Actin.
3.5.2 Proximity Ligation Assay
Neurons grown in Xona microfluidic chambers were fixed in 4% PFA in 0.1M PBS for
15 min at 25◦C, washed 2X in PBS, and washed 1X in PBS+glycine for 5 min. We then
employed the Duolink PLA kit (Sigma) according to the manufacturer’s instructions.
For the detection of the pre-synaptic proteins, we used a goat anti-MYC antibody
(Abcam ab9132), which recognizes the MYC tag on the extracellular domain of the
presynaptic proteins. For detection of the post-synaptic proteins, we used a rabbit anti-
HA antibody (abcam9110), which recognizes the HA tag on the extracellular domain of
the postsynaptic proteins. Secondary antibodies were obtained from Duolink: MINUS
Probe Donkey anti-Rabbit (Sigma DUO92005) and PLUS Probe Donkey anti-Goat
(Sigma DUO92003). The Duolink in situ far red detection reagents (Sigma DUO92013)
were used for detection.
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3.5.2.1 Electron Microscopy of PLA signals
Here, we modify the above procedure to allow visualization of the PLA rolonies with
EM. Neurons grown in Xona microfluidic chambers were fixed in 4% PFA in 0.1M PBS
for 15 min at RT, washed 2X in PBS, and washed 1X in PBS+glycine for 5 min. The
samples were then blocked in PBS + 1%BSA at 37◦C for 1 hour. Samples are then in-
cubated in primary antibodies (1:1000 in PBS+1%BSA) at 25◦C for 1 hour, washed 3X
for 5 min each in PLA Buffer A (minus Tween20). Samples are then incubated in PLA
probes diluted 1:5 in PBS+1%BSA at 37◦C for 1 hour, washed 2X for 5 min each in
PLA Buffer A (minus Tween20). The samples are then incubated with ligation mix for
30 min at 37◦C, washed 2X for 2 min each in PLA Buffer A (minus Tween20). Samples
are then incubated with amplification mix containing: .25mg/mL BSA (Life Tech-
nologies), 10mM each dATP, dCTP, dGTP (Roche), 5’-iodo-dUTP (Jena Biosciences),
.02um compaction oligo (a generous gift from Olaf Ola Sderberg), and .25U/µL Phi29
polymerase (NEB) diluted in 1X Phi29 buffer (NEB) in a total volume of 50µL at 37◦C
for 70min. Following amplification, the samples are washed 2X for 10 min each with
PLA Buffer B, and washed again for 1 min with 0.01X PLA Buffer B before proceeding
to EM fixation.
For EM, cells are fixed by immersion in 3% glutaraldehyde in .1mol/L PB at 4◦C
overnight (coverslips were fixed in a 60mm petridish). The samples were rinsed 2X in
DI water to remove glutaraldehyde and then post-fixed in 1.5% potassium ferrocyanide
and 1% glutaraldehyde in DI water for 1 hour. Cells were rinsed once in DI water to
remove osmium, dehydrated with a series of increasing % of ethanol, and embedded in
50% acetone-epon araldite resin.
The glass coverslip was removed by placing the block glass slide down in a plastic
petri dish containing 1mL of hydrofluoric acid overnight, and the remaining block was
rinsed for 10min in a large beaker. The block was dried, mounted on an epoxy stub for
micratomoe sectioning. Enface sections were made of the block-face, counter-stained
with lead citrate for 1 minute, and imaged with a Hitachi H7500 TEM at 75kv. EM
negatives were scaneed at 2400dpi with an Epson Perfection V750 pro scanner.
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3.5.3 Emulsion Overlap PCR
3.5.3.1 Design and construction of microfluidic device
Microfluidic chips were PDMS/glass hybrids fabricated using soft-lithography as pre-
viously described [Brouzes 2012]. Microfluidic channels were treated with a fluori-
nated tri-chloro silane reagent (heptadecafluoro-1,1,2,2- tetrahydrodecyl)trichlorosilane
(Gelest) diluted at 1% weight in FC3280 oil (3M). The microfluidic chips were mounted
on an inverted microscope (Motic, AE31) equipped with a Firewire camera (Scout
scA640-120fm, Basler), and illuminated by a high power LED (Luxeon) driven by a
MOSFET circuit connected to one of the digital output pins of a multifunction data
acquisition card (NI PCIe-7841R, National Instruments).
3.5.3.2 Generation of emulsion droplets
Fluids were actuated by a set of pressure controllers (MPV1, Proportion Air), which
were controlled by a Labview (National Instruments, TX) application via a micropro-
cessor (Arduino). We generated 13 pL (29 m diameter) droplets at 1 kHz, using a
15µm deep x 20µm wide hydrodynamic focusing nozzle. Droplets were stabilized with
a PEG-Krytox based surfactant [Holtze et al. 2008] dissolved at 1% weight in HFE7500
fluorinated oil (3M). Stability through thermocycling was further increased by adding
Tetronic 1307 (BASF) at 1% weight to the RT-PCR mixture [Tewhey et al. 2009].
Droplets were collected into 0.2 mL PCR tubes, the bulk oil phase was removed, and
the reaction was subjected to thermocycling as described below (subsubsection 3.5.3.3).
After completion of the reaction, samples were released by destabilizing the emulsion
by addition of one volume of destabilizing agent (Raindance Technologies).
3.5.3.3 One-step overlap reverse-transcription PCR
One-step overlap RT-PCR was performed in emulsions as previously described [DeKosky
et al. 2013]. A 100µL RT-PCR mixture was made containing:
• IP input (variable)
• 25µL OneStep MasterMix
• 5µL Primer 759 (10µM)
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• 5µL Primer 760 (10µM)
• 5µL Primer 761 (1µM)
• 5µL Primer 762 (1µM)
• 20µL 5% Tetronic
• H2O to 100µL
Briefly, RT was performed for 30 min at 55◦C, followed by 2 minutes at 94◦C. PCR
amplification was performed with the following thermocycling conditions. 1 cycle of:
94◦C for 30s, 50◦C for 30s, 72◦C for 2 min; followed by 4 cycles of: 94◦C for 30s, 55◦C
for 30s, and 72◦C for 2 min; followed by 22 cycles of 94◦C for 30s, 60◦C for 30s, 72◦C for
2 min; followed by a final extension step for 7 min at 72◦C. After thermal cycling, the
emulsion was visually inspected to ensure stability. The emulsions were broken with
emulsion destabilizer (Raindance Technologies), and the aqueous phase was collected
for subsequent purification. The PCR product was purified using a spin-column clean-
up kit (Promega Wizard SV PCR Cleanup Kit).
Table 3.3: Overlap reverse-transcription primers
Primer ID Primer Name Primer Sequence
759 emPre-RT 5’-CAGCTCGACCAGGATGGGCA-3’
760 emPost-RT 5’-TTCAGCTTGGCGGTCTGGGT-3’
761 OE-PostF 5’-TATTCCCATGGCGCGCCGCTGGTCGGTACGGTAACGGA-3’
762 OE-PreF 5’-GGCGCGCCATGGGAATACGGACGATGCCGTCCTCGTA-3’
3.5.4 Nested PCR & DNA sequencing
A nested PCR amplification was performed (Accuprime Pfx Supermix) in a total vol-
ume of 100µL using 10µL of eluted cDNA as template with 100nM primers under the
following conditions: 2 min 94◦C; followed by 30 cycles of 94◦C for 30s, 62◦C for30s,
and 72◦C 30s; followed by a final extension at 72◦Cfor 7 min. The final product was
purified by gel electrophoresis and sequenced using the PE50 protocol on the MiSeq
platform (Illumina, San Diego, CA).
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3.6.1 RNA design
The pre-synaptic and post-synaptic RNA are based on GFP and mCherry coding
sequences, respectively. In the 5’UTR of the preRNA we placed an anchor sequence
(preHandle), a 100bp spacer sequence, a NotI restriction site (for BC cloning),
the reverse complement of a qPCR tag denoting the library batch (A or B), a 30nt
barcode, the reverse complement sequence of the Illumina sequences P5-SBS3T, and
a MluI restriction site for barcode cloning. In the 5’UTR of the postRNA we placed
an anchor sequence (postHandle), a 100bp spacer sequence, a MluI restriction site
(for BC cloning), the reverse complement of a qPCR tag denoting the library batch
(A or B), a 30nt barcode, the reverse complement sequence of the Illumina sequences
P7-SBS8, and a NotI restriction site for barcode cloning. In the 3’UTR of both
sequences, we placed 4 repeats of the boxB hairpin motif (4xBoxB).
3.6.2 Sequences of RNAs
3.6.2.1 preRNA coding sequence
CGGACGATGCCGTCCTCGTAGTTCGGGCATGTACTGGAGCCGA
GAGGTAACCTCATTATAATCGTTCGCTATTCAGGGATTGACCAA
CACCGGAAAACATCTCACTTGAAGTAATATATACGACAGAGTCG
CGGCCGCAACCGGTGGACACGTCTTATGTGNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNAGATCGGAAGAGCGTCGTGTAGGGA
AAGAGTGTAGATCTCGGTGGTCGCCGTATCATTACGCGTGCCAC
CATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCC
ATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCA
GCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCT
GACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCT
GGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTC
AGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTC
CGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCA
AGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGA
GGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGAC
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TTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACA
ACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAG
AACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGG
ACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCC
ATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAG
CACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGAT
CACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCT
CGGCATGGACGAGCTGTACAAGTAAAGATCTTACCTAATTGCCG
TCGTGAGGTACGACCACCGCTAGCTGTACAGCCCTGAAAAAGG
GCTCGAGCCCTGAAAAAGGGCAATTGCCCTGAAAAAGGGCGTC
GACGCCCTGAAAAAGGGCGGAATTCATGTCCAATTTACTGACTG
TACACCAAAATTTGCCTGC
3.6.2.2 postRNA coding sequence
GCTGGTCGGTACGGTAACGGAGAGTCCGTCCCCTCTTATCCTCG
GCGTTGTGTGTCAAATGGCGTAGATCTGGATTGACTCTATGACG
GTATCTGCTGATCGGTAGGGAGACCGAGAATCTATCGGGCTAA
CGCGTAACCTCCGAAAATGCTGGCACCNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNAGATCGGAAGAGCGGTTCAGCAGGAATG
CCGAGACCGATCTCGTATGCCGTCTTCTGCTTGGCGGCCGCACT
AATCTAGGCCACCATGGTGAGCAAGGGCGAGGAGGATAACATG
GCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGG
GCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGA
GGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTG
ACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCC
TCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCG
ACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAG
TGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCG
TGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAG
GTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAAT
GCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATG
TACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGC
TGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGAC
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CACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACA
ACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTAC
ACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCA
CCGGCGGCATGGACGAGCTGTACAAGTCTTAGAGATCTTACCTA
ATTGCCGTCGTGAGGTACGACCACCGCTAGCTGTACAGCCCTGA
AAAAGGGCTCGAGCCCTGAAAAAGGGCAATTGCCCTGAAAAAG
GGCGTCGACGCCCTGAAAAAGGGCGGAATTCATGTCCAATTTAC
TGACTGTACACCAAAATTTGCCTGC
3.6.3 Protein design
We started with the interacting synaptic proteins – the presynaptic protein Neurexin1B
(Uniprot Accesion Number: P0DI97, isoform 1b) and the post-synaptic protein
Neuroligin1AB (Uniprot Accesion Number: Q99K10, isoform 1).
3.6.3.1 Neurexin1B Amino Acid sequence
MYQRMLRCGADLGSPGGGSGGGAGGRLALIWIVPLTLSGLLGVAW
GASSLGAHHIHHFHGSSKHHSVPIAIYRSPASLRGGHAGTTYIFSKG
GGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDY
LELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNA
TLQVDSWPVIERYPAGNNDNERLAIARQRIPYRLGRVVDEWLLDK
GRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDA
NIAIVGNVRLVGEVPSSMTTESTATAMQSEMSTSIMETTTTLATSTA
RRGKPPTKEPISQTTDDILVASAECPSDDEDIDPCEPSSGGLANPTR
VGGREPYPGSAEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRN
RDEGSYHVDESRNYISNSAQSNGAVVKEKQPSSAKSANKNKKNKD
KEYYV*
3.6.3.2 Neuroligin1AB Amino Acid sequence
MALPRCMWPNYVWRAMMACVVHRGSGAPLTLCLLGCLLQTFHV
LSQKLDDVDPLVTTNFGKIRGIKKELNNEILGPVIQFLGVPYAAPPT
GEHRFQPPEPPSPWSDIRNATQFAPVCPQNIIDGRLPEVMLPVWFT
NNLDVVSSYVQDQSEDCLYLNIYVPTEDGPLTKKHTDDLGDNDGAE
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DEDIRDSGGPKPVMVYIHGGSYMEGTGNLYDGSVLASYGNVIVITV
NYRLGVLGFLSTGDQAAKGNYGLLDLIQALRWTSENIGFFGGDPLR
ITVFGSGAGGSCVNLLTLSHYSEGNRWSNSTKGLFQRAIAQSGTALS
SWAVSFQPAKYARILATKVGCNVSDTVELVECLQKKPYKELVDQD
VQPARYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEG
LKFVENIVDSDDGVSASDFDFAVSNFVDNLYGYPEGKDVLRETIKF
MYTDWADRHNPETRRKTLLALFTDHQWVAPAVATADLHSNFGSP
TYFYAFYHHCQTDQVPAWADAAHGDEVPYVLGIPMIGPTELFPCN
FSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEE
VAWTRYSQKDQLYLHIGLKPRVKEHYRANKVNLWLELVPHLHNLN
DISQYTSTTTKVPSTDITLRPTRKNSTPVTSAFPTAKQDDPKQQPSP
FSVDQRDYSTELSVTIAVGASLLFLNILAFAALYYKKDKRRHDVHRR
CSPQRTTTNDLTHAPEEEIMSLQMKHTDLDHECESIHPHEVVLRTA
CPPDYTLAMRRSPDDIPLMTPNTITMIPNTIPGIQPLHTFNTFTGGQ
NNTLPHPHPHPHSHSTTRV*
3.6.3.3 Protein-protein interaction
The first problem that needed to be solved, was to engineer a tight interaction, if
possible covalent, between the two proteins, specifically at synapses. In addition, we
desired an interaction that would not preclude the co-expression of the protein partners
in the same cell – a requisite for complete circuit tracing. The reconstitution of GFP
results in a tight, albeit non-covalent, complex of two proteins spanning the synaptic
cleft. This interaction, better known as GRASP [Feinberg et al. 2008, Kim et al.
2012, Yamagata and Sanes 2012] could be used to associate two synaptic partners in
our context. Therefore, we employed the selective cross-linking (SCROSS) system, as
described [Gautier et al. 2009]. We fused MYC-CLIP and HA-SNAP to Nrx1B
and Nlg1AB, respectively. In both cases, fusion was directly after the signal peptide
sequence (after amino acid G46 in Nrx1B and K47 in Nlg1AB).
3.6.3.4 RNA-binding
In order to bind RNA, we needed to find positions within the cytoplasmic tails of each
protein that would tolerate a fusion protein. We fused Linker-λN-Linker after AA
S423 in Nrx1B and after T776 in Nlg1AB.
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The full coding sequence and AA sequence of each protein are given below. Anno-
tated plasmid maps are available upon request.
3.6.3.5 Coding Sequence: Myc-CLIP-Nrx1B-λN(i)
ATGTACCAGAGGATGCTCCGGTGCGGCGCCGATCTGGGATCGC
CCGGGGGCGGCAGTGGCGGCGGCGCAGGGGGGCGCCTGGCCCT
GATCTGGATAGTCCCGCTCACCCTCGGCGGCCTCCTAGGAGTGG
CCTGGGGGGAATTCGAACAAAAACTCATCTCAGAAGAGGATCT
ACAATTCATGGACAAAGACTGCGAAATGAAGCGCACCACCCTG
GATAGCCCTCTGGGCAAGCTGGAACTGTCTGGGTGCGAACAGG
GCCTGCACCGTATCATCTTCCTGGGCAAAGGAACATCTGCCGCC
GACGCCGTGGAAGTGCCTGCCCCAGCCGCCGTGCTGGGCGGAC
CAGAGCCACTGATCCAGGCCACCGCCTGGCTCAACGCCTACTTT
CACCAGCCTGAGGCCATCGAGGAGTTCCCTGTGCCAGCCCTGCA
CCACCCAGTGTTCCAGCAGGAGAGCTTTACCCGCCAGGTGCTGT
GGAAACTGCTGAAAGTGGTGAAGTTCGGAGAGGTCATCAGCGA
GAGCCACCTGGCCGCCCTGGTGGGCAATCCCGCCGCCACCGCC
GCCGTGAACACCGCCCTGGACGGAAATCCCGTGCCCATTCTGAT
CCCCTGCCACCGGGTGGTGCAGGGCGACAGCGACGTGGGGCCC
TACCTGGGCGGGCTCGCCGTGAAAGAGTGGCTGCTGGCCCACG
AGGGCCACAGACTGGGCAAGCCTGGGCTGGGTGTCGACGGTAC
CGCATCCAGTTTGGGAGCGCACCACATCCACCATTTCCATGGCA
GCAGCAAGCATCATTCAGTGCCTATTGCAATCTACAGGTCACCA
GCATCCTTGCGAGGCGGACACGCTGGGACGACGTATATCTTTAG
CAAAGGTGGTGGACAAATTACATATAAGTGGCCTCCTAATGACC
GACCCAGTACACGAGCAGACAGGCTGGCCATCGGGTTTAGCAC
TGTTCAGAAGGAAGCAGTGTTGGTGCGTGTGGACAGTTCCTCA
GGCCTGGGTGACTACCTTGAGCTGCACATACACCAAGGAAAAAT
TGGAGTTAAATTTAATGTTGGGACAGATGACATCGCCATTGAGG
AGTCCAATGCAATCATTAATGATGGAAAATACCATGTAGTGCGT
TTCACGAGGAGTGGTGGCAATGCCACGTTACAGGTGGACAGCT
GGCCAGTCATCGAACGATACCCTGCAGGGCGTCAGCTCACAATC
TTCAATAGCCAAGCAACCATAATAATTGGCGGGAAAGAGCAGG
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GCCAGCCCTTCCAGGGCCAGCTCTCTGGGCTTTACTACAATGGC
TTGAAAGTTCTGAATATGGCGGCAGAGAACGATGCCAACATCG
CCATAGTGGGAAATGTGAGGCTGGTCGGTGAAGTGCCTTCCTCT
ATGACAACTGAGTCGACAGCCACTGCCATGCAGTCCGAGATGTC
CACCTCAATCATGGAGACCACCACAACCCTGGCTACCAGCACAG
CTCGACGAGGAAAGCCCCCCACAAAGGAGCCTATCAGCCAGAC
CACGGATGATATCCTTGTGGCCTCGGCAGAGTGTCCCAGCGACG
ATGAGGACATTGACCCCTGTGAGCCGAGCTCAGGTGGGTTAGC
CAACCCCACCCGAGTGGGCGGCCGCGAACCATACCCAGGCTCG
GCAGAGGTGATCCGGGAGTCTAGCAGTACCACTGGCATGGTGG
TGGGGATTGTCGCAGCAGCAGCTCTGTGCATCCTCATCCTCCTC
TATGCCATGTACAAGTACAGGAACCGGGATGAAGGGTCGAGCG
CTCCACCGCTCGACGGAGCCGGAGCTGGCGCTGGAGCTGGAGC
CGGAGCTGGCGGGCTAGCCACCATGGACGCACAAACACGACGA
CGTGAGCGTCGCGCTGAGAAACAAGCTCAATGGAAAGCTGCAA
ACCTCGAGCCACCGCTCGACGGAGCCGGAGCTGGCGCTGGAGC
TGGAGCCGGAGCTGGCGGTCTAGCCACCCCACCGAGCGCTTACC
ACGTGGATGAGAGTCGAAACTACATCAGTAACTCAGCACAGTCC
AATGGGGCTGTGGTCAAGGAGATGCAACCCAGCAGTGCTAAAA
GCGCCAACAAAAACAAGAAGAACAAGGATAAGGAGTATTATGT
CTAG
3.6.3.6 AA Sequence: Myc-CLIP-Nrx1B-λN(i)
MYQRMLRCGADLGSPGGGSGGGAGGRLALIWIVPLTLGGLLGVAW
GEFEQKLISEEDLQFMDKDCEMKRTTLDSPLGKLELSGCEQGLHRII
FLGKGTSAADAVEVPAPAAVLGGPEPLIQATAWLNAYFHQPEAIEE
FPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISESHLAALVGNP
AATAAVNTALDGNPVPILIPCHRVVQGDSDVGPYLGGLAVKEWLL
AHEGHRLGKPGLGVDGTASSLGAHHIHHFHGSSKHHSVPIAIYRSPA
SLRGGHAGTTYIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQK
EAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIIND
GKYHVVRFTRSGGNATLQVDSWPVIERYPAGRQLTIFNSQATIIIGG
KEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNVRLVGEVP
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SSMTTESTATAMQSEMSTSIMETTTTLATSTARRGKPPTKEPISQTT
DDILVASAECPSDDEDIDPCEPSSGGLANPTRVGGREPYPGSAEVIR
ESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSSAPPLDGAGA
GAGAGAGAGGLATMDAQTRRRERRAEKQAQWKAANLEPPLDGA
GAGAGAGAGAGGLATPPSAYHVDESRNYISNSAQSNGAVVKEMQP
SSAKSANKNKKNKDKEYYV*
3.6.3.7 Coding Sequence: HA-SNAP-Neuroligin1AB-λN(i)
ATGGCACTTCCCAGATGCATGTGGCCAAATTATGTTTGGAGAGC
TATGATGGCATGTGTGGTCCACAGGGGATCCGGTGCCCCATTGA
CTCTCTGCTTGTTGGGATGTTTGCTACAGACTTTTCACGTACTC
TCTCAAAAGTATCCATACGACGTTCCGGACTACGCAGAATTCAT
GGACAAAGACTGCGAAATGAAGCGCACCACCCTGGATAGCCCT
CTGGGCAAGCTGGAACTGTCTGGGTGCGAACAGGGCCTGCACC
GTATCATCTTCCTGGGCAAAGGAACATCTGCCGCCGACGCCGTG
GAAGTGCCTGCCCCAGCCGCCGTGCTGGGCGGACCAGAGCCAC
TGATGCAGGCCACCGCCTGGCTCAACGCCTACTTTCACCAGCCT
GAGGCCATCGAGGAGTTCCCTGTGCCAGCCCTGCACCACCCAGT
GTTCCAGCAGGAGAGCTTTACCCGCCAGGTGCTGTGGAAACTG
CTGAAAGTGGTGAAGTTCGGAGAGGTCATCAGCTACAGCCACC
TGGCCGCCCTGGCCGGCAATCCCGCCGCCACCGCCGCCGTGAAA
ACCGCCCTGAGCGGAAATCCCGTGCCCATTCTGATCCCCTGCCA
CCGGGTGGTGCAGGGCGACCTGGACGTGGGGGGCTACGAGGGC
GGGCTCGCCGTGAAAGAGTGGCTGCTGGCCCACGAGGGCCACA
GACTGGGCAAGCCTGGGCTGGGTGTCGACTTGGATGATGTAGA
CCCATTGGTTACTACTAACTTTGGCAAGATTAGGGGAATTAAGA
AAGAACTCAATAATGAAATTTTGGGTCCTGTCATTCAGTTTCTT
GGGGTTCCATATGCCGCTCCACCAACAGGAGAACATCGTTTCCA
GCCTCCAGAACCACCATCTCCCTGGTCTGACATCCGGAACGCCA
CTCAGTTTGCTCCTGTATGTCCCCAGAATATCATTGATGGCAGA
TTGCCTGAAGTTATGCTTCCTGTGTGGTTCACTAATAACTTGGA
TGTGGTTTCATCATACGTCCAAGACCAGAGTGAAGACTGTCTAT
ACTTAAACATCTATGTCCCAACTGAAGATGGTCCCCTTACAAAG
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AAACACACAGATGATTTAGGTGATAATGACGGTGCTGAAGATG
AAGATATTCGGGACAGTGGGGGTCCCAAACCAGTGATGGTGTA
CATCCATGGCGGCTCTTACATGGAAGGTACTGGAAATCTGTATG
ATGGGAGTGTCTTGGCAAGCTATGGCAATGTGATCGTCATCACA
GTCAACTATCGGCTTGGGGTACTTGGCTTCTTGAGCACAGGGGA
TCAGGCTGCCAAAGGAAACTACGGGCTCCTTGACCTCATCCAGG
CCCTAAGATGGACCAGCGAGAACATTGGGTTCTTTGGTGGTGAC
CCCTTGCGAATCACTGTGTTTGGATCAGGCGCTGGGGGTTCATG
TGTCAACCTGCTGACTTTATCCCATTATTCTGAAGGTAACCGTT
GGAGCAATTCAACCAAAGGACTTTTTCAACGAGCAATAGCTCAG
AGTGGAACAGCCCTTTCCAGCTGGGCTGTTAGTTTCCAGCCTGC
AAAATACGCTAGAATTCTGGCCACAAAAGTTGGCTGCAATGTTT
CAGATACAGTAGAGTTAGTAGAATGCCTGCAGAAGAAGCCTTA
CAAAGAACTTGTTGATCAAGATGTTCAACCAGCCCGATACCACA
TAGCCTTTGGACCTGTGATCGATGGTGATGTAATACCAGATGAC
CCTCAGATACTGATGGAACAAGGAGAGTTCCTCAACTATGATAT
AATGTTGGGAGTTAACCAAGGGGAAGGGTTGAAGTTTGTCGAA
AATATAGTAGATAGTGATGATGGTGTATCAGCCAGTGATTTCGA
CTTTGCTGTTTCTAATTTTGTTGATAATTTATATGGATATCCTGA
AGGCAAAGATGTTTTGAGAGAAACCATTAAATTCATGTATACTG
ACTGGGCTGATCGCCATAATCCTGAAACTAGAAGGAAGACATTG
TTGGCTTTGTTTACGGACCATCAATGGGTAGCACCTGCTGTGGC
CACAGCAGACCTTCACTCGAACTTTGGCTCACCTACATACTTCT
ATGCCTTTTATCATCATTGCCAAACAGATCAAGTTCCAGCTTGG
GCTGATGCAGCTCATGGGGATGAGGTTCCCTATGTGTTGGGAAT
CCCCATGATTGGCCCTACAGAGTTATTTCCTTGCAATTTCTCCA
AGAATGATGTGATGTTGAGTGCAGTAGTAATGACATACTGGAC
GAATTTTGCTAAAACTGGTGACCCAAATCAACCAGTTCCTCAAG
ACACAAAATTCATCCATACCAAACCCAACCGCTTTGAAGAAGTA
GCATGGACCAGATATTCCCAGAAAGACCAGCTTTATCTCCATAT
TGGATTAAAACCGAGAGTTAAAGAGCATTACAGAGCCAATAAG
GTAAATCTCTGGCTGGAGCTGGTACCTCATCTGCATAATCTCAA
TGACATTTCTCAGTATACCTCGACAACAACTAAAGTGCCATCCA
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CGGACATCACTCTCAGACCTACAAGGAAGAATTCCACACCAGTC
ACATCAGCCTTTCCCACTGCCAAACAGGATGATCCCAAGCAACA
ACCAAGCCCCTTCTCGGTGGATCAGAGGGACTACTCCACAGAGC
TAAGTGTCACTATCGCAGTGGGGGCCTCTCTGCTGTTTCTCAAC
ATCTTGGCTTTTGCAGCCCTGTACTACAAGAAGGATAAGAGGAG
ACATGATGTCCACCGGAGGTGCAGCCCTCAGCGCACGACCACCA
ACGACCTAACCCATGCTCCAGAAGAGGAAATTATGTCTCTCCAA
ATGAAGCACACTGACTTGGATCACGAGTGTGAGTCCATCCATCC
ACATGAGGTGGTTCTTCGGACCAGCGCTCCACCGCTCGACGGAG
CCGGAGCTGGCGCTGGAGCTGGAGCCGGAGCTGGCGGGCTAGC
CACCATGGACGCACAAACACGACGACGTGAGCGTCGCGCTGAG
AAACAAGCTCAATGGAAAGCTGCAAACCTCGAGCCACCGCTCGA
CGGAGCCGGAGCTGGCGCTGGAGCTGGAGCCGGAGCTGGCGGT
CTAGCCACCCCACCGAGCGCTGCCTGTCCCCCAGATTATACTCT
AGCTATGAGGAGGTCACCTGATGATATTCCACTAATGACACCTA
ACACCATCACAATGATTCCCAACACTATACCAGGGATTCAGCCC
TTACATACATTCAACACATTTACTGGAGGACAGAATAATACACT
GCCCCATCCCCACCCACACCCCCATTCACATTCAACAACCAGGG
TATAG
3.6.3.8 AA Sequence: HA-SNAP-Neuroligin1AB-λN(i)
MALPRCMWPNYVWRAMMACVVHRGSGAPLTLCLLGCLLQTFHVL
SQKYPYDVPDYAEFMDKDCEMKRTTLDSPLGKLELSGCEQGLHRII
FLGKGTSAADAVEVPAPAAVLGGPEPLMQATAWLNAYFHQPEAIE
EFPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISYSHLAALAGN
PAATAAVKTALSGNPVPILIPCHRVVQGDLDVGGYEGGLAVKEWL
LAHEGHRLGKPGLGVDLDDVDPLVTTNFGKIRGIKKELNNEILGPV
IQFLGVPYAAPPTGEHRFQPPEPPSPWSDIRNATQFAPVCPQNIIDG
RLPEVMLPVWFTNNLDVVSSYVQDQSEDCLYLNIYVPTEDGPLTKK
HTDDLGDNDGAEDEDIRDSGGPKPVMVYIHGGSYMEGTGNLYDGS
VLASYGNVIVITVNYRLGVLGFLSTGDQAAKGNYGLLDLIQALRWT
SENIGFFGGDPLRITVFGSGAGGSCVNLLTLSHYSEGNRWSNSTKGL
FQRAIAQSGTALSSWAVSFQPAKYARILATKVGCNVSDTVELVECL
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QKKPYKELVDQDVQPARYHIAFGPVIDGDVIPDDPQILMEQGEFLN
YDIMLGVNQGEGLKFVENIVDSDDGVSASDFDFAVSNFVDNLYGYP
EGKDVLRETIKFMYTDWADRHNPETRRKTLLALFTDHQWVAPAV
ATADLHSNFGSPTYFYAFYHHCQTDQVPAWADAAHGDEVPYVLG
IPMIGPTELFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQD
TKFIHTKPNRFEEVAWTRYSQKDQLYLHIGLKPRVKEHYRANKVN
LWLELVPHLHNLNDISQYTSTTTKVPSTDITLRPTRKNSTPVTSAFP
TAKQDDPKQQPSPFSVDQRDYSTELSVTIAVGASLLFLNILAFAALY
YKKDKRRHDVHRRCSPQRTTTNDLTHAPEEEIMSLQMKHTDLDHE
CESIHPHEVVLRTSAPPLDGAGAGAGAGAGAGGLATMDAQTRRRE
RRAEKQAQWKAANLEPPLDGAGAGAGAGAGAGGLATPPSAACPP
DYTLAMRRSPDDIPLMTPNTITMIPNTIPGIQPLHTFNTFTGGQNNT
LPHPHPHPHSHSTTRV*
3.6.4 Protein-RNA interaction
The protein-RNA interaction, λN-boxB binding, was efficient only when 4 repeats of the
boxB sequence were employed (Figure 3.8). Initially, we maintained the stoichiometry
between the λN repeats and boxB repeats for simplicity. It may indeed be the case
that some of our initial constructs in which a single λN domain was placed within the
cytoplasmic tail of Nrx1B or Nlg1AB without a flexible linker were sufficient to bind
4xBoxB RNAs. The presence of the linker may be deleterious in some settings and
thus, may be removed if necessary (assuming that the 1xλN does indeed bind 4xboxB
when fused directly within the cytoplasmic tail – i.e. no linkers).
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4Discussion
The wiring of a neural circuit largely influences its function. To date, no high-throughput
method of tracing neural circuits exists. We have developed a set of tools for converting
neural connectivity into a form that is amenable to high-throughput DNA sequencing,
thereby converting the problem from one of imaging to one of molecular engineering.
Despite our progress, challenges remain for the full realization of this goal. Here, we
outline the shortcomings of this technique and discuss routes to addressing each. Of
course, knowledge of the wiring diagram alone may, in many cases, be necessary but
insufficient to fully describe the circuit. Additional layers of information including po-
sition, cell-type, neuromodulatory state, synaptic strength, and neural activity are also
important variables to be measured. In many cases, this information can be encoded
in DNA and integrated into the existing framework.
4.1 Scaling to whole brains
In its present form, the technique we have outlined lacks the ability to scale to trace a
full connectome. There are several reasons for this. First, viral expression of proteins
and/or RNA only allows for sparse tagging of neurons. Transgenic animals which can
generate barcodes in vivo (see chapter 2) as well as express the synaptic proteins will be
required. Second, the system we have developed currently allows only for unidirectional
tracing. Third, the proteins we have developed are based on the endogenous proteins
Neurexin1B and Neuroligin1AB – which have some nonzero affinity for each other that
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may prevent co-expression and proper trafficking. Finally, our RNA joining method is
based on emulsions which are inefficient due to the requirement for limiting dilutions.
4.1.1 Transgenics
A transgenic animal expressing all of the components necessary for the system will
be required for scaling to a full brain. To avoid any changes during development, the
expression of the components should be made inducible (i.e. by employing the Tetra-
cycline inducible promoter). In addition, an in vivo barcoding system (see chapter 2)
will be necessary. Our current in vivo barcoding system has shown promise, but does
not yet function efficiently in mammalian cells. Additional in vivo barcoding systems
based on non-homologous end joining – i.e. by employing CRISPRs [Cong et al. 2013,
Mali et al. 2013] to induce DNA damage – will allow for shorter barcodes, but will need
to overcome significant biases.
4.1.2 Enabling bi-directional tracing
To enable bidirectional tracing, both the pre- and post-synaptic components must be
expressed within the same cell. Moreover, the pre- and post-synaptic barcode must be
the same, or the correspondence must be known. Currently, the pre- and post-synaptic
barcodes are expressed from two different viruses, and have sequence elements that are
unique to pre or post for joining and identification.
In the simplest form, bidirectional tracing could be enabled by employing orthogonal
RNA binding proteins on each of the synaptic protein partners (i.e. PRE:λN and
POST:MS2, see Table 3.1, Table 3.2). To endow the cell with two forms of the RNA
barcode, alternative splicing could be used to select one of two mutually exclusive exons
carrying the pre-specific or post-specific sequence elements.
4.1.3 Preventing endogenous interactions
Although many neurons express both Neurexin1B and Neuroligin1AB, it is unclear if
overexpression of the interacting proteins will result in cytoplasmic interaction that pro-
hibits proper sorting to the pre- and post-synaptic terminals respectively. In addition,
because of the roles of these proteins in formation and stabilization of synapses, their
interaction with endogenous proteins may disrupt proper synapse formation/stability
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– most likely resulting in new synapses. For these reasons, it will likely be advanta-
geous to remove the endogenous interaction domains from each protein, which can be
accomplished by introducing well-characterized point mutations [Leone et al. 2010].
4.1.4 Efficient RNA joining
Currently, we employ overlap extension RT-PCR in emulsion for RNA barcode joining.
This method is efficient in emulsion droplets containing a complex. However, it suf-
fers from the requirement for single occupancy per droplet. Large volumes of emulsion
would be needed to scale this system to full brains – something which is feasible but not
ideal. Other RNA joining methods (see C) based on proximity ligation or proximity-
based amplification will be more efficient but will require extensive optimization. Sim-
ply moving from emulsion to overlap extension RT-PCR on a solid surface (similar to
bridge amplification techniques performed by Illumina) should greatly improve the ease
of scaling the technology.
Employing an alternative RNA polymerase (i.e. PolI or PolIII transcripts) will allow
for easier manipulations of the resulting barcodes (no 5’cap, no 3’polyA tail). However,
the maximum transcript length that such polymerases can support is not well tested a
major consideration for in vivo barcode generation. Moreover, subcellular localization
of non pol-II transcripts could pose problems for tethering of RNA barcodes to the
synapse and must be tested. Nonetheless, the ability to express short barcodes without
5’cap or 3’polyA tail enables efficient RNA joining methods based on splint ligation.
4.2 Porting to other organisms
In theory, the tools developed here can be modified for use in other organisms includ-
ing D. melanogaster or C. elegans. While it may be possible to employ the proteins
developed for mouse for tracing in other organisms, a preferable solution is to engineer
a species-specific version based on each species’ Neurexin and Neuroligin proteins. Of
course, each species will come with its own set of issues including, for example, the
requirement to remove the cuticle to infuse the synthetic cross-linkers in C. elegans.
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4.3 Missing information
In its simplest form the wiring diagram lacks many types of useful information including
spatial position of the soma of each barcoded cell, the cell-type or expression profile of
each cell, the activity of the cell, the potential neuromodulatory states of the circuit,
the presence of gap junctions, etc. We would like to recover as much of this information
as possible, and be able to overlay this information on the circuit wiring diagram.
4.3.1 Spatial information
It is important to note that, for the purposes of an electrical circuit, the positions of
the nodes of the circuit in space (or on the circuit board) – given a wiring diagram – are
irrelevant. This is likely true in the mammalian brain as well. For example, a neuron in
auditory cortex responds to a sound not because it is located in the auditory cortex, but
because it is connected – through a series of synapses – to neurons which sense sound
frequencies (i.e. the cochlea). In essence, the spatial position of a cell (i.e. auditory
cortex) is a proxy for its connectivity (i.e. receives information from the cochlea), and
thus predicts a neurons function (i.e. responsive to sound). In an idealized case, the
complete wiring diagram and identity of the nodes obviates the need for spatial infor-
mation. In practice, however, our wiring diagrams will be incomplete and will, at least
initially, lack cellular identity and other important information. Therefore, in order to
be able to connect with decades of neuroscience research, it will be advantageous to
retain the spatial position of each barcoded soma and – if possible – the position of
each synapse.
In simpler organisms, such as C. elegans it may be possible to barcode every cell
with a “static” barcode that is the same across individuals. This could be accomplished,
for example, by employing a cell-type specific promoter (or combination of promoters)
to drive the individual barcode transcripts carried on an extrachromosomal array, or
integrated into the genome. In higher-organisms this will not be possible. Spatial
information could be preserved by virally introducing “anchor” barcodes throughout
the brain that correspond to spatial position of the injection. Moreover, the brain
can be cubed prior to homogenization and the barcode-pairs in a given region can be
“zip-coded” by spatial position.
88
4.3 Missing information
Finally, by converting the method such that RNA joining and sequencing takes
place in situ via fluorescent in situ sequencing (FISSEQ) [Lee et al. 2014], the spatial
position of each cell and/or synapse can be preserved (see subsection 4.4.1, Appendix
F).
4.3.2 Cell types
Knowledge of cell-type is perhaps one of the most important missing pieces of informa-
tion in the current instantiation of our system. In an electrical circuit, knowledge of the
wiring diagram is necessary, but not sufficient to explain the behavior of the circuit. The
identity of the individual nodes – capacitor, resistor, transistor, etc. – must be known
or able to be inferred from other measurements. Using Cre-driver lines [Taniguchi et al.
2011], the components of our system can be expressed in specific cell-types. While this
approach will be useful to understand statistics of connectivity (i.e. how often do SOM
cells synapse on PV cells), it will not allow for simultaneous reconstruction of a full
circuit containing many heterogenous cell-types. Cell-types could be labeled by differ-
ent fluorescent proteins, and then registered to the connectome determined by in situ
sequencing (see subsection 4.4.1).
An ideal solution would provide information about the transcript profile of each
barcoded cell in the wiring diagram. To this end, wee have explored preliminary solu-
tions for joining barcodes to cellular transcripts, via hijacking of the spliceosome (see
E). Other methods, including FISSEQ (see Appendix F, subsection 4.4.1) will allow
for sequencing of endogenous RNAs and barcode RNAs in the same preparation.
4.3.3 Cell physiology
Combining NO-C with cellular physiology is non-trivial, but could be theoretically
accomplished in a variety of ways. Activity-dependent promoters [Kawashima et al.
2014] including c-fos could allow for expression of the individual components in ac-
tive cells. Alternatively, functional imaging combined with light-activated promoters
[Konermann et al. 2013] would allow for expression in cells of interest as identified by
functional properties.
FISSEQ could also be combined with functional imaging. Methods to register
the positions and identities of neurons monitored in vivo during two-photon calcium
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imaging with the same neurons in an acute brain slice have recently been developed
[Ko et al. 2011].
4.3.4 Neuromodulation
Neuromodulation allows for drastic changes of neural circuit activity. In simple ner-
vous systems, such as that of C. elegans, neuromodulators have been implicated in
the multiplexed function of circuits. In higher organisms, such as mice, the exten-
sive of neuromodulation is only beginning to emerge. Without the information about
neuromodulation, and how it shapes neuronal activity, the wiring diagram alone will
be insufficient to describe all neural circuit function [Bargmann 2012, Bargmann and
Marder 2013]. Therefore, a way to recover this information would be desirable.
The use of neuromodulatory sensors in vivo including glutamate-sensing fluorescent
reporter (GluSnFRs) [Hires et al. 2008] or TANGO [Inagaki et al. 2012] will allow for
imaging of neuromodulation – perhaps in conjunction with functional imagaing. This
information can then be incorporated into a wiring diagram uncovered by imaging (i.e.
by FISSEQ). Employing a modified version of TANGO which cleaves an exogenous
transcription factor (i.e. Gal4) for activation of a specific promoter could allow for the
re-encoding of neuromodulatory activity into RNA expression. Of course, this would
need to be done in parallel for a variety of neuromodulators, and the transcripts would
need to somehow be joined to the cellular barcode. Despite the challenges, it remains
at least theoretically plausible that this type of information could be incorporated into
the wiring diagram.
4.3.5 Gap Junctions
Besides synaptic connectivity, some neurons communicate through gap junctions. This
important mode of information transfer will be missed by the current instantiation of
our technique. However, modifications of connexins involved in gap-junction formation
could allow for similar barcode tethering/joining to occur at gap-junctions and enable
this information to be encoded into DNA for recovery.
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4.4 Future directions
4.4.1 In situ sequencing
To enable many of the imaging based approaches aforementioned, and to retain spatial
information of the cell-body and synapse, we have begun preliminary work to trace
connectivity based on a modified version of PLA which relies on FISSEQ for readout.
The components of the system are identical, except that CLIP/SNAP are no longer
necessary. Briefly, the synaptic proteins drag RNA barcodes to the synapse, forming a
transneuronal complex of a barcode-pair spanning the synaptic cleft. The tissue is fixed,
sliced, and barcodes are joined in situ by proximity ligation. At this point, the joined
barcode pairs are sequenced by FISSEQ to determine the identity of each barcode pair.
Additional sequencing rounds reveal the somatic position of each individual barcode,
and endogenous RNA transcripts. Because all of the sequencing is done in situ the
spatial position of all of the sequences is preserved, thereby allowing measurement
of the spatial position of the cell bodies, synapses, and endogenous transcripts. In
addition to enabling the recovery of detailed spatial information, FISSEQ makes it
possible to incorporate other imaging-based information into the data-set as discussed
above (subsection 4.3.2, subsection 4.3.3, subsection 4.3.4).
4.5 Conclusions
The general principle of encoding synaptic connectivity into a form that can be read out
by DNA sequencing can be applied in many other domains of neurobiology. Tethering
RNA barcodes to well localized proteins involved in synaptogenesis, synaptic stability,
and/or synaptic pruning could allow for a dynamic look at the connectome. For ex-
ample, tethering barcodes to AMPA receptors may allow for identification of recently
potentiated circuits in the full wiring diagram. In every case, the protein of choice
will need to be selected wisely, and assays will need to be developed (similar to our
PLA assay) to determine proper functioning of the engineered protein. Nevertheless,
we believe that the general approach outlined here will be extended to incorporate a
host of useful information into the DNA-based connectivity measurement.
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Appendix A
Rci in mammalian cells
A.1 Introduction
We previously showed that Rci can be employed in bacterial cells, including E. coli, to
shuﬄe artificial cassettes for the purpose of cellular barcoding (see chapter 2). However,
our long-term goal is to be able to produce barcodes in mammalian cells, such as mouse
neurons. Here, we tested whether Rci functions in mammalian cells.
A.2 Expression of Rci in mammalian cells
A.2.1 Cellular localization of Rci
In order to test the cellular localization of Rci, we created a plasmid, IDP013 (Fig-
ure A.1A), which expresses Rci fused at its N-terminal to GFP. Expression of this
plasmid in mammalian cells (HEK293 cells) via transient transfection revealed nu-
clear localization of Rci, despite the lack of detection of a known nuclear localization
signal (NLS) (Figure A.1B). Other recombinases, namely the widely employed Cre-
recombinase, reach the nucleus of mammalian cells without modification [Le et al. 1999].
In many cases, however, the addition of a nuclear localization signal (NLS) enhances
efficiency that can be dependent on its fusion position [Andreas et al. 2002, Raymond
and Soriano 2007]. Therefore, we created several variants of the Rci construct, in which
the SV40 NLS was fused to the N- or C-terminal.
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Figure A.1: Rci expression in mammalian cells - (a) Rci is expressed as a fusion
protein with an N-terminal eGFP. (b) eGFP-Rci is localized to nuclei. Green=eGFP-Rci,
Blue=Dapi.
A.3 Functional testing of Rci in mammalian cells
A.3.1 Rci-mediated inversion
To test if Rci can mediate inversion in mammalian cells we set up a highly sensitive,
PCR assay. Briefly, DNA sequences were designed in which PCR can proceed only if
inversion has taken place. This is accomplished by placing one primer (P1) binding
site outside of the recombination cassette and an additional primer (P3) binding site
within the recombination cassette – i.e. flanked by sfx sites in opposing orientation
(Figure A.2A). Before recombination, the two primer binding sites are in the sense
orientation. However, after inversion, the second primer binding site is inverted to
antisense orientation, permitting PCR to occur using the primer pair (Figure A.2A).
Additional primers (P1, P4, P101) are included in the design for detection (P3-P101,
P3-P4) or excision (P2-P3, discussed in subsection A.3.2).
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A.3.1.1 Rci-mediated inversion on a plasmid substrate
To test for Rci-mediated inversion, we co-expressed several variants of Rci with a plas-
mid substrate containing the sfx sites sfxaa201 in opposing orientation (i.e. for inver-
sion). The site sfxaa201, which is a symmetric sfx site (except for the directional core),
was shown in bacteria to be the most efficient sfx site and was therefore used for initial
testing [Gyohda et al. 2006]. It should be noted that this site was shown in bacteria to
permit excision events [Gyohda et al. 2006], and thus the sfxaa201 site was only used
initially to test the function of Rci under the best case conditions in mammalian cells.
We co-transfected the inversion test plasmid with sfxaa201 sites incubated for 24 or
48 hours, and isolated DNA using a column-based plasmid extraction [Motmans et al.
1997]. Approximately 10ng of each sample was loaded into a PCR reaction to probe
the presence of the test cassette as well as inversion. We found that Rci mediates in-
version on a plasmid substrate with or without an NLS (Figure A.2B). Recombination
is inhibited by additional tags, specifically those on the C-terminal, as expected based
on the posited role of the C-terminus of Rci in forming tetramers [Gyohda et al. 2002;
2006].
A.3.1.2 Rci-mediated inversion on a genomic substrate
To test for Rci-mediated inversion on a genomic substrate, we first created a cell-line
harboring the test cassette (Figure A.2A). To accomplish this, we took advantage of a
HEK cell line, which harbors a PhiC31 landing site within the genome [Keravala et al.
2008, Thyagarajan et al. 2001]. The test cassette was cloned into an integration plas-
mid designed to integrate specifically at the genomic landing site via PhiC31-mediated
integration. Co-transfection of the plasmid harboring the cassette and a plasmid ex-
pressing a mutant version of PhiC31 resulted in integration of the cassette into the
genome, and allowed for selection of a stable cell-line [Thyagarajan et al. 2001]. After
isolation of a stable cell-line, we expressed variants of Rci via transient transfection,
incubated for 48 hours, and isolated genomic DNA using a column-based genomic ex-
traction (Promega). Approximately 10ng of isolated DNA from each sample was loaded
into a PCR reaction to probe the presence of the test cassette as well as inversion (Fig-
ure A.2C). We found that Rci mediated inversion on the genomic substrate with or
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without an additional SV40 NLS. No recombination was detected in the absence of Rci
expression (Figure A.2A).
A.3.2 Rci-mediated deletions
Rci is a site-specific invertase and has not been shown to mediate excision events in
bacterial cells. Unlike other site-specific invertases like Gin and Hin [Johnson 2002],
no required co-factors have been discovered that confer this exquisite specificity. How-
ever, Rci function has not previously been described in mammalian cells, and thus the
specificity of Rci for inversion over excision must be empirically determined in this
setting. We designed a PCR-based assay, analogous to that for inversion, in order to
probe the ability of Rci to mediate excision in mammalian cells Figure A.3. We tested
several different sfx sites that had previously been identified and shown to function in
bacterial cells [Gyohda et al. 2006]. Importantly, these are wild-type sequences which
allow Rci to selectively mediate inversion. However, it is unknown if this specificity re-
mains in mammalian cells. In the inversion constructs, sfx sites are placed in opposing
orientation, whereas in the excision constructs they are placed in the same orientation
Table A.1.
Table A.1: Constructs used for inversion and excision testing of Rci
Construct sfx site 1 sfx site 2 orientation
IDP081 sfxa101 sfxa101 inverted repeat
IDP082 sfxa101 sfxd103 inverted repeat
IDP083 sfxa101 sfxb107 inverted repeat
IDP084 sfxa101 sfxa101 direct repeat
IDP085 sfxd103 sfxd103 inverted repeat
IDP086 sfxd103 sfxb107 inverted repeat
IDP087 sfxd107 sfxd107 inverted repeat
We observed recombination regardless of the specific sfx sites employed. In addition,
we observe excision when sfx sites are placed in the same orientation (IDP084). It
remains possible that the excision events detected are low-frequency events that are
detected only because of the highly-sensitive PCR assay. Further work will be needed
to quantitatively asses the efficiency of inversion and excision in both bacterial and
mammalian systems.
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Figure A.2: Rci-mediated inversion in mammalian cells - (a) Inversion cassettes
consist of several primers (P1-P4, P101) and two sfx sites in opposing orientation. Primers
P3 and P101 are always in opposing orientation and can be used for detection via PCR.
Primers P1 and P3 begin in the same orientaiton and cannot be used for PCR. Rci-
mediated inversion flips primer P3 relative to P1 and allows PCR-detection of inversion
events. (b) co-transfection of Rci expression plasmids and the inversion cassette results in
inversion. (c) A genomic inversion substrate is inverted after the transient expression of
Rci via transient transfection.
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Figure A.3: Rci-mediated excision in mammalian cells - (a) The excision cassette.
(b) Amplicons formed in the PCR assay. The excision amplicon is dependent on excision
to properly orient primers P3 and P2 for PCR. (c) Co-transfection with Rci results in
recombination in every scenario. Rci mediates excision only when the sites are in direct
repeat.
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A.4 Discussion
Here we have shown preliminary evidence that Rci indeed functions in mammalian cells.
Our highly sensitive PCR assay, however, cannot discriminate rare from high-efficiency
events. It will be necessary to quantitatively measure the inversion and excision effi-
ciency of Rci in mammalian cells in order to assess the feasibility of employing Rci for
mammalian barcoding (see chapter 2).
Our initial attempts to shuﬄe a barcode cassette in mammalian cells using Rci,
was largely unsuccessful. We found very low frequency (1/80 genomes assayed) re-
combination and observed, anecdotally, toxicity associated with Rci expression in cells
that harbor the genomic cassette. This may be due to genomic instability caused by
repeated double-stranded break events caused by recombination. It is possible that
this could be overcome with inducible expression of Rci, and/or expression of Rci only
in non-dividing cells (such as neurons). In addition, Rci recognizes highly degener-
ate sequences, therefore decreasing the effective length of the sfx site to roughly 19
nucleotides [Gyohda et al. 2002; 2006]. At this length, it is probable that many pseudo-
sites exist within the human genome, by chance alone, perhaps providing a substrate
for Rci binding/recombination that could result in large chromosomal translocations
and subsequently, cell death. Other recombinases, such a PhiC31 and/or Cre recom-
binase, work well in mammalian cells, and could perhaps be modified for shuﬄing
schemes. Indeed many mutant recombination sites for both PhiC31 and Cre have been
developed with interesting characteristics [Colloms et al. 2014, Langer et al. 2002, Lee
and Saito 1998, Missirlis et al. 2006, Siegel et al. 2001], and it has been proposed that
the asymmetric nature of the sfx site confers the specificity for inversion with respect
to Rci-mediated recombination [Gyohda et al. 2006]. To date, no such site has been
isolated for PhiC31 or Cre, but targeted high-throughput screening may reveal asym-
metric sites with preferences for inversion. Alternative methods that take advantage
of new tools which allow the precise targeting of double-stranded DNA breaks that
stimulate DNA repair processes (CRISPR, TALENs, ZFNs) could prove fruitful in the
near future. By stimulating non-homologous end joining, it may be possible to direct
the non-templated addition of DNA nucleotides to a specific locus in order to create a
de novo DNA barcode.
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Appendix B
Mapping long-range projections
with high-throughput sequencing
B.1 Introduction
There is increasing interest in mapping long-range connectivity in the mammalian ner-
vous system – the “projectome.” The Allen Brain Projection Atlas, for example, pro-
vides the brain-wide pattern of projections from each of about 1000 injection sites in
the mouse brain [Oh et al. 2014]. Such information is very useful for designing experi-
ments for investigating how information is transmitted from one brain area to another.
Here we propose to develop a relatively simple, inexpensive, and high-yield method for
establishing the projection pattern of single neurons to a given target in the mouse
brain.
Most existing methods used for probing long-range projections, including those used
to generate the Allen Projection Atlas [Oh et al. 2014], provide information only about
the aggregate projections of neurons from one region to another. These methods do
not readily resolve single neurons. Thus these methods can tell us that neurons in
area X projects to areas Y1, Y2, and Y3, but they cannot in general discover, for
example, that one subset of neurons projects mainly to Y1 and Y2, whereas another
subset projects mainly to Y2 and Y3. To the extent that the information represented
in one area is partitioned among distinct output “streams,” determining these distinct
output targets is a crucial first step in formulating hypotheses about the functional role
of these different streams.
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Historically, the only method for determining projection patterns at single neuron
resolution has been to label neurons very sparsely and image the labeled axonal tree.
Such studies are very labor intensive. A recent study [Kita and Kita 2012] on the
projections of layer V corticofugal neurons illustrates the state of the art. Tracer in-
jections into 28 rats yielded 25 reconstructed projections. Although throughput could
potentially be increased somewhat by “Brainbow” [Livet et al. 2007] in which neurons
express unique combinations of different colored fluorophores, the number of colors re-
solvable in a single specimen is limited, so in practice the increase in throughput for
assessing long-range connections is modest. We recently proposed using FISSEQ (see
F) of cell-identifying barcodes expressed throughout neuronal processes for tracing of
long-range projections with single neuron resolution. While this technology has the
potential to scale to full brains, it remains prohibitively costly and time-consuming for
most laboratories. Here we outline a simple, efficient, and cost-effective method for trac-
ing long-range projections at single-neuron resolution using standard high-throughput
sequencing techniques that will be easily accessible for labs with standard molecular
biology equipment.
Our goal is to develop an efficient method for mapping neuronal projections based
on DNA-sequencing that can be adopted by neuroscience laboratories with only basic
molecular biology expertise. Therefore, it is our objective to simplify the method to the
form of a simple protocol, or “kit” in order to make the technology as widely available
as possible. By converting projection mapping to a DNA-sequencing problem, the pro-
jections of hundreds or thousands of individual neurons can be traced simultaneously,
in a single experiment. The core of our approach is to use viruses to barcode a pop-
ulation of neurons near an injection site with a random short sequence of RNA. The
barcode, which is read out by sequencing, acts as a unique identifier for each neuron.
The barcode, either through passive diffusion or active transport, reaches the distal
projections of cells. In this way, in contrast to all existing approaches, we can identify
distant targets of a neuron without tracing its entire axon. Here we propose to develop
a relatively simple, inexpensive and high-yield iteration of this method for establishing
the projection pattern of single neurons in the mouse brain and employ our method
to two areas Auditory Cortex (A1) and Locus coeruleus (LC) to demonstrate the
potential of the technology across brain regions with different properties.
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The basic strategy is depicted in Figure B.1. First, we inject a barcoded virus (Fig-
ure B.1A) into a brain region of interest (Figure B.1B). A barcode of length 30nt has
a theoretical diversity of 430 = 1018, far more than the number of neurons infected in
a typical experiment (102− 104). In practice the actual diversity of < 107 we routinely
obtain is limited by several bottlenecks encountered during viral production, but is still
far in excess of the number of neurons in a typical experiment. The barcoded virus thus
acts as a unique identifier for the neuron it infects. The barcode is transported, ether
by passive diffusion or by engineered binding to a modified pre-synaptic protein, to the
distal projections (Figure B.1C). The animal is then sacrificed, and target brain regions
of interest (ROIs) are dissected. The resolution of the projection map is determined
by the size of the dissected target ROI. Depending on the dissection methods used,
target ROIs of ∼500um can readily be obtained, and with some optimization ROIs as
small as 100um or even smaller are feasible. Finally the barcode mRNA is extracted
from the ROI, reverse transcribed, PCR amplified and subjected to multiplexed high
throughput sequencing (Figure B.1D). The sequencing information is disentangled to
form a map of which neurons project to which ROIs (Figure B.1E) and the strength of
the projection (in number of neurons) to each ROI (Figure B.1F).
B.2.1 Tracing of neurons originating in auditory cortex
Barcoded Sindbis virus was injected into the left auditory cortex of a mouse. RNA
transport to axons was facilitated by co-expression of a modified form of the pre-
synaptic protein Neurexin1B, engineered to interact specifically and efficiently with the
RNA barcode by virtue of the λN functional domain, which binds to a short RNA
sequence, boxB, that has been inserted in 4 copies into the RNA barcode transcript
[Daigle and Ellenberg 2007]. This protein, represents the pre-synaptic half of our design
for mapping neuronal connectivity via high-throughput sequencing (see chapter 3). The
protein binds the RNA with high affinity as shown by RNA-IP and traffics properly to
synapses as measured by the proximity ligation assay (see chapter 3 for details).
Forty-eight hours after infection, animals were sacrificed and acute slices were pre-
pared for dissection of target ROIs. Seven target regions of interest were dissected,
and barcodes from each region were extracted and sequenced. These regions included:
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Figure B.1: Employing DNA sequencing for projection mapping - (a) A high-
diversity barcode library is packaged into a virus (i.e. Sindbis, Lentivirus, Adeno Associ-
ated Virus). (b) Barcoded virus is infected focally into the brain region whose projection
pattern is to be analyzed. (c) Viral RNA is transported into projecting axons in distant
brain regions. (d) Brain regions of interest (ROIs) are dissected and RNA is extracted.
Sequencing libraries are prepared with ROI barcodes added during library construction.
(e) A binary projection map is generated based on sequencing data and clustered to reveal
the higher-order structure of the projection pattern with single neuron resolution. (f) A
strength of projection diagram can be drawn based on the number of injected neurons
projecting to each target ROI.
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(ipsilateral striatum anterior, ipsilateral striatum posterior, ipsilateral thalamus, ipsi-
lateral inferior colliculus, contralateral inferior colliculus, contralateral auditory cortex,
and contralateral striatum. The overall pattern of projection (Figure B.2A) was consis-
tent with the known anatomy. For example, one of the most numerous projections was
to the ipsilateral auditory striatum. The single neuron projection data (Figure B.2B)
highlighted some surprising results. For example, we observe very few neurons which
project to the contralateral striatum. Further work will be needed to understand the
single-neuron projection data in more depth and is discussed in chapter 4.
Figure B.2: Reconstruction of projectome from left auditory cortex - The left
auditory cortex was injected with barcoded Sindbis virus. (a) Reconstructed projection
strengths from auditory cortex to various regions. Line thickness represents the number of
neurons projecting to each area. (B) Single neuron clustergram. Each row represents an
individual neuron (barcode) and each column denotes a region of interest. The data are
clustered to reveal structure of the projection pattern at single neuron resolution.
B.3 Discussion
This pilot experiment demonstrates the basic feasibility of the approach. Several as-
pects require optimization. PCR is very sensitive, so we expect the false negative rate
to be low. On the other hand, false positives (i.e. false discovery of barcodes in area
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to which the neurons do not project) arising from RNA contamination during tissue
dissection are a significant concern; we expect they can be minimized by thorough
washing and RNAase treatment prior to membrane lysis. RNA contamination from
fibers of passage is another concern which can be addressed with other methods.
These conclusions are preliminary; further control experiments must be performed
to rule out alternative interpretations. First, we must minimize the rate of false posi-
tives, i.e. the rate at which barcodes that appear in a given ROI arise from contami-
nation from another region. Such contamination can arise during tissue dissection and
RNA extraction. We have spent considerable time optimizing the protocol to minimize
such contamination (using as a negative control the fact that the auditory cortex does
not project to the cerebellum), and now estimate it to be quite low. Second, we must
minimize the rate of false negatives. False negatives can occur due to failure of bar-
code RNA to reach the synapse, inefficient RNA reverse transcription, or insufficient
sequencing depth.
As discussed above, our bulk sequencing methods do not allow for the precise knowl-
edge of the position of the soma of each individual neuron. Imaging of the infection site
(i.e. if RNA barcodes are within the 5’UTR of the transcript of an XFP) will reveal the
extent of the labeling, but will not resolve the correspondence between spatial position
of a soma and its barcode. By sequencing barcoded RNAs in situin a brain slice –
FISSEQ will allow us to determine the laminar position of each barcoded soma (see
F). FISSEQ may also make it possible to relate projection information with physiol-
ogy data including functional calcium imaging within the same preparation, e.g. by
extending the techniques of (Ko et al. 2011).
B.4 Methods
B.4.1 Injections
Stereotactic injections of barcoded Sindbis virus were performed to introduce the com-
ponents into the brain. All injections were performed in 5-week old male CBA/CaJ
mice in left auditory cortex under anesthesia (ketamine medetomidine). Following in-
jections, mice were returned to their cages for 48 hours before sacrificing.
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B.4.2 RNA isolation
Brains were dissected in HEPES buffer at room temperature and individual regions
of interest were placed immediately in Trizol (Life Technologies), homogenized, and
frozen on dry ice. RNA isolation was performed according to the Trizol manufcaturer’s
protocol.
B.4.3 RT-PCR
Reverse transcription was performed with gene-specific primers that add a Solexa II
adapter to the cDNA sequence. PCR was performed using SolexaI and SolexaII primers
(P5-SBS3T and P7-SBS8).
B.5 Acknowledgements
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RNA ligation methods
C.1 Introduction
In the context of our project to map neural connectivity via DNA sequencing (see
chapter 3), the immunoprecipitated RNA barcode pairs representing synaptic partners
(Figure 2.1b) must be covalently linked for subsequent reverse-transcription PCR and
DNA sequencing (Figure 2.1c). This is, in concept, very similar to ligation methods that
have previously been developed for RNA and/or DNA [Kalhor et al. 2012, Kudla et al.
2011]. Initially, we pursued several alternative RNA-linking methodologies in parallel
before ultimately settling on overlap extension emulsion reverse transcription PCR
(OEemRTPCR). Here we describe the other methods that were considered and their
limitations. Finally, we consider additional methods which, with further development,
may be more optimal than OEemRTPCR.
C.2 General considerations
C.2.1 Maintaining the Protein-RNA complexes
Because of the set-up employed in our project (see chapter 3), there are several con-
straints which must be considered. First, the RNA and protein are tightly associated
by a non-covalent bond. Therefore, any ligation method employed must be compatible
with the protein-RNA interaction. In addition, the membrane proteins bound to the
RNA must be kept in solution. This requires the use of detergent and glycerol sub-
subsection 3.5.1.1 in all buffers – which may be incompatible with certain enzymatic
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reactions.
C.2.2 Stoichiometry of ligation reactions
Stoichiometry is crucial when performing a ligation. An excess of the joining molecule
be it a bridge oligo or a bifunctional ribozyme will lead to each target containing a
bridge, thus prohibit joining. This poses a significant challenge because, once on beads,
the exact quantities of all of the species present are difficult to ascertain.
C.2.3 Pol-II transcripts
It is important to note that many of the issues we faced could potentially be circum-
vented by the use of an alternative RNA polymerase. However, the maximum transcript
length that such polymerases can support is not well tested a major consideration for
in vivo barcode generation (see chapter 2 for a description of the constraints). More-
over, subcellular localization of non Pol-II transcripts could pose problems for tethering
of RNA barcodes to the synapse and must be tested empirically. Finally, the use of
alternative promoters to drive the expression of RNA would prohibit the use of certain
viruses, namely Sindbis. We use Sindbis for purely strategical reasons (fast turn-around
time, high expression), and thus substitution with other viruses that tolerate alterna-
tive promoters is possible. In any case, because we employed Pol-II, all of our barcode
transcripts are 5’capped and polyadenylated. These modifications prohibit many direct
biochemical ligation methods, as will be discussed.
C.3 ssRNA ligation
Perhaps the simplest method of joining two RNAs relies on the ssRNA ligase, T4 RNA
Ligase 1 (T4RNL1). T4RNL1 catalyzes the nonspecific intra- or intermolecular ligation
of two single stranded nucleic acid chains (ssRNA or ssDNA) terminating in 3’OH (ac-
ceptor) and 5’P (donor), respectively. ssRNA ligation has been successfully employed
previously to join two closely apposed RNA molecules [Kudla et al. 2011]. However,
T4RNL1 has strong preferences for intramolecular ligation and severely reduced liga-
tion efficiencies for intermolecular ligation. Intermolecular ligation is often plagued by
unwanted side products (i.e. intramolecular circularization and/or concatemers [Kalhor
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et al. 2012, Kurschat et al. 2005]. The efficiency of intermolecular ligation can be in-
creased by creating a pseudo intramolecular reaction via a bridge oligo [Stark et al.
2006] or by exploiting complementarity between the two RNA molecules to be joined
[Kudla et al. 2011, Nishigaki et al. 1998]. These techniques, however, require synthetic
blocking groups on the ends of the ssRNA substrates in order to prevent concatenation
and/or circularizaiton – technically challenging to achieve with transcripts prepared
in vivo. In addition, the presence of a long polyA tail makes the splinting of PolII
transcripts non-trivial – requiring some sort of predictable trimming to < 7 A’s [Jan
et al. 2011]. Finally, T4RNL1-mediated RNA ligation is traditionally employed for
the ligation of short RNA molecules. Long RNA molecules have significant secondary
structure that will increase the likelihood of unwanted side-reactions. This problem can
be somewhat ameliorated by heating and snap cooling, or heating in the presence of
complementary oligos, but our ability to heat the sample is limited by the requirement
to maintain the protein-RNA interaction. For these reasons, we did not pursue ssRNA
ligation.
C.4 Splint ligation
In splint ligation, two RNA molecules are bridged by an oligonucleotide provided
in trans (Figure C.1). Ligation by T4 DNA ligase (T4DNL) or T4 RNA ligase 2
(T4RNL2) occurs if and only if a 5’P and 3’OH are perfectly aligned by the bridge oligo,
thus largely prohibiting side-reactions including circularization and concatemerization
[Kurschat et al. 2005]. This method is largely employed for the ligation of synthetic
RNA molecules, produced either via chemical synthesis or in vitro transcription.
C.4.1 Splinted ligation of short oligonulceotides
We tested the two ligases, T4DNL and T4RNL2 for the ligation of two fluorescently
labeled oligonucleotides. Briefly we mixed a 5’Cy3 labeled acceptor oligonucleotide
(Cy3) and a 5’Phosphorylated, 3’Cy5 labeled acceptor (Cy5) with a splint and either
ligase. We found this reaction to be highly efficient using both T4DNL and T4RNL2
(Figure C.2). Previous research has shown that T4RNL2 is the most efficient of the bac-
teriophage T4 ligases at sealing an RNA-RNA nick bridged by a DNA strand [Bullard
and Bowater 2006], and therefore, we continued with T4RNL2.
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Figure C.1: Splint Ligation of RNA - An acceptor molecule with a free 3’OH and a
donor molecule with a free 5’P are splinted by a bridge oligonucleotide. A ligase seals the
nick between the splinted acceptor and donor RNA molecules.
C.4.2 Adapting splinted ligation for Pol-II transcripts
To adapt this method for our purposes – to ligate two long RNA molecules transcribed
in vivo by Pol-II – we had to solve several problems. Importantly, because of the
exquisite base-pairing specificity of T4DNL and T4RNL2, it is an absolute requirement
that the sequences at the ends of both RNA molecules are known. In addition, there
is a requirement for a free 3’OH on the acceptor RNA molecule and a free 5’P on the
donor molecule (Figure C.1). Because our barcodes are expressed as Pol-II transcripts,
the ends are not suitable for splint ligation directly. First, the terminal sequences are
not known with certainty, particularly the 3’ end at which the length of polyA tails are
highly variable. In addition, the 5’ ends of Pol-II transcripts are capped, and therefore
lack the necessary 5’P for ligation.
In order to generate ends suitable for RNA ligation, we desired a method for the
site-specific cleavage of RNA transcripts that results in the appropriate ends (i.e. 3’OH
and 5’P). It has been reported that certain restriction enzymes can cleave RNA in an
RNA-DNA hybrid [Murray et al. 2010] but these methods were inefficient in our hands.
Instead, we used RNAseH mediated cleavage, in which RNAseH is directed to cleave
118
C.4 Splint ligation
Figure C.2: Splinted ligation of short oligonucleotides - (a) A Cy3-labeled acceptor
olignucleotide is ligated with a Cy5 labeled donor olignucleotide in the presence of a splint.
Perfect base pairing is required at the junction for ligation. (b) Ligation occurs only in the
presence of both oligos, a splint, and either T4 DNA ligase (T4DNL) or T4 RNA ligase 2
(T4RNL2).
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specifically by a 2’Ome/DNA hybrid oligo [Inoue et al. 1987, Lapham and Crothers
1996].
C.4.2.1 RNAseH cleavage
RNAseH is an endoribonuclease which cleaves the phosphodiester bond of RNA molecules
that are hybridized to complementary DNA. If the RNA is hybridized to a modified nu-
cleotide, such as 2’O-methyl (2’Ome) RNA nucleotides, RNAseH is unable to cleave the
RNA strand. However, hybrid 2’Ome/DNA oligonucleotides, when properly designed,
direct the RNAseH cleavage at a single dincucleotide junction in the targetRNA strand
Figure C.3. Regions of the RNA that are hybridized to the 2’Ome nucleotides are pro-
tected from enzymatic cleavage. The RNA bases that are paired with complementary
DNA bases are, however, available for cleavage. The footprint of the RNAseH protein
permits the cleavage only at a single dinucleotide junction (when a 4nt DNA segment
is present in the targeting oligo). Importantly, the exact position at which the cleavage
occurs is dependent on the source of the RNAseH [Lapham et al. 1997] and must be
considered.
Figure C.3: Site-specific RNAseH cleavage directed by 2’Ome/DNA hybrids -
A 2’Ome/DNA hybrid oligonucleotide is annealed to a target RNA. RNAseH cleaves at a
specific position – in the RNA strand at the 5’ junction of the DNA/2’Ome nucleotides
in the complementary oligonucleotide – leaving a 3’OH and a 5’P on the newly generated
RNA fragments.
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To test RNAseH cleavage we in vitro transcribed two RNA molecules (RNA5 and
RNA8) and designed 2’Ome/DNA hybrid complementary oligonucleotides to direct
cleavage to a specific site (Figure C.4A). We first tested 2’Ome/DNA directed RNAseH
cleavage under idealized conditions in which we allowed heating and cooling for efficient
hybridization of the oligonucleotide to the RNA molecule. RNAseH-mediated cleavage
under these conditions was specific and efficient (Figure C.4B). The reaction could be
driven to near 100% efficiency by increasing the ratio of oligonucleotide to target RNA
(autorefFigureC-4B).
Because of the limitations of our system, we are unable to heat our samples for hy-
bridization. Therefore, we tested the performance of RNAseH cleavage after different
hybridization conditions. We tested a range of hybridization temperatures from 37◦C
to 95◦C and observed only slight changes, qualitatively, in the efficiency at the lower
hybridization temperatures (Figure C.4C). The binding of 2’Ome bases to RNA bases
is considerably stronger than RNA:RNA binding or DNA:RNA binding. Therefore,
the requirements for efficient hybridization may be reached even at physiological tem-
peratures (i.e. 37◦C). It is possible to compensate for the reduced efficiency at lower
temperatures by the addition of higher concentrations of oligo (Figure C.4D).
Figure C.4: RNAseH-mediated cleavage of in vitro transcribed RNA - (a) Two
RNAs, RNA5 and RNA8 are targeted via complementary 2’Ome/DNA hybrid oligonu-
cleotides. (b) Different ratios of oligo:target were tested for cleavage efficiency. (c) A range
of hybridization temperatures was tested to determine the effects of heating on proper hy-
bridization and subsequent cleavage. (d) Oligos were added at different ratios at different
hybridization temperatures.
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C.4.2.2 Ligation
RNAseH mediated cleavage is efficient and specific and results in RNA fragments with
known end sequences that have the appropriate 3’OH and 5’P that are necessary for
subsequent ligation. Following RNA cleavage, an oligo that bridges the pre-synaptic and
post-synaptic RNA barcodes must be annealed for ligation. Therefore, after RNAseH
cleavage, we purified the RNA by phenol:chloroform extraction and then performed
splint ligation with a splint that bridges the cut RNA5 and RNA8. Unfortunately,
we found that the targeting oligo remains bound at physiological temperatures via
the extensive 2’Ome:target-RNA base-pairing (Figure C.5A). When the splint oligo is
added and the mixture is heated for ideal-case annealing, the 2’O methyl oligo (which
was used for cutting but which is still present) competes with the splint oligo and
there is no ligation across the two RNA. The splint oligo in turn competes with the
2’O methyl for the re-ligation of the original molecule, and thus here we observe little
re-ligation (Figure C.5B). However, if the splint oligo is added without any heating,
2’O methyl oligo remains bound and directs the re-ligation of the original target RNA
(Figure C.5B).
Again, in our system, heat denaturation to remove the 2’Ome/DNA oligo from the
cleavage reaction is not possible because of potential dissociation of the RNA/protein
complexes. Moreover, heat denaturation and cooling in the presence of both the splint
and cleavage-directing oligos causes competition for annealing and lowers the splint
efficiency – higher concentrations of the splint will inhibit the reaction due to each
RNA molecule annealing to a separate splint (Figure C.5B).
This problem is primarily an issue for the acceptor (RNA5) because here, the splint
will not be able to displace the 2’Ome oligo. In the case of the donor (RNA8), the
splint should easily displace the 2’Ome oligo, as the 2’Ome only binds to 4 bases where
the splint will bind. Therefore, we wondered if RNAseH digestion could be performed
on the acceptor RNA with an oligo that would serve to direct both the digestion and
the subsequent ligation (Figure C.6A,B,C). The addition of the overhang to the oligo
resulted in ∼50% efficiency of cutting. The loss of efficiency could not be compensated
for easily with additional oligo. We therefore pursued a different method, based on
strand replacement.
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Figure C.5: Competition of targeting oligo and splint - (a) The target RNAs are
hybridized to the RNAseH-directing 2’Ome/DNA hybrid oligonucleotides. (b) RNAseH
nicks the RNA strand at a single dincucleotide. Heating in the presence of splint results
in competition between the splint and the 2’Ome oligo for binding to the target RNA.
Without heating, the splint cannot compete with the strong binding of the 2’Ome oligo
and re-ligation is possible. (c) Religation occurs in the presence of splint without heating.
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Figure C.6: Dual cleavage and splint oligo - (a) 2’Ome/DNA hybrid oligos are
annealed to target RNAs to direct cleavage. To the acceptor RNA (RNA5), an oligo
which serves to direct cleavage and subsequent ligation (via an overhang) is annealed). (b)
RNAseH digests both target RNAs. (c) The overhang from the acceptor (RNA5) targeting
oligo displaces the 2’Ome on the donor RNA (RNA8), splinting the two target RNAs for
ligation. (d) Comparison of the cutting efficiency using a normal targeting oligo (Oligo
481) and a targeting oligo with overhang (Oligo 533).
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C.4.2.3 Strand replacement
We took advantage of strand-replacement to replace the 2’Ome/DNA cleavage oli-
gos with a 2’Ome splint oligo. Strand replacement is a phenomena by which one
oligonucleotide will replace another oligonucleotide on a target strand if it is thermo-
dynamically favored (Figure C.7A). In this case, the splint oligo must also be 2’Ome
because of the thermodynamics associated with strand replacement (2’Ome binds to
RNA stronger than DNA binds to RNA). To make the reaction thermodynamically
favorable, the splint oligo binds to each RNA strand with higher binding energy than
the cleavage oligo. This is achieved by additional base-pairing, known as a toehold
(Figure C.7B) [Srinivas et al. 2013]. The splint will then replace the original oligo
through a random walk process (Figure C.7C,D). Once the splint oligonucleotide is
in place, the RNA strands can be ligated with either T4DNL or T4RNL2. We tested
strand displacement using a 2’Ome oligo (Figure C.7E,F). Briefly, an Alexa-488 labeled
oligo was annealed to RNA5 or RNA8 via heating to 95◦C and slow cooling to 37◦C.
Next, an Alexa-594 labeled oligo was added to the reaction and incubated at 37◦C for
0, 6, or 16 hours (Figure C.7E,F). We found the reaction to be slow, but efficient, with
nearly all of the Alexa-488 oligo displaced by the Alexa-594 oligo after 16 hours.
C.4.2.4 Strand replacement and ligation
Finally, after performing RNAseH digestion of the acceptor (RNA5) and donor (RNA8)
molecules, and strand replacement with the splint oligonucleotide, we attempted RNA
ligation. The entire reaction took place isothermally, at 37◦C so as not to disturb the
RNA/protein interaction. While we do observe a ligation product when the splint and
ligase are added, the reaction was inefficient Figure C.8. Moreover, because of the
slow reaction times associated with RNAseH digestion (4 hours), strand replacement
(16 hours), and ligation (4 hours), we worried about the stability of the complexes
on the beads. In addition, the presence of the 2’Ome oligo poses additional problems
on reverse transcription – the 2’Ome oligo cannot be displaced efficiently by reverse
transcriptase and cannot be enzymatically degraded. For these reasons, this method
was therefore ruled out.
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Figure C.7: Monitoring strand replacement with fluorescent oligos - (a) A green
oligo (Alexa488 labeled) is annealed to a target RNA strand (pink). A longer red oligo
(Alex594 labeled) is added to the tube. (b) The 594-oligo anneals to the unoccupied bases
(toehold). (c) The 488-oligo is replaced via a random walk process, initially a single base
at a time until (d) the 594-oligo has completely replaced the 488-oligo. (e) Time course
of strand replacement of a 488-oligo annealed to target RNA5, displaced by 594-oligo. (f)
Time course of strand replacement of a 488-oligo annealed to target RNA8, displaced by
594-oligo.
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Figure C.8: Strand replacement and ligation - (a) After digestion with RNAseH,
the 2’Ome targeting oligos were replaced with the splint and the target RNAs were ligated
together.
C.5 Catalytic nucleic acids
C.5.1 Ribozymes
Next, we tested Ribozymes – catalytic RNA molecules – for the cleavage/ligation of
the two RNA molecules. The L21 ribozyme from Tetrahymena [Zaug et al. 1988] has
been shown to mediate 3’ replacement through a cleavage/ligation reaction. This allows
for ligation of a ”donor” RNA transcript onto an acceptor RNA molecule by cleavage
of the acceptor and ligation at its 3’ end. Recently, a 5’ replacement ribozyme has
been described [Alexander et al. 2005] which performs cleavage of an acceptor RNA
molecule and subsequent ligation at its 5’ end. Generally, these ribozymes carry the
donor transcript in cis. We wondered if it would be possible to generate, via in vitro
transcription, a ”bifunctional” ribozyme by concatenating the 3’ replacement and 5’
replacement ribozymes, that would ligate two RNA molecules when added in trans
(Figure C.9).
Because stoichiometry is crucial (see subsection C.2.2) the ribozyme must be added
in equimolar concentration to the two target RNAs to be joined. Unfortunately, how-
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Figure C.9: Bifunctional ribozymes for ligation - A bifunctional ribozyme composed
of the concatenation of a 3’ L21 ribozyme and a mutant 5’ replacement pCarinii Ribozyme,
could in theory direct two transplicing reactions resulting in the ligation of two target RNA
molecules.
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ever, these ribozymes are inefficient. Successful splicing (even under best conditions)
requires many fold excess of ribozyme relative to the target. In addition, the ribozymes
require a high concentration of Mg for catalytic activity. Mg is a potent non-specific
RNA endonuclease and may cause problems when dealing with small amounts of RNA.
For these reasons we have decided not to further pursue this method.
C.5.2 Deoxyribozymes
We then tested Deoxyribozymes, catalytic ssDNA molecules that mediate cleavage or
ligation reactions. We reasoned that we could build deoxyribozymes with binding
energies sufficient to cleave the RNA transcripts, but insufficient to remain bound
to either of the cleaved halves, such that the need for strand replacement would be
circumvented. We tested deoxyribozymes for cutting and ligating RNA and found these
reactions to be very inefficient compared to similar methods based on protein-mediated
RNA cutting (RNAseH) and ligation (T4 RNA ligase, T4 RNA ligase 2, T4 DNA
ligase). In addition, as with ribozymes, deoxyribozymes require high concentrations of
divalent cations (Mg, Mn, Zn, etc) that cause nonspecific cleavage of the target RNA.
Therefore we have not continued with this approach.
C.6 Joining by reverse transcription
C.6.1 Overlap extension reverse transcription
Two RNAs with complementary 3’ ends can prime RT off of each other resulting in
a joined RNA/DNA hybrid molecule (Figure C.10)A. This can then be amplified via
PCR resulting in a joined barcode pair. We observed that this reaction can indeed join
two RNA molecules in vitro (Figure C.10B). Interestingly we observed that RT can
proceed in the absence of a primer, when either of the RNA molecules is left unpaired
(Figure C.10B).
The method, however, has several important limitations. First, if the complemen-
tary region is not the extreme 3’ end of the RNA molecule (as is the case with PolII
transcripts containing polyA sequences), this cannot work. Precise trimming of the
sequence to the point of complementarity is difficult to achieve in practice – we tried
using Phi29 polymerase [Lagunavicius et al. 2009], ExoT, and a few other exonucleases
to achieve this, but none could trim to the exact spot of complementarity in a way that
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would allow subsequent RT. In addition, this method requires heating for the proper
annealing of the two RNAs – which will likely cause disruption of the protein:RNA
complex.
Figure C.10: Overlap reverse transcription - (a) Schematic of overlap RT joining.
(b) Overlap RT joins molecules in vitro.
C.6.2 dsDNA primed reverse transcription
We tested whether we could perform reverse transcription of both molecules from RT
primers that shared a complementary region and had been pre-annealed. In this case,
RT proceeds from each ssDNA region and thus joins the two barcodes. RNA can then
be degraded and the DNA barcode pair can be double stranded via 2nd strand synthesis
– sealing the nicks with ligase (conceptually similar to Gibson assembly [Gibson et al.
2009].
Unfortunately, we found that the secondary structure of the RNA allows reverse-
transcription even in the absence of any primers, consistent with previous reports [Feng
et al. 2012] This could perhaps be ameliorated by addition of an excess of RT primer –
as is done in typical reverse transcription reactions, or heating of the sample to reduce
secondary structure and increase primer binding. However, we are limited by the stoi-
chiometry of the molecules (see subsection C.2.2, and the requirement to maintain the
protein-RNA interaction. The addition of a DNA primer at an equimolar concentration
to the RNA is insufficient to prime reverse transcription preferentially from the DNA
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primer (as compared to from the RNA secondary structure) [Feng et al. 2012]. Finally,
this method may pose a higher risk of ”false positives” because the joined barcode pairs
rely only on the short stretch of complementarity at their center from the pre-annealed
DNA primer to maintain the correct association.
C.7 Discussion
We tried many unsuccessful RNA joining methods. However, with further optimization,
it may be possible to employ one of these methods for RNA barcode joining. RNAseH
digestion followed by splint ligation was the most promising of the methods. It may
be possible to engineer additional DNA nucleotides into the 2’Ome splint at strategic
locations to allow partial enzymatic digestion of the oligonucleotide, allowing release
from the target after cleavage – thereby circumventing the need for the slow strand
displacement reaction. For example, the introduction of dU, dispersed throughout the
2’Ome oligo should allow for cleavage of the 2’Ome oligo by Uracil-DNA Glycosylase.
However, the RNAseH cleavage reaction will need to be tested with this type of an
oligo to ensure that specificity is retained. Similar tricks could be employed in the
splint for its degradation following ligation, to allow uninhibited reverse transcription
to take place.
Additional methods which rely on overlap PCR may also allow efficient joining.
For example, reverse transcription using biotinylated primers, or in the presence of a
low-concentration of biotinylated nucleotides, would allow reverse transcription of the
RNA molecules such that they would be bound to the streptavidin beads close to their
original complex. Bridge overlap-PCR could then be used to fuse the two molecules
into a single nucleic acid string representing the barcode pair. If this were done under
dilute conditions on beads, it should allow for high-efficiency joining with low cross-over
(i.e. false negative) rates.
In the limit, this method is equivalent to the emulsion PCR reaction which we have
developed subsubsection 3.5.3.3, but is simpler in practice. Emulsion PCR requires the
formation of high volumes of uniform droplets – a time consuming, and limiting process
in practice. Methods that would permit the joining of RNA molecules without require
emulsification would drastically increase the throughput of the connectome sequencing
technique.
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C.8 Methods
C.8.1 Splint ligation
For splint ligation, oligonucleotides were annealed to RNA to be ligated by first mixing
at a ratio of 1:1.2:1.3 (Acceptor:Donor:Splint). EDTA was added to a final concentra-
tion of .1mM, and NaCl to a final concentration of 50mM. H2O was added to reach
a final volume of 5µL. The reaction was placed in a thermocycler and heated to 95◦C
for 5 min and then cooled slowly at a rate of -.1◦C/s until reaching 35◦C. To the an-
nealed product, 1µL of 10X ligase buffer (NEB), .5µL of RNAsin (Promega, 40U/µL),
1.5µL H2O, and 2µL Ligase (NEB – T4RNL2 or T4DNL) was added. The reaction
was incubated at 37◦ for 1 hour.
C.8.2 RNAseH digestion
The target RNA (3pmol) is incubated with 3.3pmol of 2’Ome oligonucleotide in the
presence of 100mM KCl and .1mM EDTA. H2O is added to a final volume of 13µL. The
mixture is heated in a thermocycler to the desired annealing temperature (ranging from
37◦ to 95◦) for 5 minutes and the cooled slowly at a rate of -.1◦C/s until reaching 35◦C.
To the annealed product, 5µL of RNAseH buffer (NEB), 1.5µL of RNAsin (Promega
40U/µL), .5µL DTT (100mM), 15µL of RNAseH (NEB, 5U/µL), and 10µL H2O is
added. The reaction is incubated at 37◦C for 4 hours.
C.8.3 Reverse transcription
All of the reverse transcription reactions were performed using SuperScript-III (Life
Technologies) according to the manufacturer’s instructions.
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Appendix D
Non-transgenic, cell-type specific
expression of Cre recombinase
D.1 Introduction
A central challenge in neuroscience is to understand how behavior arises from neural
circuits. Circuits in the brain consist of diverse neuronal subtypes and subpopula-
tions. Neurons have classically been distinguished on the basis of many characteristics,
including morphology, receptor expression, neurotransmitter, and connectivity. More
recently, neuronal subtypes have been defined by the selective expression of specific
genes. The ability to target gene expression to genetically-defined neuronal subtypes
provides a powerful tool for dissecting neural circuits. In Drosophila melanogaster,
thousands of cell-type specific transgenic lines are available, and have been invaluable
in unraveling the neuronal mechanisms underlying learning, development and behav-
ior [Jenett et al. 2012]. A growing number of cell-type specific mouse lines have also
become available. For example, the somatostatin (SOM) and parvalbumin (PV) tran-
scripts define functionally different subclasses of interneurons, and these interneuron
subpopulations may play different roles in circuit computation [Kvitsiani et al. 2013].
Our goal is to develop a broadly applicable method for conveniently manipulating the
expression of transgenes, including fluorescent proteins and optogenetic tools, in geneti-
cally defined neuronal populations in the brains of rats, primates and other mammalian
species.
We propose to develop a novel strategy for the expression of reporter genes in specific
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neuronal subtypes. Our strategy is based on the specific expression of either Cre or Flp
recombinase in specific neuronal cell-types. The expression of transgenes can then be
restricted to neurons that express the recombinase. However, unlike previous strategies
in which cell-type specific recombinase expression is achieved through the generation
of transgenic knock-in mice, our method can deliver both the recombinase and the
transgene via recombinant viruses. Thus our method can be applied in organisms in
which the potential for genetic manipulation is limited.
D.1.1 Current approaches
There are two main strategies for achieving cell-type specific gene expression in mam-
mals. It is important to note that we use the term “cell-type” to refer to any collection
of neurons defined by their shared expression of a particular gene. We do not mean
to imply that a cell-type defined by shared expression of a single gene corresponds to
a functional cell-type, although in some cases gene expression does correlate well with
neuronal function. The preferred strategy in mice is to make a “knock-in” – a mouse
in which the transgene is placed directly at the locus of an endogenous gene such as
SOM. With this approach, the expression of the transgene is driven directly from the
promoter of the endogenous gene, and therefore in principle – and often in practice –
recapitulates the expression pattern of the endogenous gene. However, there are at least
two important limitations of the knock-in approach. First, the only mammalian species
in which knock-ins are made routinely is the mouse. Although transgenic animals have
been generated in a variety of other species, including rats and even marmoset mon-
keys, in these animals the transgene inserts into a random place in the genome. New
methods, such as CRISPR [Cong et al. 2013, Mali et al. 2013], should allow for tar-
geted insertions across a varitey of species, but this method has not yet been employed
widely. The second limitation is practical. Even in mice the generation of such tar-
geted knock-ins is expensive, labor-intensive and slow. Furthermore, the maintenance
of large mouse colonies is expensive, and breeding up the crossed mice can take several
generations. Nevertheless, in spite of the challenges associated with generating and
maintaining knock-in mice, their tremendous utility has driven a growing number of
laboratories to switch at least partially to mice as their model organism.
The second strategy for driving transgene expression uses some reduced or “mini-
mal” form of the endogenous promoter. These strategies have the advantage that the
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transgene can be delivered virally, and therefore have the potential to work well in
mammalian species other than mice. However, mammalian promoters are often very
large, and the rules governing mammalian gene expression – i.e. how gene expression
depends on promotersremain poorly understood. One strategy has been to express a
transgene under the control of a “minimal” endogenous promoter – a promoter short
enough (<10 kb) to fit into a virus such as adeno-associated virus (AAV) or lentivirus.
Unfortunately, with some notable exceptions (e.g. hypocretin), this strategy typically
does not recapitulate the expression pattern of the endogenous gene. Another clever
strategy involves the use of short promoters from the puffer fish (Takifugu rubripes),
an organism with a much more compact genome in which the regulatory sequences
are shorter. Unfortunately, fugu promoters also failed to recapitulate mammalian ex-
pression patterns. Thus at present there is no general viral strategy for delivering
transgenes to genetically defined neuronal populations in mammals.
D.1.2 Ribozyme mediated trans-splicing
The ideal approach to achieving cell-type specific expression would combine the speci-
ficity of knock-in transgenics with the convenience of viral delivery. We propose to
develop such a technique based on ribozyme-mediated RNA trans-splicing. The key to
our approach is that instead of coupling expression of the transgene to the promoter
driving the endogenous gene (e.g. SOM) of interest, we move a step downstream, and
couple the translation of the transgene directly to the mRNA transcript encoding the
endogenous gene.
The core idea underlying our approach is to use ribozyme-mediated trans-splicing
to couple an mRNA encoding a recombinase such as Cre or Flp into the mRNA of
an endogenous gene such as somatostatin (SOM) (Figure D.1). The expression of the
recombinase can then be used to switch on expression of an exogenous transgene such
as GFP.
The trans-splicing ribozymes we propose to use are derived from the group I intron
from Tetrahymena thermophile, a catalytic RNA (or ribozyme) with the ability to
perform a cleavage-ligation reaction in the absence of proteins. Though its normal
activity is to splice itself out of an mRNA transcript (joining the preceding and following
segments into an uninterrupted transcript), it is possible to engineer the ribozyme to
trans-splice (join part of one “donor” transcript to another “target” transcript). The
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Figure D.1: Cell-type specific expression via trans-splicing - (a) A ribozyme is
constructed that consists of the Cre open reading frame (1 kb), the 1A sequence (66
bp), the trans-splicing ribozyme ( 400 bp), and the target antisense ( 100 bp). (b) The
ribozyme recognizes its target mRNA by complementary base pairing via the internal and
external guide sequences (IGS/EGS). (c) Trans-splicing occurs at a conserved G:U wobble
pair, ligating the donor transcript (Cre) to the acceptor target (SOM). (d) During protein
translation, the 2A peptide sequence causes cleavage of the protein, resulting in a functional
Cre protein and a cleaved SOM fragment.
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tetrahymena group I intron recognizes its target via a 6bp complementary sequence
known as the internal guide sequence (IGS). In the case of trans-splicing, the ribozyme
is engineered to contain an IGS complementary to the target gene at the desired splice
position. The only absolute requirement for splicing is an available uracil U in the
target mRNA. Additional specificity, and efficiency, is achieved by adding a second
complementary region (complementary to the target mRNA) known as the extended
guide sequence (EGS). After recognizing its target, the ribozyme cleaves the target
and ligates its cargo (the donor transcript, i.e. Cre) into the target transcript allowing
translation of donor mRNA into a functional protein.
Figure D.1 summarizes our strategy for using ribozyme-mediated trans-splicing to
couple an mRNA encoding a trans-activator into the mRNA of an endogenous target
gene such as the D2R receptor. To limit expression specifically to cells which express a
specific gene (i.e. SOM), we engineer the IGS and EGS sequences to target complemen-
tary sequences in the target mRNA transcript. The engineered ribozyme contains all of
the necessary coding sequence of Cre, but is missing a translational start codon. In the
absence of its target the ribozyme is expressed but its cargo is not translated; only upon
trans-splicing into the appropriate target does it acquire the start codon necessary for
translation. The resultant transcript includes a portion of the target gene, but this is
co-translationally cleaved at a virally-derived cis-acting hydrolase element (CHYSEL)
2a sequence included in the ribozyme. The result is that the expression of functional
trans-activator protein is conditional on the presence of a target mRNA.
Our strategy exploits the high specificity of ribozyme-mediated trans-splicing. The
specificity of trans-splicing has been demonstrated in experiments with Diphtheria toxin
A (DTA), a potent cytotoxin. When a trans-splicing ribozyme encoding DTA is tar-
geted to a particular target mRNA, cells expressing the target are killed with high
efficiency. This demonstrates the very high specificity of the trans-splicing reaction,
since even a very low level of off-target DTA trans-splicing would reduce cell viability.
Similarly, trans-splicing ribozymes have been engineered to correct mutations in beta
globulin transcripts responsible for sickle cell anemia and were able to discriminate
mRNAs differing by only a single base (wt vs. mutant). Thus trans-splicing has the
potential to provide the specificity needed to target a trans-activator in a cell-type
specific manner.
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Using a trans-activator allows breaking the problem of cell-type specific expression
of any gene into two components – cell-type specific trans-activator expression and
activator-dependent transgene expression. This has two advantages compared with
expressing the transgene directly from the locus of the endogenous gene (e.g. ex-
pressing GFP directly under the control of the SOM promoter). First, because the
trans-activator acts as a switch, the expression level of the transgene is decoupled from
the expression level of the endogenous gene (e.g. the D2R receptor) for which it is
a marker; expression of the trans-activator need only surpass the threshold sufficient
to activate the switch, and the expression of the transgene can be driven by a strong
promoter. Thus robust expression of a transgene coupled to a particular promoter can
be achieved, even in a neuron for which that promoter is only weakly active. The
second advantage is combinatorial: there is no need to generate and maintain a sepa-
rate transgenic mouse line for each combination of expression pattern and transgene,
since novel combinations can be produced by a single generation of breeding. Thus
N trans-activator-dependent transgenes and K recombinase knock-in mouse lines can
yield potentially NxK distinct mice. A substantial fraction of the > 104 gene expres-
sion patterns mapped in the Allen Brain Atlas are of potential interest, and there are a
growing number of useful transgenes, including variants of channelrhodopsin (ChR2),
halorhodopsin, GFP, etc; generating a new mouse for each possible combination is not
feasible. The use of trans-activators reduces the number of mice needed to at most
N +K instead of NxK.
Here, we employ recombinases as transactivators. Recombinases are enzymes which
catalyze the recombination of DNA between pairs of specific DNA sequences called
recombination sites. Several recombinases have been used in mammalian neurons, in-
cluding Cre and Flp. In both Cre and Flp, the recombination sites consist of specific
sequences of 34 nucleotides (called loxP and FRT sites, for Cre and Flp, respectively).
FRT and loxP sequences are very different; Cre does not act at FRT sites, nor does
Flp act at loxP sites. Recombinases can be used to render the expression of transgenes
of interest such as GFP or ChR2 conditional upon their presence by means of a tran-
scriptional “stop” cassette flanked by recombination sites placed between the promoter
and the transgene. The stop cassette prevents transgene expression unless it is excised
by the recombinase, in which case the transgene is expressed. Conditional expression
can also be achieved by flip-excision (FLEX). Transgene expression thus depends on
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the logical and of the recombinase and the appropriately engineered transgene with
properly placed recombination sites.
This approach has at least three potential advantages over the conventional trans-
genic mouse approach in which Cre is knocked in to a given genetic locus (e.g. the
D1R locus). First, generating a viral trans-splicing ribozyme is both faster (weeks
vs. months/years) and less expensive (<$3K vs. >$20K) than generating a knock-in
mouse. Second, with the viral approach, different subpopulations of neurons can be
targeted with different constructs in the same animal. For example, SOM expressing
neurons could be targeted with Cre/ChR2, whereas PV expressing neurons could be
targeted with Flp/halorhodopsin in the same animal, thereby enabling bi-directional
control of neuronal activity within a single brain region. Finally, this approach is not
limited to mice. Indeed, this strategy has the potential to transform research on model
organisms such as rats and primates by making it possible to target reporter genes to
specific neuronal subtypes in these preparations, and when combined with optogenetic
approaches may even be useful in the treatment of human neuropsychiatric diseases.
D.2 Results
D.2.1 Cre recombinase
Our approach requires that the Cre ORF not be translated until the Cre transcript
acquires a start codon (ATG) through trans-splicing. Unexpectedly, initial experiments
revealed that functional Cre protein was produced even in the absence of the first
ATG. We hypothesized that Cre translation was initiating downstream of the first
ATG, perhaps at the second ATG. To test this hypothesis we made a construct termed
CreM2S (Cre initiating on the second Methionine), which was an N-terminal truncation
of Cre, starting at the second in frame ATG. This construct failed to express a functional
Cre. Thus we reasoned that Cre translation is initiating somewhere between the first
and second ATG sequence. Using a binomial search algorithm, we designed a series of
truncated Cre sequences to identify a sequence in which the expression of functional
Cre required the addition of an ATG start codon (Figure D.2A). We co-transfected the
Cre variants into HEK293 cells with a reporter plasmid (Figure D.2B). The reporter
contains a constitutively active mCherry expression cassette, and a GFP expression
cassette that was dependent on the activity of Cre. We employed flow cytometry to
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measure the activity of Cre from transfected cells – measuring the fraction of mCherry+
cells that were also GFP+. Two truncations, CreM1.5 and CreM1.75, showed little or
no activity in the absence of a start codon but were fully active upon addition of an
in-frame ATG – CreM1.5S and CreM1.75S (Figure D.2C,D). We selected CreM1.75 for
all subsequent experiments.
D.2.2 Construction and testing of a SOM-targeting Ribozyme
We first attempted to target the somatostatin transcript with a ribozyme carrying the
CreM1.75 ORF as its 3’ donor transcript. A uridine towards the 5’ end of the SOM
transcript, in frame with the protein coding sequence, was chosen at random – 10U. A 9
nucleotide IGS sequence was designed flanking the target U, 10U, by 5 nucleotides in the
5’ direction and 3 nucleotides in the 3’ direction. In general, for detectable activity in
mammalian cells, ribozymes also require a 5-terminal extension – the extended guide
sequence (EGS) [Sullenger and Cech 1994]. Therefore, we added 105bp of sequence
complementary to the SOM mRNA at the 5’ end of the ribozyme IGS.
We tested this ribozyme construct via transient transfection into HEK293 cells,
with or without the target transcript. 48 hours after transfection, RNA was isolated
and subjected to RT-PCR to detect the spliced product (Figure D.3A). We detected the
trans-spliced transcript, Som-Cre, in samples where the target and ribozyme had been
co-trasnfected (Figure D.3B). Importantly, no product was detected in samples that
had been separately transfected with the Ribozyme or target and then mixed during
lysis (Figure D.3B), indicating that the trans-splicing reaction took place in vivo and
not during the biochemical manipulations performed in vitro for detection.
Having detected successful trans-splicing in vivo we next tested if the trans-spliced
Cre could mediate recombination on a co-transfected reporter (Figure D.2B). Unfortu-
nately, we found no difference in the Cre-dependent reporter expression with or without
the target RNA transcript. Moreover, the overall levels of Cre activity were extremely
low, perhaps suggesting inefficient splicing.
It is known that the specific uridine chosen on the target can influence splicing
efficiency. Although every uridine within the target RNA is a potential splice site, the
accessibility of the uridine, in theory, determine the efficiency of trans-splicing [Ayre
et al. 2002, Jones et al. 1996, Jones and Sullenger 1997]. Therefore, we set out to map
the most accesible uridines on the SOM transcript via an exhaustive in vitro screen.
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Figure D.2: Function of Cre truncations - (a) The first 87bp of Cre coding sequence
are shown, with the positions of the truncations denoted. (b) A reporter plasmid was
constructed such that transfection resulted in mCherry expressing cells. Exposure of the
plasmid removed a stop cassette between the mCherry open reading frame and the GFP
open reading frame. (c, d) Flow cytometry results for co-transfection of the reporter
plasmid and the Cre variant plasmids. (S) denotes addition of a Kozak-ATG.
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Figure D.3: Trans-splicing in vivo - (a) The ribozyme ligates the Cre transcript onto
the Som target transcript. The spliced product can be detected by RT-PCR with primers
that bind in the target (SOM) and cargo (Cre). (b) Trans-splicing is detected when target
and ribozyme are co-transfected.
D.2.3 Identification of efficient trans-splicing sites on target mRNA
In order to dertermine which uridines on the target transcripts (i.e. SOM, PV) are most
accessible for splicing, we used a uridine mapping strategy [Lan et al. 1998]. Briefly,
total RNA isolated from mouse brain was incubated with a ribozyme library containing
randomized internal guide sequence (IGS). Because the IGS is only 6 nucleotides, the
entire space – 46 = 4096 combinations – can be explored easily via DNA synthesis. The
trans-splicing products are amplified by RT-PCR with primers specific for the 5’end of
somatostatin and the and for CreM1.75 located at 3end of ribozyme. The amplified
splicing products were then Topo-cloned and sequenced to identify accessible uridines.
The uridine at position 446 of SOM mRNA appeared to be the most accessible, as 5 of
11 clones sequenced contained this splice site. Therefore we engineered the ribozyme,
aSOM-446Rz-CreM1.75 to contain the corresponding IGS to target the 446U on the
SOM mRNA.
D.2.4 Addition of an extended guide sequence
The IGS sets the region of the SOM transcript that can be targeted for additional
binding via an extended guide sequence. This sequence, the EGS, is important for
stabilizing the binding between the mRNA target and the ribozyme to permit efficient
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trans-splicing, and is particularly necessary in vivo [Kohler et al. 1999]. While the po-
sition of the EGS is set by the IGS, the optimal length must be empirically determined.
A series of ribozymes containing different lengths of the EGS (56bp, 96bp, 145bp) were
generated to identify the optimal length, but minimal differences in efficiency were de-
tected. It has previously been postulated that a longer EGS can result in non-specific
cleavage [Herschlag 1991] and may stimulate dsRNA mediated degradation pathways.
Therefore, in the absence of a detectable difference in efficiency, we choose the short-
est EGS sequence tested and constructed the ribozyme aSOM-446Rz56E-CreM1.75 for
further testing.
D.2.5 Trans-splicing in stable cell-lines
After the optimal ribozymes were identified, we next examined the efficiency and speci-
ficity of these ribozymes in vivo in mammalian cells (HEK293). Because the target
mRNA expression level could affect the efficiency of trans-splicing, we established sta-
ble cell lines expressing SOM to keep the expression at a constant level. To examine
the efficiency and specificity of trans-splicing, ribozymes were co-transfected with the
Cre-dependent reporter into either SOM- HEK cells or stable cell lines expressing SOM
(SOM+). The efficiency of ribozymes was determined by the percentage of cells express-
ing reporter genes in SOM+ cells, whereas the specificity of ribozymes was determined
by comparing the percentage difference of reporter gene expression between SOM+ and
SOM- cells. The percentage of cells expressing reporter genes was quantified by flow
cytometry. This SOM targeting ribozyme induced expression in 0.4
D.3 Discussion
Our results are preliminary, but highlight the possibility of using a new approach to
induce reporter gene expression in specific cell types expressing a particular gene via
ribozyme-mediated trans-splicing. Further work will be needed to increase the efficiency
of the reaction, without sacrificing specificity.
Simple theoretical considerations clarify the challenge of achieving specificity and
efficiency. Trans-splicing is a bimolecular reaction between the ribozyme and a target
mRNA, the result of which is the trans-spliced product (in our case a recombinase
with a start codon) and an RNA fragment. To first order, the amount of trans-spliced
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product depends on (1) the concentration (i.e. expression level) of ribozyme; (2) the
concentration (i.e. expression level) of mRNA; and (3) the probability with which
splicing occurs when the ribozyme encounters a given mRNA – ignoring here the other
potentially important determinants, such as the cellular localization of RNA. Specificity
is defined as the concentration of trans-spliced product (recombinase) resulting from
encounters with the target mRNA, compared with the concentration of recombinase
resulting from encounters with all other (off-target) mRNAs in the cell. Efficiency is
defined by the fraction of ribozyme that successfully undergoes trans-splicing. Since we
have no control over the concentration of either the target mRNA or of all other po-
tential off-target mRNAs – these are defined by their expression levels in each neuronal
subtype – the opportunities for engineering are limited to (1) the expression level of the
ribozyme and (3) the probability of splicing given an encounter between the ribozyme
and an mRNA.
The expression level of the ribozyme, like that of any expressed RNA, is determined
in large part by the promoter. As suggested by the simple model above, increasing the
concentration of the ribozyme leads to increased trans-splicing, but may come at the
cost of higher off-target (non-specific) splicing. Using strong promoters such as CAGS,
it is possible to achieve high levels of expression in the brain with AAV. Moreover,
titration of expression levels can be achieved with inducible systems such as the Tet-off
system in which doxycycline delivered intraperitoneally is used to reduce the expression
of ribozyme. In this way the expression of the ribozyme can be tuned to a particular
target without making new constructs under different promoters.
Manipulation of the probability of splicing is achieved by engineering of the IGS
and EGS. We optimized the IGS sequence using an in vitro screen, which may highlight
different accesibility than exists in vivo. Repetition of this screen in vivo should aid
in determining the most accessible uridines on the mRNA target in a more relevant
context.
Finally, efficiency is likely a product of expression levels and time. Given more
time, the ribozyme should convert more target mRNA to spliced product, resulting
in accumulated protein levels of Cre recombinase, and thus reporter gene. In our
experiments in HEK cells, it was difficult to propagate the cells for more than 72 or 96
hours. Perhaps longer expression times will increase the efficiency of the reaction.
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This method builds on established ribozyme trans-splicing technology to achieve
cell-specific expression of transgenes without the need to generate a knock-in trans-
genic. Improvements to the technique may allow for multiplexed cell-type specific
targeting across a variety of organisms with the simplicity and cost-effectiveness of a
viral infection.
D.4 Materials and Methods
D.4.1 Trans-splicing
In vitro trans-splicing was performed as described [Jones et al. 1997].
D.4.2 Flow Cytometry
Immediately before flow cytometry, cells are washed 2X with PBS, trypsinized, resus-
pended in DMEM and spun down for collection. The cell pellet is washed once by
resuspending in 1mL of PBS and spun down for collection. The pellet is resuspended
in 4% PFA and fixed at 25◦C for 15 min. Cells are spun down, resuspended in PBS, and
filtered through a cell strainer. Flow cytometry was performed on the LSR-II (BD).
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Appendix E
Sparse transcriptome profiling
via nonspecific trans-splicing
E.1 Introduction
Heterogeneity plays an important role in the proper and abnormal functioning of many
biological systems from neural computation to tumor development. Methods of prob-
ing heterogeneity in cellular expression have been limited by technical challenges (i.e.
sorting and separating individual cells, isolation of sufficient quantity and quality RNA
from individual cells, etc). A method for rapidly profiling large numbers of cells, while
retaining identities of individuals, within a population would be a major advance. Here
we describe a novel method for tagging transcripts within individual cells of a hetero-
geneous population by hijacking the cellular splicing machinery.
Previously, researchers have attempted to use the spliceosome to splice RNA molecules
in trans. This technique, known as Spliceosome Mediated RNA Trans-splicing (SMRT),
has the potential to target individual RNA molecules with the purpose of repairing mu-
tated transcripts and/or delivering targeted therapeutics (i.e. cytotoxins to kill can-
cerous cells). However, the technique is plagued by promiscuity of the splicing events
– expression of an intron sequence followed by an exon causes transsplicing to occur
between the artificial exon and many cellular transcripts [Kikumori et al. 2001]. We rea-
soned that, combined with cellular barcoding this lack of specificity could be exploited
to stochastically tag actively transcribed mRNA via SMRT.
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In the mammalian genome, many mRNA molecules are initially transcribed as pre-
mRNA with the coding sequence interrupted by one or more intron (Figure E.1A).
Overexpression of an intron-Barcode (Figure E.1B) causes replacement of the 3 exon of
a target mRNA molecule with a unique cell-identifying barcode via trans-splicing (Fig-
ure E.1C). In this way, sparse expression profiles of individual cells within a population
can be identified by high-throuhput sequencing.
Figure E.1: Tagging cellular trancripts via promiscuous trans-splicing - (a) A
typical pre-mRNA containing several exons and introns. (b) Adenovirus IE gene introns
fused directly to a barcode are exogenously expressed at high levels. (c) The spliceosome
catalyzes the trans-splicing of the barcode into endogenous transcripts, thereby tagging
endogenous transcripts with a cell-identifying barcode.
E.2 Results
We tested whether SMRT-mediated barcode tagging of mRNA transcripts can occur in
vivo in mammalian cells. We separately co-transfected HEK293 cells with INTRON-
BC1 and GFP (with an intron) or INTRON-BC2 and mouse SST (with an intron) and
harvested cells 48 hours after transfection. The cells were mixed together before lysis
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to emulate a heterogenous population. RNA was then Trizol extracted, reverse tran-
scribed into cDNA, and PCR amplified adding adapters for Illumina high-throughput
sequencing. We expected to find many instances of the GFP transcript tagged with
BC1 and SST tagged with BC2 but not the opposite (GFP tagged with BC2 or SST
tagged with BC1). Using bowtie2 we mapped reads to GFP and SST and found that
4046 reads of BC1 aligned to GFP, while only 10 reads aligned to SST (as expected).
For BC2 we found 5170 reads map to SST and only 3 reads to GFP (Figure E.2) Addi-
tional analysis showed that splicing occured to many types of RNA, the largest target
of which was mRNA (Figure E.3a). The splicing occured to transcripts throughout
the genome (Figure E.3b) and, in many cases, occurred at sites near an intron (Fig-
ure E.3c). There was a high correspondence between cellular transcripts tagged in BC1
and BC2 and, encouragingly, among the most abundant transcripts were some that
were cell-type specific (Table 1).
E.3 Discussion
The results shown here are preliminary, but highlight the possibility of using this simple
approach for sparse sampling of many cellular transciption profiles, with single cell
resolution.
At present, it is unclear if the sparse transcript profiles obtained via this method
will be sufficient to identify cell-types. Typical cells contain as many as 100,000 mRNA
molecules (Islam et al. 2011), but most of these transcripts are not distinct. For-
tunately, genes that are differentially expressed between neuron types are generally
among the most abundant transcripts (Mellen et al. 2012). That is not to suggest that
the transcripts that are most informative for cell-type identification are necessarily the
same transcripts that cause differentiation. For example, transcription factorswhich
drive gene expression and largely define the cell’s transcriptomeare expressed at low
levels. While it may not be possible to identify cell-types de novo in this way, it should
be possible to use this sparse information to ”call” cell-types based on a reference set
of known transcription profiles.
In the context of the connectome project (see chapter 3), cellular transcripts tagged
with the same barcodes used for circuit mapping may allow integration of cell-type
information into the connectivity matrix.
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Figure E.2: Barcode trans-splicing to defined transcripts - (a) A splicing cassette
(Intron-BC1) was co-transfected with GFP-INTRON-GFP in one population of cells and
a splicing cassette (Intron-BC2) was co-transfected with SOM-Intron-SOM in a separate
population of cells. (b) Trans-splicing labels random transcripts with BC1 or BC2, includ-
ing the co-transfected transcripts GFP and SOM, respectively. (c) The cells are pooled and
lysed for RT-PCR and the barcode splicing results to the control transcripts are shown.
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Figure E.3: Barcode trans-splicing genome wide - (a) The barcode transplices into
a variety of RNA molecules (b) across the genome. (c) Many times, the splicing event
occurs near a defined intron.
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E.4 Materials and Methods
E.4.1 Design of splicing cassette
The splicing donor consists of the Adeno Virus immediate early intron followed by a
3 splice site (5’-CAG-3’), although it is expected that any intron will work for this
purpose. The sequence of the intron is given below. Immediately following the 3
splice site is a unique barcode sequence. This barcode sequence can be a static single
barcode, or can consist of a high-diversity barcode library generated by a variety of
means including but not limited to shotgun cloning of oligonucleotides, in vivo barcode
generation by a recombinase, etc. Following the barcode, additional known sequence
elements are present to aid in reverse transcription, and high-throughput sequencing
library preparation.
ADENO VIRUS IE Intron: GGCCTACTTATCCTGTCCCTTTTTTTTCCACAG
E.4.2 Mapping and analysis
Mapping to the genome or to the artificial transcripts GFP and SOM (which were sep-
arately transfected) was performed using Bowtie2. Additional analysis was performed
in Galaxy. All genome browser plots were generated from the UCSC genome browser.
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Appendix F
Color by number Brainbow
F.1 Abstract
Traditional large-scale projection mapping techniques group large popula-
tions of neurons together as a single functional unit. Heterogeneity of pro-
jection targets, however, exists even within highly spatially restricted cell
populations. Brain-wide mapping of projection patterns with single-neuron
resolution will allow for the stratification of cells based on their downstream
targets – a characteristic which is likely to correlate with other functional
properties. We have developed a method that marries DNA barcoding of
individual neurons (BOINC) with readout via fluorescent in situ sequencing
(FISSEQ) to trace the projections of several hundred neurons with single-
neuron resolution. At scale, this method – effectively an infinite-color, or
digital, Brainbow – will allow brain-wide, multiplexed tracing of millions
of neurons across dozens of injection sites, within a single brain. High-
resolution reconstructions of single-neuron projections will have a profound
impact on our ability to dissect neural circuits.
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The cortex has a striking laminar organization. To a first approximation, excitatory
cells in each layer have characteristic morphological and physiological properties. They
also make specific local and long-range connections, suggesting that excitatory neurons
within a layer constitute a class – inhibitory neurons are classified separately. According
to the “canonical cortical circuit” hypothesis [Douglas and Martin 2004, Oviedo et al.
2010], information from the thalamus flows from cortical layer 4 to 2/3 to 5 and thence
to other cortical and subcortical targets, with thalamic feedback arising in layer 6. This
hypothesis, though useful, is based on a highly simplified model of neocortex as discrete
modules defined by layer identity. In reality, cellular heterogeneity within each layer
may be critical in establishing the functional diversity of computation both within
and across cortical areas. For example, two classes of projection neurons in mouse
layer 5b can be distinguished by distinct target regions (bilateral striatum only vs.
ipsilateral striatum and subcortical structures), distinct physiology (single vs. bursting
action potentials) and distinct morphology (small vs. large cell bodies) [Hooks et al.
2013]. However, these cells are not yet separable in most tracing experiments due to
their juxtaposition. Similarly, some neurons in mouse barrel cortex project to primary
motor cortex, whereas others project to secondary somatosensory cortex [Yamashita
et al. 2013] likely with profound functional consequences.
Traditional projection tracing techniques rely on viral expression of fluorescent pro-
teins within a defined group of cells (spatially, genetically, or both). These techniques
have revealed bulk projection patterns, which have been important in forming our
current understanding of neural circuit function [Oh et al. 2014]. However, these tech-
niques lack single-cell resolution, which is - in many cases [Hooks et al. 2013, Yamashita
et al. 2013] – critical for understanding the functional differences between juxtaposed
cells. Brainbow [Livet et al. 2007], permits the tracing of single-cells with relatively
high-throughput via the combinatorial expression of a set of fluorophores – yielding a
palette of about a hundred unique colors. Here, we expand the potential of Brainbow
for neuronal tracing, by employing unique nucleic acid sequences, rather than unique
colors. The result is an infinite expansion of Brainbow. A string of 30 nucleotides yields
430 = 1018 unique barcode sequences far more than enough to label every one of the
roughly 108 neurons in the mouse brain [Roth and Dicke 2005].
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The method we have developed, fluorescent in situ barcoding of individual neural con-
nections (FIBOINC), utilizes fluorescent in situ sequencing (FISSEQ) [Lee et al. 2014]
to read individual RNA barcode molecules at sites distant from the cell soma. Briefly,
RNA barcodes are tethered within the axonal compartment via modifications to the
pre-synaptic protein Neurexin1B (Figure F.1A). The brain is thinly sliced and sub-
jected to FISSEQ, which involves reverse transcription of the mRNA barcode into
cDNA, circularization of the cDNA molecules via single-strand DNA ligation, and am-
plification of the cDNA by rolling circle amplification to yield rolling circle colonies –
rolonies (Figure F.1B). The resulting rolonies are sequenced via the sequential imaging
of oligonucleotide-conjugated fluorophores during sequencing-by-ligation (Figure F.1C)
to reconstruct cell-identifying barcodes for axonal tracing (Figure F.1D) [Lee et al.
2014].
In order to ensure high-concentrations of RNA barcodes in distant processes, we
employed the pre-synaptic protein Neurexin1B (Nrx1B), which has been modified to
bind RNA barcodes for tethering in the axonal compartment (Figure 2A). This was
accomplished via the fusion of the 22 amino acid RNA binding protein λN to the cyto-
plasmic domain of Nrx1B, and the engineering of RNA barcodes to contain four repeats
of the λN cognate RNA binding motif, the 15 nucleotide boxB hairpin. This interac-
tion was previously shown, in HEK cells, to be specific and efficient (see chapter 3,
Figure 3.9A,D). During the first step of FISSEQ, any fluorescence is quenched, and
does not interfere with the subsequent imaging required for sequencing.
We packaged the two components (protein and RNA barcode) into a single Sindbis
vector, which allows high expression levels and rapid expression timing. A barcode
library [Gerlach et al. 2013, Golden et al. 1995, Lu et al. 2011], reaching diversities
of > 1M – was produced to allow the unique labeling of individual cells. We intro-
duced the barcoded virus into the left auditory cortex. The virus expresses a unique
barcode in each cell as well as the modified RNA-binding Nrx1B protein. Forty-eight
hours after infection, the brain was fixed before thinly sectioning (10um) on a cryostat
using the tape-transfer (Cryojane, Leica) method (Figure F.2A). Slices were placed
individually on cover-glass for FISSEQ. Imaging of rolonies detected the barcode RNA
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Figure F.1: Overview of the FISSEQ neuronal tracing - (a) An RNA barcode
transcript and an engineered pre-synaptic protein are expressed via viral transduction. The
presynaptic protein has been modified to bind to the RNA barcode, thereby preferentially
localizing the barcode transcripts to the axonal compartment. (b) The barcode mRNA
is reverse transcribed into cDNA, the cDNA is circularized, and the circularized cDNA is
amplified by rolling circle to form a FISSEQ ”rolony” in situ. (c) Rolonies are sequenced
via sequential imaging of oligo-conjugated fluorophores during sequencing-by-ligation. (d)
Barcodes are identified by sequence, allowing axons to be unambiguously traced throughout
the slice irregardless of the distance from the soma.
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(Figure F.2B), which had traveled throughout the slice, with many rolonies found dis-
tant from the injection site (Figure F.2C). Little labeling was detected in a non-injected
slice (Figure F.3). The labeling of rolonies probing for circularized DNA is equivalent
to tracing of a single fluorophore. We are currently in the process of sequencing and
analyzing data from several slices for the long-range tracing of neuronal processes.
In addition to barcode sequencing, FISSEQ has the capability to capture and se-
quence endogenous transcripts within a cell. This capability, when combined with
FIBOINC, will allow for simultaneous tracing of projections (or even connectivity, see
subsection 4.4.1) and cell-type identification. We sliced and sequenced a wild-type
brain slice to determine the transcription profile in a region of the auditory cortex.
Briefly, transcripts were fixed, reverse transcribed, and amplified to form rolonies (Fig-
ure F.4A) which were sequenced by sequential cycles of ligation (Figure F.4B). After
mapping to the mouse genome, we observed ∼ 60,000 rolonies – of which 20,000 mapped
to an mRNA sequence (the remaining derived from rRNA) – throughout the slice. Im-
portantly, many of the most abundant genes are neuron-specific. We are currently
analyzing the data to determine the extent to which gradients of expression exist in
this region of the brain.
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Figure F.2: Barcode FISSEQ in a coronal brain slice - (a) A typical cryo-slice
using the tape-transfer system. (b) Rolony imaging in a single slice after rolling circle
amplification of barcoded RNA transcripts. (c) Zoom-in on rolonies distant from the
injection site (subcortical).
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Table F.1: FISSEQ gene hits from coronal mouse brain sample
Gene Read Count
Rn28s1 9588
Rn45s 6495
Rn45s 846
Lars2 556
Malat1 467
Gm20594 381
Chrna4 210
C2cd5 181
Habp2 151
Rn28s1 151
Meg3 141
Rn18s 138
Mgmt 117
Rn18s 117
LOC102638644 102
Rn45s 94
Esrrg 93
Fut11 91
Slc1a2 86
Atp1a3 73
Gene Read Count
Camk2a 68
Cmip 68
Nf1 66
Lars2 61
Calm2 60
Calcoco2 59
Map1b 59
Pnck 59
Ncf2 58
Synj2bp 57
Itsn1 56
LOC102635337 53
Sparcl1 53
Atp1b1 52
Ghrl 51
Top1mt 51
Kcnq1ot1 49
LOC102639444 47
Calca 45
Calm1 44
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Figure F.3: Negative control - unbarcoded slice after FISSEQ -
F.4 Discussion
This method, in its current form, can be applied to several specific brain regions to track
innervations from a relatively small (∼100s) population of barcoded cells. However, the
method can be easily scaled to trace the projection patterns of orders of magnitude more
cells throughout the entire brain while maintaining single-cell resolution. Transgenic
techniques, combined with an in vivo barcoding scheme [Peikon et al. 2014] will allow
for scaling this technology to mapping the projection patterns of all cells within a single
brain.
The projection map alone will likely be insufficient for a full understanding of neu-
ronal circuit architecture and/or function. However, a projection map will provide
a framework for disentangling the heterogeneity of brain areas, testing the roles of
important upstream/downstream brain areas for a given region of interest, and/or in-
tegrating knowledge of other cellular measures such as physiological properties and/or
transcription profile (Figure F.4) [Marblestone et al. 2014] within a single specimen.
Improvements to FISSEQ will increase the speed and affordability of this technique, as
has been the case for other DNA sequencing platforms.
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Figure F.4: FISSEQ of endogenous transcripts in a coronal slice - (a) Rolonies
probed with a fluoroescent oligonucleotide. (b) Rolonies after one cycle of sequencing-by-
ligation. Each color in colorspace is later converted to bases. (c) Rolonies which mapped
to the mouse genome.
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F.5.1 Injections
Stereotactic injections of barcoded Sindbis virus were performed to introduce the com-
ponents into the brain. All injections were performed in 5-week old male CBA/CaJ
mice in left auditory cortex or bilatterally under anesthesia (ketamine medetomidine).
Following injections, mice were returned to their cages for 48 hours before sacrificing.
F.5.2 Cryoslicing
Brains were prepared for cryoslicing as previously described [Pinskiy et al. 2013]. Mice
were sacrificed 48 hours post-infection and the brain was fixed via intracardial perfusion
with cold saline for 5 minutes followed by cold 4% paraformaldehyde (PFA) for 10
minutes. Brains were removed and post-fixed overnight at 4◦C in 4% PFA with 10%
sucrose. The following day, the brain was placed in PBS + 20% sucrose for 24 hours
at 4◦C. Brains were flash frozen into cubes of NEG50 (Richard-Allan Scientific) and
then sliced on a cryostat (Leica) at a thickness of 10µm. Slices were transferred to
cover-glass coated with Solution A and Solution B (Leica CryoJane) by a tape-transfer
system (Leica) and affixed to the slide by brief UV curing (Leica).
F.5.3 FISSEQ
FISSEQ was performed as previously described [Lee et al. 2014].
F.5.3.1 FISSEQ of endogenous transcripts
A 200 uL mixture containing 4,000U M-MuLV reverse transcriptase (Enzymatics),
250µM dNTP (Enzymatics), 40µM aminoallyl dUTP(Anaspec), 50U RNase inhibitor
(Enzymatics), and 100 pmol tagged random hexamers (/5PhosTCTCGGGAACGCT-
GAAGANNNNNN), prepared on ice is added to cells at 25◦C for 10 minutes. The con-
centration of aminoallyl dUTP can vary depending the cell type and the application.
Generally, a high incorporation rate of aminoallyl dUTP results in better cross-linking
and reduced cDNA diffusion but a lower amplicon density. The sample is then incu-
bated overnight in a humidified 37◦C chamber. The sample is washed using 1X PBS
and cross-linked using BS(PEG)9 (Thermo Scientific), diluted to 50mM in PBS, for 1
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hour at 25◦C. 1M Tris (G Biosciences) is added to quench the reaction for 30 minutes at
25◦C. A mixture of DNase-free RNases (Roche Diagnostics) and RNase H (Enzymatics)
is added to degrade residual RNA for 1 hour at 37◦C. A 100µL circularization reaction
mixture (1X reaction buffer, 2.5mM MnCl2, 1M Betaine and 5µL CircLigase II from Il-
lumina/Epicentre) is then added to the sample well and incubated at 60◦C for 2 hours.
After circularization, the sample is washed using H2O and incubated with a 200µL
mixture containing 0.1µM rolling circle amplification primer (TCTTCAGCGTTCC-
CGA*G*A from IDT) in 2X SSC and 30% formamide for 15 minutes at 60◦C. The
sample is washed using 2X SSC, and a 200µL amplification mixture containing 500U
Phi29 DNA polymerase (Enzymatics), 250µM dNTP, and 40µM aminoallyl dUTP is
added. The sample is incubated in a dry 30◦C chamber overnight and cross-linked
using BS(PEG)9 diluted to 50mM in PBS for 1 hour at 25◦C. After a rinse with PBS,
1M Tris is added to quench the reaction for 30 minutes. At this point, the sample can
be stored in nuclease-free 1X PBS at 4◦C.
Sequencing reactions, imaging, and analysis was performed as described [Lee et al.
2014].
F.5.3.2 FISSEQ of barcode transcripts
The FISSEQ reaction is identical to the above, except that a gene specific primer
(/5PhosTCTCGGGAACGCTGAAGA-GGAAAGTTGGTATAAGACAAAAGTG) is used
for reverse transcription.
F.5.3.3 FISSEQ Barcode RNA sequence
The FISSEQ RNA coding sequence is flanked on either side by a NotI restriction site
and a MluI restriction site for barcode cloning. The intervening sequence contains: 5’
FISSEQ Universal Sequence-Barcode-3’ FISSEQ Universal.
DNA SEQUENCE:
ACGCGTGCCTGGAGCAATTCCACAACACNNNNNNNNNNNNNNNG
TGCAATCACTTTTGTCTTATACCAACTTTCCGCGGCCGC
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